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SUMMARY
In this thesis the psychosocial morbidity of treatment for breast 
cancer —  in particular, adjuvant chemotherapy and radiotherapy 
after mastectomy —  is examined. However, factors other than 
postoperative treatment which contribute to morbidity are 
considered, and the opportunity is taken to compare different ways 
of measuring psychosocial morbidity.
A relationship between psychosocial morbidity and breast cancer 
has long been recognised, but only recently has it been the 
subject of reliable, systematic investigation. Reliable studies 
conducted shortly before work for this thesis began showed that 
prior to breast biopsy and following mastectomy, a substantial 
minority of patients —  perhaps as many as a quarter —  
experienced psychological morbidity of clinical degree. However, 
it was not clear how much of the pre-operative morbidity was 
specific to impending surgery for breast disease. Also, it had 
been suggested that post-operative radiotherapy increased 
psychological morbidity after mastectomy, but there were no 
quantitative data to confirm this belief. Hence the precise 
contribution of mastectomy and radiotherapy to post-operative 
morbidity was uncertain. There was little information in the 
literature on what factors other than treatment influenced 
liability to morbidity. The psychosocial effects of adjuvant 
chemotherapy after mastectomy had not been reported.
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Using reliable observer and self rating scales, answers to the 
following main questions were sought.
(1) Does psychosocial morbidity prior to breast biopsy exceed that 
prior to routine surgery? What factors independently predict 
morbidity?
(2) What is the extent of psychosocial morbidity in patients 
allocated to adjuvant chemotherapy, and how does it compare with 
the morbidity in patients receiving post-operative radiotherapy?
(3) Does post-operative radiotherapy cause more psychosocial 
morbidity than no further treatment?
(H) What is the extent of morbidity in a sample of patients with 
"early” breast cancer receiving several types of treatment, and 
what factors independently predict morbidity?
(5) Compared with observer scales, how well do self rating scales 
perform in patients treated for breast cancer?
The results were respectively as follows.
(I) Psychosocial morbidity was compared in 91 patients awaiting 
breast biopsy and 30 patients awaiting elective cholecystectomy. 
The breast biopsy group was subdivided into patients proving to 
have cancer and those with benign disease. Contrary to 
expectation, the highest levels of morbidity occurred in patients 
with benign disease. Such patients may be a self-selected, 
anxiety-prone subset of all patients with benign disease. Patients
111
with cancer had levels of anxiety and depression similar to those 
in the cholecystectomy control group. However, subdivision of the 
cancer group by age showed there was a marked excess of anxiety in 
cancer patients aged 4-5 or less. Independent predictors of 
morbidity in the cancer group were age and a previous psychiatric 
history.
(2) Psychosocial morbidity was compared over two years in 74- 
patients with stage II breast cancer randomized to three forms of 
treatment after mastectomy: a three-week course of post-operative 
radiotherapy; a year of adjuvant chemotherapy (cyclophosphamide, 
methotrexate and 5-fluorouracil —  CMF); and radiotherapy followed 
by CMF. At one and three months after surgery, there were no 
significant differences among the groups. At six months, in the 
groups allocated to chemotherapy, there was a significant excess 
of social morbidity, and several patients were subject to 
conditioned reflex nausea and vomiting. At one year, the patients 
allocated to chemotherapy (alone or after radiotherapy) showed 
significant excesses of depression, anxiety and social dysfunction 
compared with those treated with radiotherapy alone. Conditioned 
reflex symptoms increased markedly in the second six months of 
chemotherapy and persisted for up to a year thereafter.
Thus adjuvant chemotherapy had its main psychological impact 
during the second six months of treatment. Much of this morbidity 
could be prevented, without compromising survival, if courses of 
treatment were restricted to six months.
(3) Psychosocial morbidity was compared in 4-7 patients receiving 
post-operative radiotherapy and 39 receiving no further treatment
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after mastectomy. One month after surgery, there were no 
significant differences in morbidity between the two groups; 
knowledge of impending radiotherapy did not seem to increase 
emotional distress. At three months, there were significant 
excesses of somatic symptoms and social dysfunction in patients 
who had completed radiotherapy. At six months, a significant 
excess of somatic symptoms persisted in the radiotherapy group. Up 
to half of these patients found that the treatment was very 
unpleasant. However, in the year after surgery there was never a 
significant excess of depression or anxiety in the radiotherapy 
group. Radiotherapy sometimes provoked anxiety, but some patients 
seemed reassured by the fact of receiving further treatment and 
having regular contact with the clinic staff. Patients on no 
further treatment did not have the opportunity to be reassured in 
this way.
(H) Psychosocial morbidity was measured over two years in 90 
patients with stage I or II breast cancer. Depression and anxiety 
of clinical degree were found to be less frequent than in previous 
studies, affecting around 10% of patients rather than around 20%. 
However, patients aged under 50 showed higher morbidity compared 
with those aged 50 or above, and compared with matched control 
subjects with benign disease. The main independent predictors of 
morbidity at one year after surgery were age, neuroticism, 
emotional distress one month after surgery, and treatment with 
chemotherapy. Together, these predictors explained about a third 
of the variance in psychological morbidity; further work is needed 
to define more precisely those patients at risk.
(5) When compared with observer ratings, the principal self rating
16
scales used in this study, namely the general health questionnaire 
and the Leeds depression and anxiety scales, were found to be 
valid measures of psychosocial morbidity in patients receiving 
treatment for breast cancer. They would probably be valid for 
early cancers in other sites, and provide useful and economic 
measures of morbidity.
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PREFACE
A relationship between psychosocial morbidity and breast cancer 
has long been recognised, but only recently has it been the 
subject of reliable, systematic investigation. Reliable studies 
conducted shortly before work for this thesis began showed that 
prior to breast biopsy and following mastectomy, a substantial 
minority of patients —  perhaps as many as a quarter —  
experienced psychological morbidity of clinical degree. However, 
it was not clear how much of the pre-operative morbidity was 
specific to impending surgery for breast disease. Also, it had 
been suggested that post-operative radiotherapy increased 
psychological morbidity after mastectomy, but there were no 
quantitative data to confirm this belief. Hence the precise 
contribution of mastectomy and radiotherapy to post-operative 
morbidity was uncertain. There was little information in the 
literature on what factors other than treatment influenced 
liability to morbidity. The psychosocial effects of adjuvant 
chemotherapy after mastectomy had not been reported.
Using reliable observer and self rating scales, an attempt is made 
in this thesis to answer the following main questions.
(1) Does psychosocial morbidity prior to breast biopsy exceed that 
prior to routine surgery? What factors independently predict 
morbidity?
(2) What is the extent of psychosocial morbidity in patients 
allocated to adjuvant chemotherapy, and how does it compare with 
the morbidity in patients receiving post-operative radiotherapy?
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(3) Does post-operative radiotherapy cause more psychosocial 
morbidity than no further treatment?
(Z|.) What is the extent of morbidity in a sample of patients with 
"early” breast cancer receiving several types of treatment, and 
what factors independently predict morbidity?
(5) Compared with observer scales, how well do self rating scales 
perform in patients treated for breast cancer?
Insofar as the available data permit, the opportunity is also 
taken to examine the effects of recurrent disease, the mechanisms 
whereby psychosocial morbidity might be produced, and how it might 
be prevented.
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CHAPTER ±:
HISTORICAL INTRODUCTION AND REVIEW OF THE LITERATURE 
Historical introduction
Breast cancer was recognised in the time of Hippocrates, who was 
born around 460 BC. Treatment by mastectomy seems to have evolved 
because surgeons of the day recognised that an untreated breast 
cancer could ulcerate and fungate, causing much pain and distress. 
On the other hand surgeons were often reluctant to operate, since 
the patient could die of surgery, itself very painful.1
Thus Henri de Mondeville, surgeon during the years 1285-1314 to 
two kings of France (Phillipe le Bel and Louis le Hutin) 
distinguished between "palliative" treatment (for example diet and 
purgation) and "curative" treatment. The latter comprised surgery, 
cautery or the use of "medicines corrosives" to destroy the 
tumour. He recommended that in deciding the treatment, the surgeon 
should consider the patient’s capacity to tolerate pain and heat: 
a primitive recognition of the relevance of psychological factors 
to treatment choice.2
The early forms of mastectomy were crude. In one sixteenth century 
operation two enormous needles to which cords were attached were 
pushed through between the breast and the underlying muscle. Once 
the two cords were in place under the breast, their four ends were 
tied together in front of it and pulled. The breast was thus drawn 
away from the chest wall to be cut off with a large knife. Cautery 
was then applied, though some bleeding might be allowed in the
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belief that bad humours —  in particular black bile —  would be
released.3
This belief in an association between cancer and the body humours 
had started in Greek times. For example, Paul of Aegineta wrote: 
"For cancers are formed by black bile overheated; and if 
particularly acrid, it is attended with ulceration."4 Black bile 
(melancholy) was also linked with mood, and according to Leshan, 
Galen believed that cancer was commoner in melancholic women than 
in sanguine women.5 *
Later medical writers —  for example Walshe, Paget, Gendron and 
Snow —  also believed in a link between temperament and proneness 
to cancer.5 However, other eminent clinicians did not seem to 
share this opinion. The Scottish surgeon John Hunter, in a careful 
review of possible causes of cancer, made no mention of emotional 
factors;6 nor do they feature as causes in the writings of Sir 
Benjamin Brodie —  an authority on breast cancer who described 
sero-cystic disease.7
The nineteenth century French surgeon Velpeau dismissed emotional 
factors as causes of breast cancer: "In short, my observations 
authorise me to say, that no organic constitution, no state of 
health, general or habitual, affords protection from cancer; there 
is no ground for seeking here the predisposing cause of the
fcHowever, scrutiny of the Latin translation of the complete works of Galen 
(Galeni C, Opera Omnia. Kuhn DCG ed. Vols 1-20. Leipzig: Cnobloch,
1821-1833) suggests that Galen did not state this belief directly. Rather, 
he believed in an association between black bile and cancer, especially of 
the breast (volume 11, page 139); and also in an association between black 
bile and melancholic mood (see, for example, volume 8, pages 177-8).
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disease. I may say as much of the moral condition; sadness, grief, 
uneasiness of mind absolutely play no part in the production of 
cancer; and if one does take any notice of it, it is rather to 
humour the patient, than to satisfy a scientific requirement.”8
The emotional consequencies of mastectomy in the postoperative 
period are little evident in the writings of these authors, 
perhaps because clinical practice was so different from now. 
Before anaesthesia, antisepsis and modern histology became 
available, mastectomy tended to be performed late in the course of 
the breast cancer, if at all. Some surgeons were apparently 
reluctant to operate in patients of a melancholic disposition.9 
Brodie warned against surgery in ”those women... with a hysterical 
nervous system, a small pulse, and cold hands and feet...”10 Much 
distress arose from unoperated local disease invading adjacent 
structures, ulcerating and becoming infected. In patients 
undergoing surgery, terror of the operation with its inevitable 
pain and high risk of death, may well have overshadowed the 
effects of loss of the breast. In many cases the breast would have 
been destroyed or grossly disfigured prior to mastectomy. In those 
who survived surgery, removal of a fungating growth might have 
improved, relatively speaking, the quality of life.
A moving account of mastectomy without anaesthesia is given by the 
English novelist Fanny Burney (1752-1840) in a letter written in 
1811 to her sister Esther.11
T here w as much d e lib e ra t io n  among h er m ed ica l a d v is e rs  as  to  
w hether an o p e ra tio n  should be perfo rm ed. "M Dubois [an em inent 
P a r is  surgeon, Fanny Burney h av ing  m a rrie d  a  Frenchman] g ave  me a
p re s c rip tio n  to  be pursued fo r  a  month... b u t u tte re d  so many 
charges to  me to  be tra n q u il, & to  s u ffe r  no uneasiness, th a t  I 
could not but suspect th e re  was room fo r  te r r ib le  inquietude."
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F in a lly  a  decis ion  was reached  th a t  she be o p e ra te d  on by M L a rre y  
(s h o rtly  to  become Napoleon's s u rg e o n -in -c h ie f). Told  she would  
g e t on ly  tw o hours n otice  o f surgery, she nonetheless had to  w a it:
"A fte r sentence thus passed, I was in  hourly  e x p e c ta tio n  of a  
summons to  execution; judge, then, my su rp rise  to  be s u ffe re d  to
go on fu l l  3 Weeks in  the same state!"
On the  d a y  of the o p e ra tio n  she was g iven  a w ine c o rd ia l, in  the  
hope o f m aking her somnolent, w h ile  a  team  of seven men, d ressed  
in  b la c k , assem bled. "M Dubois p lac e d  me on the  M attre s s , & spread  
a  cam bric  h an d kerch ie f o ver my fac e . I t  was tra n s p a re n t, however,
& I saw  through i t ,  th a t  the bed was in s ta n t ly  surrounded b y  the  7 
men & my nurse. I re fused  to  be held; b u t when, B rig h t through the  
cam bric , I saw the  g l i t t e r  of po lished  stee l... I  c losed my 
eyes... re lin q u ish in g  a l l  w atch ing , a l l  res is tance... th is
reso lu tio n  once tak e n , was f irm ly  adh ered  to , in  d e fia n c e  of a
te r ro r  th a t  passes a l l  d es c rip tio n , & the  most to r tu r in g  p a in . Yet
  when the d re a d fu l s te e l was p lunged in to  the b re a s t ------ cu ttin g
through veins ------ a r te r ie s    fles h    nerves - I  needed no
in junction  not to  re s tra in  my cries . I began a  scream  th a t  la s te d
u n in te rm ittin g ly  d uring  the whole tim e of the  inc is ion  -------- & I
a lm ost m arv e l th a t  i t  rin g s  not in  my E ars  s ti l l!  so e x c ru c ia tin g  
w as the  agony. When the wound was made, & the  instrum ent was 
w ith draw n , the  p a in  seemed undim inished, fo r  the  a i r  th a t  suddenly  
rushed in to  those d e lic a te  p a r ts  f e l t  l ik e  a  mass of m inute but 
sharp  & fo rk e d  po inards, th a t  w ere te a r in g  the  edges o f the  wound
  b u t when ag a in  I f e l t  the instrum ent -------  d escrib ing  a  curve ------
c u ttin g  a g a in s t the  g ra in , i f  I may so say, w h ile  the  flesh
re s is te d  in  a  manner so fo rc ib le  as to  oppose & t i r e  the
o p era to r... then, indeed, I thought I must have e x p ire d .
"...I concluded the o p e ra tio n  was o ver ------ Oh no! p re s e n tly  the
te r r ib le  c u ttin g  was renew ed   & worse than  ever, to  s e p a ra te  the
bottom , the  fou nd atio n  of th is  d re a d fu l g lan d  from  the  p a r ts  to  
which i t  adhered... I then f e l t  the  k n ife  ra c k lin g  a g a in s t the
b re a s t bone ------ scrap in g  it!... M Dubois p o in ted  to  some fu r th e r
re q u is itio n  ------ & a g a in  began the scraping!"
"...My d e a re s t Esther, not fo r  Weeks, b u t fo r  Months I could not 
sp eak  o f th is  te r r ib le  business w ith ou t n e a r ly  a g a in  going through  
it !  I  could not th in k  o f i t  w ith  im punity! I w as s ick , I was
d is o rd e re d  by a  s ing le  question  ------ even now, 9 months a f te r  i t  is
over, I have a  head ache from  going on w ith  the  account! I d a re  
not re v is e , nor re a d , the  re c o llec tio n  is  s t i l l  so p a in fu l"
"When a l l  w as done... my s treng th  was so d im inished th a t  I was  
o b lig e d  to  be c a rried ... & then I saw my good Dr L a r ry  [sic], p a le  
as  m yself, h is  fa c e  s tre a k e d  w ith  b lood, & i ts  expression
d e p ic tin g  g r ie f ,  apprehension, & alm ost horror."
The o p e ra tio n  notes s ta te d  th a t  a l l  the  roo ts  o f the  cancer had  
been rem oved and th e re  was high hope o f success. F o rtu n a te  to  
escape p o s t-o p e ra t iv e  in fe c tio n , Fanny Burney liv e d  a lm ost fo r ty
y e a rs  longer (b u t p o ss ib ly  the  tum our was not r e a l ly  m alignan t).
Because mastectomy struck terror, there had long been interest in 
non-surgical methods, which could be thought of as "topical
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chemotherapy”. Thus Velpeau stated: ”A cutting operation has
always occasioned so much alarm, that practitioners have never 
abandoned the idea of curing tumours without it... Two 
circumstances militate in favour of caustics in the eyes of the 
public. First, patients are less terrified of them; second, their 
action is less painful than that of a cutting instrument. Upon 
this subject, however, the unfortunate patients are deceived. No 
species of caustic can destroy a tumour of the breast, without 
occasioning acute and long continued pain... The agony... is in 
some cases so violent, I have known patients find it more painful 
than a cutting operation to which they may previously have 
submitted with much dread... It cannot be denied, however, that 
caustics do possess some advantages. As they do not give the idea 
of an operation, they are less terrifying to the patients, and 
their application will be permitted much more cheerfully, and with 
infinitely less effort than the knife... No definite Judgment can 
be given as to the real value of caustics in practice.”12
Examples of caustics included butter of antimony, Vienna paste 
(mixture of lime and potash), caustic potash, nitric and sulphuric 
acids, zinc and gold chlorides, and arsenic paste.
The advent of anaesthesia, allowing developments in surgery, 
stopped the use of caustics. The radical mastectomy, removing the 
axillary lymph nodes and pectoralis major muscle, was proposed by 
Bernard Peyrihle in 1774 and a century later adopted by Halsted.13 
The idea was to rid the patient of every possible trace of cancer, 
preventing further spread. Radical mastectomy remained the 
standard operation for more than 50 years after the turn of the 
century, despite pioneering work in the 1930s by Geoffrey Keynes,
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who showed that treatment of the cancer with interstitial radium 
needles and conservation of the breast whenever possible did not 
compromise survival.14 Keynes was well aware of the adverse 
psychological effects of radical mastectomy, referring to it as a 
hideous mutilation. Why Keynes's methods were not more widely 
adopted at the time is unclear. However, simple mastectomy 
followed by radiotherapy became common after McWhirter showed it 
was as effective as radical mastectomy.15
It is now accepted that radical treatment of local disease does 
not prevent metastatic spread. In many cases of "early" breast 
cancer, especially if the axillary nodes are involved, 
micrometastases already exist at the time of diagnosis.16 From the 
point of view of survival, extensive local treatment is thus a 
case of locking the stable door after the horse has bolted. This 
has led to the use of systemic treatments: hormonal manipulation 
or adjuvant chemotherapy.17 18 Agents such as cyclophosphamide, 
methotrexate, 5-fluorouracil, vincristine and doxorubicin were 
found to induce remission in some cases of advanced breast cancer. 
Combinations of drugs were more effective than single agents. Such 
combinations, labelled "adjuvant chemotherapy", have been used in 
"early" breast cancer in the hope of destroying any 
micrometastases before they can develop into overt systemic 
disease. The most widely recognised regime of adjuvant 
chemotherapy has been "CMF": cyclophosphamide, methotrexate and
5-fluorouracil.19 The nature of the local treatment being 
unimportant for survival, there has been greater emphasis on less 
mutilating surgery; radical mastectomy is seldom performed 
nowadays, and "lumpectomy" is commoner.20
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REVIEW OF THE LITERATURE
In this review, the literature will be examined prior to May 1977, 
when work for the thesis began. However, occasional references 
will be made to publications after that date, for example research 
presented as a preliminary communication in 1977 but not published 
in full until later.
Studies of the psychosocial consequences of breast cancer will be 
divided into two broad categories: the mainly qualitative, and the 
mainly quantitative. Qualitative studies will refer usually to 
unstandardized, uncontrolled observations, on samples of patients 
which are often ill-defined. Quantitative studies are those using 
standardized measures on well-defined samples, usually with a 
control group. There is naturally some overlap between the 
categories. Some studies classed as mainly qualitative contain 
much numerical data, but are regarded as qualitative because it is 
difficult to draw general conclusions from them. However, the two 
categories enable a rough chronological sequence to be maintained. 
Most of the "mainly qualitative" studies were published before the 
early 1970fs and most of the "mainly quantitative" were published 
thereafter.
Much of the literature on psychosocial aspects of breast cancer is 
conceptually heterogeneous. However, after the various studies 
have been described and criticized, their results will be drawn 
together and summarized under several headings.
Early uncontrolled qualitative studies
The first attempt to study systematically the psychological
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consequences of breast cancer appears to be that of Renneker and 
Cutler in 1952.21 The former a psychoanalyst and the latter a 
surgeon, they sought to ’’correlate the status of current surgical 
treatment with applicable psychoanalytic knowledge of behaviour.” 
Fifty patients operated on by the second author were interviewed. 
It is not clear how they were selected, no demographic data were 
given, and there was no control group. The authors focused on the 
"dual psychological conflict facing a woman with breast cancer”:
(1) adjustment to breast mutilation; (2) adjustment to invasion by 
a potentially fatal disease. The authors noted frequent post­
mastectomy depression, characterised by anxiety, insomnia, 
depressive attitudes, occasional ideas of suicide and feelings of 
shame and worthlessness. ’’One can say that these women mourn the 
loss of their breast. They are concerned with what their husbands, 
or men in general, will think of them in their new mutilated 
state. Feminine pride has been severely damaged. They are faced 
with the problem of changing the mind’s picture of their body 
image to one with a unilateral breast, or none at all.”
Renneker and Cutler emphasised the psychological, sexual, and 
maternal significance of breasts. They wrote: ’’...when we examine 
the situation critically we see that the breasts are the only 
positive evidence of femaleness.” After this extraordinary 
statement they exhorted surgeons to ’’understand that the primary 
emotional reaction connected with disease of the breast is usually 
not a fear of cancer or death, but is rather the shocking feeling 
that the basic feminine role is in danger.”
The women in this study were classed as ’’mature" or ’’neurotic.” A 
’’mature” woman ’’accepted her breasts, good or bad, with a
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proportionate amount of pride...” A "neurotic” woman was
"masculine, frigid or superficially sexual in an exaggerated
fashion.” Her sexuality was "fused with guilt.” She might 
"overvalue” her breasts. If so, she might show extreme depression 
after mastectomy. Apart from "neurotic” women, those most liable 
to show marked reactions were young women of childbearing age. 
Older married women with children would show milder reactions.
Some of these opinions were questionable, inferential judgments 
rather than observations. On the other hand, Bard and Sutherland 
(1955) were less influenced by the preconceptions of psycho­
analysis.22 They studied patients derived from two sources: those 
undergoing radical mastectomy (n=20, age range 20-58 years); and 
mastectomy patients who had been referred to a psychiatric 
consultation service (number and age range not stated). Exactly 
how these patients were chosen for inclusion in the study is 
unclear. There was no control group. Notwithstanding, this work
was important. The authors provided a sensible and believable 
account of the psychological consequences of breast surgery, based 
on detailed and perceptive interviews.
Bard and Sutherland found that discovery of a breast lump
frequently provoked fear and anxiety. Excessive fear might cause 
denial of the possibility of serious illness, leading to delay in 
treatment. When told that surgery was necessary, all women were 
shocked, terrified, numb, panicky or stunned. Some were afraid 
they would die during the operation. However, the "primary source 
of anxiety" probably lay in ”an enormous fear of cancer and all 
its implications." This anxiety might be due to the consequences 
for the patients’ families, such as children being left without a
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mother. On the other hand many patients expressed fears of 
deformity or disfigurement, some saying they would prefer death to 
mastectomy. This was because mastectomy would affect not just 
sexual relationships, but self-esteem and the ability to dress 
naturally.
Following operation, many patients experienced transient relief at 
being alive, followed by anxiety, anger, resentment or dependence. 
On discharge home they feared their families and friends would be 
horrified at having to deal with a mutilated person. Any problem 
with the wound, for example infection, was seen as ominous. Trauma 
to the wound or to the opposite breast, from knocks received in a 
crowd or from sexual intercourse, engendered fears of serious 
consequences such as further and more extensive surgery. Minor 
depressions were common, often manifest as irritability, 
nervousness, lack of patience and being difficult to live with. 
Post-operative care of the wound served to remind the patients of 
their deformity, and thereafter dressing and undressing 
constituted a "dreaded emotional crisis" for most women. Some said 
they were "half man, half woman." Many lost sexual desire, feeling 
unattractive to their husbands, and some slept in a darkened room. 
Outside home, many tried to conceal having undergone the 
operation. A few were devastated and became chronically depressed.
Bard and Sutherland carefully emphasised the need to understand 
the patient in the context of her own personal circumstances. For 
example, to the casual observer two patients might appear equally 
hostile or resentful. One such patient was angry because she was a 
self-sufficient person who disliked having to depend on others 
during her stay in hospital. Another was angry because she
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believed her aspiration biopsy had caused a benign lesion to turn
malignant.
This study contained the patients’ verbatim statements, which 
illustrated anxieties and concerns more vividly than formal rating 
scales. A patient who feared that normal daily activity after her 
operation might be harmful commented, "You treat yourself like a 
soft-boiled egg. You might break your shell at any moment." 
Another who feared her children would notice her deformity said, 
"If I told them about it, they might take a morbid interest. You 
know kids are sadists that way. The way they stare at cripples, 
for instance. They don't mean to be that way, curiosity makes them 
be that way, but they are very sadistic."
The authors noted that mastectomy might pose a real threat to 
marriages, especially if already unhappy. Husbands might show 
anxiety, guilt or rage. They might be appalled by the wound and 
prolong invalidism by being over-protective.
Bard and Sutherland disagreed with Renneker and Cutler's opinion 
that the patient's main problem was protecting her breast, rather 
than protecting her life. They criticized Renneker and Cutler for 
dividing women into the "mature" and "neurotic." This was because 
"mature" women seemed to be those who coped with mastectomy and 
"neurotic" women those who did not: a circular argument. Bard and 
Sutherland regarded this classification of women's personalities 
as moralistic and lacking in meaning. Perhaps surprisingly they 
were unable to confirm the finding of Renneker and Cutler that 
exaggerated emotional reactions occurred in younger women still 
able to bear children and milder reactions in married
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postmenopausal women who had borne children.
Despite its limitations of method, the work of Bard and Sutherland 
was notably open-minded and free of unhelpful Jargon. Many of its 
findings have since been confirmed.
In a related paper,23 Bard attempted to predict those patients who 
would show psychogenic invalidism following radical mastectomy. 
(This was really a quantitative paper, but belongs here 
historically.) Bard studied 20 patients with no previous history 
of surgery or of psychiatric consultation, who were free of 
menopausal symptoms. The precise source of the sample was not 
stated, but presumably it coincided partly with that of the 
previous paper. Shortly before surgery, Bard sought to measure the 
personality factor of dependence, which he thought might predict 
invalidism. Dependence was defined as "a basic personality 
component expressed in the solicitation of support and protection 
from those regarded as powerful and nurturant. Its presence is 
further defined as the extent to which a patient has been unable 
to free herself from maternal control.” He used three techniques 
to assess dependence: a focused interview covering personal,
inter-personal and sexual history, the Rorschach Ink Blot Test, 
and a modification of the Thematic Apperception Test. Independent 
psychologists then evaluated the projective tests for evidence of 
dependence, and a psychiatrist evaluated the interview data. 
Summaries of the three components for each patient were prepared 
and then ranked by two Judges on a dependence scale ranging from 1 
to 20. Similarly, six to 10 weeks after surgery, a further 
focused interview took place and an independent psychotherapist 
scrutinized it for evidence of invalidism, basing his opinion on
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"the quality of depression, weakness, social participation and 
motor activity." Two Judges then ranked the psychotherapist’s 
summary to provide a 1 to 20 invalidism score.
This elaborate procedure resulted in surprisingly high inter-rater 
reliability, though there was some doubt as to whether the 
projective tests actually measured dependence. These tests failed 
to predict invalidism at the five per cent level of significance. 
However, dependence as assessed from the focused interview was 
significantly associated with invalidism (r=0.5). This was a good 
study for its day, with careful attention to reliability. However, 
since Bard seems to have conducted both the pre- and postoperative 
interviews, bias could still have occurred despite the independent 
assessors.
Bard and Waxenberg24 also sought to predict invalidism in these 
patients from the Cornell Medical Index (CMI), which, like the 
other procedures, was administered before surgery and between six 
and 10 weeks thereafter. The CMI has three components: physical 
symptoms, general medical symptoms, and mood and feeling. 
Pre-operative scores on the first two of these correlated 
significantly with postoperative invalidism; scores on mood and 
feeling failed to do so. Despite the significant correlations, 
prediction of invalidism in individual patients was, 
disappointingly, no better than chance. However, there was a high 
correlation (r=0.88) between the pre- and postoperative mood and 
feeling scores.
In 1963, Quint published a paper based on interviews with 21 women 
admitted over a six week period to a university hospital for
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mastectomy.25 With the exception of one refusal, these women 
appear to have been consecutive cases of stage I and II breast 
cancer. They told the author their views on "the three basic 
changes which this operation initiates. First, it precipitates a 
period of shock and unexpected events. Second, it leaves a change 
in body appearance. Third, it mars the future by the prospect of 
shortened life and the possibility of slow, painful death." The 
article contained some moving verbatim accounts of the women’s 
experiences. The author noted that patients in hospital were 
shocked and that the real impact of mastectomy did not occur until 
they had gone home. Then agitation, upset, exhaustion and "blue 
spells" set in. The period of upset tended to be longer if there 
were wound problems. Personal appearance was a major preoccupation 
for some, especially those who had had big breasts, and there were 
difficulties with prostheses. However, the uncertain future was a 
greater concern.
Like that of Bard and Sutherland, Quint’s study was notable for 
sensitive and perceptive interviewing. Given the unselected 
sample, it is perhaps unfortunate that no measure of the frequency 
of problems was given, other than the author’s overall 
impressions.
In the same year, Adsett published a paper entitled "Emotional 
reactions to disfigurement from cancer therapy.’’26 This paper did 
not present data; it reflected the author’s reading and clinical 
practice. He believed that in the breast-conscious American 
society, some women who had undergone mastectomy would project 
onto their husbands their own loss of self-esteem, even if the 
husbands were supportive. This would lead to unrealistic fears of
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having disrupted the marital relationship. Adsett suggested that a 
nurse could help a woman to adapt to the loss of her breast by 
"continuous contact with the patient as well as providing a woman 
figure with which the patient can identify and use as an object 
for her reality testing." However, he quoted no evidence in 
support of this rather convoluted statement. Overall, this paper 
did not advance knowledge, but it anticipated the use of nurse 
counsellors.
Slightly more informative was a chapter by Eisenberg and 
Goldenberg (1966), who described an evaluation of "quality of 
survival” in breast cancer.27 "It was the intent of this study to 
evaluate the ability and capacity of the patient to resume her 
pre-operative responsibilities whether it meant returning to 
outside work or to her household chores." The study concerned 
physical performance more than mood. The patients were identified 
from the Connecticut Cancer Registry. Of 606 patients, 234 were 
not available for interview. Of those 234, 125 were excluded
arbitrarily because they were older than 70 years, 104 were 
notified too late to enter the study, and a handful had died or 
moved house. Of the 372 remaining, 120 were excluded because they 
or their physicians refused. Finally, 252 were interviewed, of 
whom 91% had radical mastectomies, and the remainder "limited 
surgery.” Ninety-five patients underwent postoperative 
radiotherapy. The patients were interviewed twice within a period 
of 18 months, but the timing of the first interview in relation to 
surgery was not clear.
Results were reported in terms of lymphoedema, arm movement, 
activity and attitude status. Arm swelling occurred in 173 women
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(69%), and was severe in 16 (6%). Just over half of all patients 
had limitations of arm movement which tended to improve with time. 
Half the patients had resumed their usual activities by the time 
of the first interview, and 92% by the second interview. The 
"attitude status" was "good" if the patient had no complaints, 
"fair" if she had some complaints, and "poor” if she "expressed to 
a great extent her unhappiness about the whole episode.” On this 
basis, 54% of patients were said at initial interview to have had 
good attitudes, 42% fair and 4% poor. At follow-up, however, only 
43% had good attitudes, 57% fair and 1% poor.
These definitions of attitude might be thought to provide more 
information about the attitudes of the investigators than about 
those of the patients. Clearly the patients* distress could not 
have been Judged properly on the basis of voiced complaints. 
So Eisenberg and Goldenberg’s study contributed little to the 
understanding of the psychological state of mastectomy patients.
Postal questionnaire studies
In the early 1970s, several postal questionnaire studies were 
published. Although easy to administer, they had definite 
drawbacks. These included poor response rates, limitations on what 
could be asked because of lack of personal interaction, and 
ignorance of the reliability of information obtained. Even so, 
some researchers managed to compound these errors with further 
avoidable ones, principally a failure to define the origin and 
nature of the samples studied and the time since surgery.
The study of Torrie (1970) demonstrates these problems.28 Torrie
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posted a questionnaire to an unstated number of women who had 
undergone mastectomy throughout the United Kingdom. He received 
replies from 1400 drawn from 368 hospitals, but failed to report 
how the original sample was selected, what the response rate was, 
which patients dropped out, nor the time elapsing since 
mastectomy. Notwithstanding, the survey showed that some women 
with breast cancer faced serious problems. Nearly half of the 
women wrote that the operation had not been clearly explained. Too 
often, information appeared to have been given in an offhand, 
insensitive way. After the operation, many women had been upset by 
the scar, and the provision of prostheses had sometimes been very 
unsatisfactory. Although relationships with husbands had often 
become closer, several husbands had reacted badly to the 
mutilation and. had sought out other women. There had not been 
enough information on how to make love following a mastectomy. 
Depression had occurred in 83*5% of the women. Half of these had 
become depressed within a week and mood disturbance had lasted 
from one month to a year.
Sixty-two per cent of Torrie’s sample had received radiotherapy, 
and nearly half reported they had been adversely affected. 
"Radiotherapy seemed the worst part of the treatment for most of 
the women; they did not understand it, were unprepared, and 
received no explanation of the procedure..."
In such a poorly defined survey, the figures had little meaning, 
but there could be no doubt that serious problems could occur 
after mastectomy and radiotherapy, and that well-designed 
systematic studies were needed. However, in the same year another 
disappointing postal study was published.
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Schottenfield and Robbins (1970) used a questionnaire to survey 
retrospectively the quality of survival among patients who had 
undergone radical mastectomy.29 Quality of survival was defined in 
terms of the patients’ ability to work, perform normal activities 
and care for themselves. There were no direct assessments of mood. 
The data were obtained by sampling a population of 5472 Caucasian 
women operated on between 1949 and 1962. A patient sample of 826 
was obtained, partly by random sampling and partly from lists of 
attenders at follow-up clinics. Of these 653 (79%) responded to 
the authors’ postal questionnaire. The time since operation was 
very variable —  up to 15 years. Forty-four per cent of the women 
were found to be employed full-time or part time, 54% not employed 
but performing normal daily activities and two per cent unable to 
function without help. Seven per cent of the sample had returned 
to their normal activities within seven to 12 months of 
mastectomy, and a further seven per cent after one year. Five 
years after operation 16% of survivors were unable to work or 
perform normal daily activities, at 10 years 9% and at 15 years 
12%. At five years performance status was significantly lower in 
those who had presented with regional disease than in those who 
had presented with local disease, but at 10 and 15 years 
differences between these two groups were no longer statistically 
significant.
The authors believed that the survey would ’’personalise, in a most 
gratifying way, the follow-up of cancer patients.’’ They thought 
that if physical deformity, functional disability and 
psychological stress were to be prevented in the cancer patient, a
comprehensive rehabilitation program must be provided. They did
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not however state how psychological stress might be defined, how 
its extent might be demonstrated, nor how a rehabilitation 
programme might be shown to prevent it. Their results have limited 
application: selection bias may have occurred despite a large 
sample; in the absence of a control group it is difficult to 
interpret the information presented; the methods of assessment 
were superficial. At best, their results showed that radical 
mastectomy could not be universally devastating in its effects.
In 1977 Winick and Robbins reported what they optimistically 
described as an evaluation of the Memorial Hospitals1 PMRG (Post 
Mastectomy Rehabilitation Group) program.30 The program, based at 
the Sloan-Kettering Cancer Center in New York City, was presumably 
developed as a result of the work of Schottenfield and Robbins 
(1970) described in the preceding paragraphs. It comprised four or 
five days of exercises intended to prevent physical complications, 
and discussions on emotional and psychological anxieties with a 
social worker and a volunteer.
Eight hundred and sixty three out of about 1700 patients who had 
undergone mastectomy at the Memorial Hospital between 1970 and 
1974, and who had attended the PMRG program, were studied. Of the 
1700 about 1400 filled in a questionnaire posted by the authors. 
Of the 1400, only 963 completed more than a few questions. The 
authors decided to omit the 437 who did not finish the 
questionnaire. What happened to some 800 patients who did not 
respond to or complete the questionnaire was not recorded. 
Furthermore, there was no information on those patients who did 
not attend the PMRG program; the proportion of actual attenders 
was therefore unknown.
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Hence the data obtained were almost certainly biased and of 
doubtful general validity. The authors’ findings that younger 
patients appeared to resume normal activities sooner than older 
patients, and that extensive surgery resulted in delayed return to 
work are plausible enough. However, their data on emotional stress 
are almost impossible to interpret. On the basis of the patients’ 
responses to open ended questions, the authors divided emotional 
distress into two categories: none or minimal, and moderate or 
severe. Only 406 (47%) of their sample of 863 patients gave
information on emotional distress, and of the 406, 13% experienced 
moderate or severe symptoms as Judged by the authors. Perhaps 
surprisingly, distress appeared to be less severe in younger 
patients. The authors commented: ’’...the fact that only 52
patients (13%) indicated experiencing moderate or severe stress is 
sufficient to Judge the PMRG program ’clinically significant’ and 
a major accomplishment in mastectomy rehabilitation.” This 
conclusion was totally unjustified. It was all the more surprising 
since the authors in the next sentence stated that a comparison 
group who did not have rehabilitation after mastectomy would have 
been desirable.
The conclusion from this study has to be similar to that of the 
Schottenfield and Robbins paper: merely that after mastectomy not 
all patients become very upset emotionally. The data on prevalence 
and on the effect of age on emotional adjustment were potentially 
too biased to be trustworthy.
In contrast, Craig, Comstock and Geiser (1974) took the precaution 
of using control subjects in their questionnaire study of quality
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of survival in breast cancer.31 They focused on adjustment to 
mastectomy in the long term. Most of their cases had been 
diagnosed more than five years previously, and none less than nine 
months previously. The cases (n=134) were identified from a county 
cancer registry likely to detect over 90% of those treated in the 
local county hospital, which covered a well-defined catchment 
area. The control subjects were obtained from census data. There 
were, in fact, two control groups, both matched by age and sex 
with the breast cancer patients. The second control group was also 
matched by neighbourhood with the cancer patients. This was 
because the authors feared a bias due to an effect of geographical 
location on hospital use and indices of disability. In the event 
the fears were unfounded and the two control groups were merged 
(total n=260). The women in the study received a postal 
questionnaire which asked them to rate themselves on physical 
health, employment, happiness and depression. The completion rate 
for questionnaires, helped by follow up interviews in those not 
immediately responding, was high: about 90% for patients and 80% 
for control subjects.
On the whole, psychological morbididy seemed low, with little or 
no difference between the cases and the control subjects. Only six 
per cent of cases and 3% of controls chose the term "unhappy" to 
describe their "attitude". Notwithstanding, 21% of cases and 20% 
of controls reported symptoms of depression. Only five women in 
the entire study reported a "pessimistic attitude to life"; 
notably, three of the five had recurrent breast cancer and died 
shortly after the survey. The main finding was a slight excess of 
physical disability and a tripling of mortality in patients with 
breast cancer. This was one of the better-conducted questionnaire
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surveys, and strongly suggested that breast cancer was not usually 
associated with major psychological upset in the long term. 
However, the meaning of the questions asked was too imprecise; 
their range was insufficient to detect subtle psychological 
effects of mastectomy.
In fact, an uncontrolled study from Australia (Buis &t al, 1976) 
showed that certain problems did persist in the long term. A 
single observer interviewed 100 women presenting consecutively to 
a follow-up surgical clinic.32 The time since mastectomy was very 
variable: up to 111 years. Radical mastectomy was the commonest 
operation and 8>ll% of the patients had received postoperative 
radiotherapy. Mastectomy had a serious and lasting effect. One 
third of patients experienced anxiety and embarrassment due to the 
absent breast and this proportion did not diminish with time. Arm 
oedema, which affected about half the patients, may have 
contributed to the cosmetic anxieties, and absent or poor advice 
on prostheses undoubtedly did so. Surprisingly, only three 
patients reported sexual difficulties, and the authors mentioned 
no adverse psychological effects of radiotherapy.
However, in the United States Peck (1972) had meantime reported 
his uncontrolled observations on a series of 50 patients 
undergoing radiation therapy.33 The sample was selected at random 
from patients with health insurance who were suffering from a 
variety of neoplasms in the chest, throat, pelvis or reticulo­
endothelial system. The most frequent diagnosis was carcinoma of 
the breast (n=18). Not all patients had been informed they had 
cancer, but most inferred the diagnosis from being given 
radiotherapy. All 18 patients who had undergone mastectomy thought
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that the operation was definite evidence of cancer.
The principal emotional reactions to having cancer were depression 
and anxiety. In til patients (81%) anxiety was moderate to severe. 
Guilt and anger were also common. Four patients had suicidal ideas 
related to cancer. Peck noted that patients occasionally denied 
their illness, but more often they acknowledged it but denied that 
it was life-threatening. Other mental mechanisms noted were 
displacement (worrying about other people rather than about 
themselves) and identification with the physician (being involved 
in the fight against the disease).
The specific role of radiotherapy in inducing depression or 
anxiety was not discussed in this paper, but Peck and Boland 
(1977) devoted a subsequent paper to the emotional reactions to 
radiation treatment of a further series of 50 patients.3* The 
composition of the sample was similar to that of the previous 
series, although only 11 patients suffered from breast cancer. 
Forty two patients had potentially curable cancer, but in the 
remaining eight treatment was only palliative. In fact, a third of 
the sample died within three years of the study. The patients were 
interviewed before and after radiotherapy. There was no control 
group, but the interviews were detailed.
Initially the patients were found to have little idea as to the 
nature and duration of their treatment. Most thought that 
receiving radiotherapy was "bad news", and feared it might be 
physically damaging or might induce cancer. Fears of burns, pain 
and scarring were common. At this pre-treatment interview, over 
half of the sample were judged by the authors to be depressed or
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anxious. As in the previous paper, depression and anxiety were not 
clearly defined.
Some of the patients were treated with cobalt, whilst others were 
treated by the Betatron, a large noisy machine. One week after 
treatment, those patients who had had to lie under the Betratron 
reported that the experience was frightening. Some had been 
distressed by seeing dying patients. The majority of patients were 
now judged to be depressed or anxious, but not severely so. A few 
patients were angry because the treatment had made them feel 
worse.
This study, though uncontrolled, provided definite evidence that 
radiotherapy could induce emotional distress; but it was unclear 
to what extent distress occurred in the patients with breast 
cancer.
Meantime, in the United Kingdom, Lyon had commenced prospective 
research on psychological problems in 100 women with breast cancer 
of whom all received radiotherapy. Unfortunately he failed to 
publish the full results of what appears to have been a well- 
designed study. A patchy review of his findings can be found in a 
chapter on the management of psychological problems in breast 
cancer.35 There was no information on the precise source of the 
sample. Thirty-eight per cent of the patients had not undergone 
mastectomy; presumably some patients must have had advanced 
disease.
Measures of morbidity included the Eysenck personality inventory,
the Beck depression inventory and a visual analogue scale. The
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patients had high scores on the Eysenck personality inventory 
"lie” scale. This suggested some were ’’faking good." Nonetheless, 
11% of the patients were Judged by the Beck inventory to have been 
moderately or severely depressed. During the course of 
radiotherapy, the visual analogue scale showed that mood was 
initially low, possibly because of uncertainty as to what was to 
come. Mood then lifted slightly, but thereafter declined steadily 
until the end of the course of treatment, especially in patients 
who had undergone mastectomy. Thirteen per cent of the total 
sample expressed thoughts of suicide during radiotherapy, mostly 
at the beginning of the course. So this study suggested a strong 
association between depression and treatment of breast cancer with 
radiotherapy; fortunately there were no actual suicide attempts.
However, it was the unexpected suicides of three of his patients 
that prompted Ervin, a surgeon, to interview in depth 12 patients, 
chosen mostly at random, on whom he had operated over the 
preceding 10 years.36 These suicides were not related to 
radiotherapy, and Ervin concluded that mastectomy was a 
devastating experience in which emotional suffering far outweighed 
physical suffering. "Initially the woman sees herself mutilated 
and repulsive, desexed, and suffering from a disease which can 
only end in a lingering and lonely death." He recommended a policy 
of scrupulous honesty tempered with hope, with acknowledgement of 
emotional problems. This paper showed intuitive wisdom even though 
there was virtually no quantitative data or formal evaluation.
In 1978 Jamison and her colleagues published two reports on 
psychosocial aspects of mastectomy, one describing the woman's
perspective37 and the other the man’s perspective.38 In the former
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paper, a sample of 41 women was obtained from two sources: a self 
help recovery group (Women for Women) and the American Cancer 
Society. The authors acknowledged that the sample was biased. The 
degree of bias cannot be determined since the authors did not 
state how the patients were selected from the two sources. 
However, since the mean age of the sample was 52.7 years and 80% 
of the patients were married, it may not have been seriously 
biased with respect to age and marital status. The women were seen 
at a mean of 22 months (median=10 months) after mastectomy, and 
completed several questionnaires. Sixty per cent judged that their 
post-mastectomy emotional adjustment was excellent or very good, 
23% that it was good, seven per cent that it was adequate and 10% 
that it was poor. A quarter had experienced suicidal ideation 
after mastectomy, and a third had increased their use of 
tranquillizers. Several had consumed more alcohol. Those with 
suicidal ideation had high Eysenck Personality Inventory 
neuroticism scores. Over half the women reported phantom breast 
sensations, usually painful but occasionally erotic. A fifth to a 
quarter had experienced sexual problems such as decreased desire 
for intercourse, lack of orgasm or a general deterioration in 
sexual relationships. On the other hand, occasional improvements 
in sexual relations occurred. Younger women had significantly 
poorer adjustment to mastectomy.
To determine the effect of mastectomy on men, Wellisch &t al38 
sent questionnaires to the husbands or partners of another sample 
of women contacted through Women for Women and the American Cancer 
Society. The response rate was only 15%. Around the time of the 
women’s operations, a third of these men had lost their appetite, 
and about two fifths reported sleep disturbance or impaired work
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performance. Over a third thought that the sexual relationship 
with their partners had been spoiled by the operation. Twenty per 
cent of the men had not seen their partners naked after 
mastectomy.
In these two papers, biased sampling and poor response rates made 
the detailed figures unconvincing. However, the finding that 
younger age predicted morbidity was interesting, given so few 
previous attempts to define predictors. One such attempt was 
reported by Cobliner, a psychotherapist.39 In an impressionistic 
study, he interviewed personally some 300 patients with early 
breast or gynaecological malignancies. There was almost no 
information on the source or precise nature of the sample —  not 
even the numbers with each type of cancer. Nor were there any 
details of how morbidity was assessed. Notwithstanding, he felt 
able to identify several factors which seemed to influence 
successful adjustment to these cancers. They included a high 
self-image, a positive image of femininity which suffered little 
or no change as a result of the disease and its treatment, a high 
level of faith in the clinic, the doctors and the treatment, the 
ability to tell worries to a confidante, good relations with other 
people, a satisfying occupation, and success in coping with 
problems in the past.
There was no empirical support for these findings. Some of the 
factors might be regarded as manifestations of good adjustment, 
rather than their causes. However, there is an element of common 
sense in the essence of his thesis: namely, that well adjusted 
people can be expected to cope well.
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Psychosocial effects of chemotherapy.
A literature search in 1977 failed to show any study of the 
psychosocial effects of chemotherapy after mastectomy. Bonnadonna 
and his co-workers, the pioneers of adjuvant chemotherapy with 
cyclophosphamide, methotrexate and 5-fluorouracil (CMF) for early 
breast cancer, maintained the treatment was well tolerated. In 
1976 they reported the results of a randomized study in which, 
after radical mastectomy, 207 women were given CMF and 179 control 
subjects no further treatment. They stated: ”The quality of life 
during CMF was, in general, good. It can be approximately 
estimated that less than 10 per cent of patients showed a lowering 
of performance status as a result of prolonged administration of 
CMF... Seventeen patients refused to complete the chemical 
treatment more for psychological reasons than because they were 
severely affected by toxic manifestations.”18 Unfortunately, 
after this passing comment, they made no further reference to the 
"psychological reasons”.
There was little information on the psychosocial effects of 
chemotherapy in general. Bond (1967) in a detailed and extensive 
monograph on chemotherapy in the treatment of advanced malignant 
disease, reported that mental depression was a side effect of 
treatment with vinblastine.40 However, mood disturbance was not 
implicated as a complication of the many other chemotherapeutic 
agents reviewed, including cyclophosphamide, methotrexate and 
5-fluorouracil, although their unpleasant physical side effects 
were well documented. At that time methotrexate had been used as 
a single agent for nearly 20 years and the other two for over five 
years. Indeed Bond noted that chemotherapy sometimes produced
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short-term subjective (as well as objective) improvement —  
subjective benefit being based on clinical impression rather than 
on any detailed measurement. He emphasised that candidates for 
chemotherapy should be carefully selected; this policy might have 
prevented mood upset.
Two years later, in a text on cytotoxic drugs in the treatment of 
cancer, one author commented that alkylating agents —  for 
example, mustine hydrochloride —  administered to the upper part 
of the body might cause toxic effects on the brain, including 
"deafness, general depression and inability to concentrate".41 
Depression was not reported as a side effect of the other drugs 
reviewed.
After the introduction of combined chemotherapy, for example to 
treat blood cancers and lymphomas, Whitehead (1975) stated in a 
letter to the New England Journal of Medicine that the nausea and 
vomiting induced by such regimes had received insufficient 
attention. He made two pertinent observations: that some patients 
vomited before their treatment; and that some could become deeply 
depressed or even suicidal.42 He appears not to have recognised 
pre-treatment vomiting as a Pavlovian conditioned response, 
stating it attested to "the abhorrence with which [the patients] 
regard the treatment".
In the same year Burge and colleagues reported on quality and 
quantity of survival in acute myeloid leukaemia.43 They said that 
the quality of life was improved as a result of less aggressive 
chemotherapy. However, quality of life was assessed solely by an
observer's global five-point rating based on length of time in
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hospital, physical symptoms and ability to work or lead a normal 
life. Since there was no assessment of quality of life in control 
patients treated with more aggressive chemotherapy, the basis of 
the authors* statement of an improvement is not clear.
Priestman and Baum (1976) were aware of the need for controlled 
studies, and described the use of linear analogue scales to assess 
quality of life in patients with advanced breast cancer treated 
with chemotherapy and with endocrine treatment. This preliminary 
methodological paper, which showed the linear analogue scales to 
be reliable, did not provide a clear statement about quality of 
life on the two regimes.44
Conclusions from the “mainly qualitative" studies
Clearly many of the above studies on the psychosocial effects of 
treatment for breast cancer had serious drawbacks. These can be 
classified under several headings.
(1) Definition and selection of subjects
Samples need to be defined precisely, with a clear indication of 
their origins and any methods used to select them. Possible biases 
in selection must be considered. Many studies failed to provide 
such information; perhaps some investigators thought this was 
unimportant. Very seldom were there any references to consecutive
patients. Where patients were clearly not consecutive, often the
method of selection was not defined; bias cannot be ruled out.
Also, the exact nature of the disease and its treatment was
sometimes unclear. Authors usually stated the nature of primary
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surgical treatment (for example, radical mastectomy), but often 
did not give enough information on the stage of the cancer, or on 
what proportion of patients received additional treatment such as 
postoperative radiotherapy. Metastatic breast cancer could be 
expected to have different psychological effects from early 
cancer, and extra treatment to influence morbidity. These problems 
tended to be worse in postal questionnaire studies.
(2) Experimental design
Most of the research cited was retrospective, or at least partly 
so. This might have caused bias in the recall of information. Too 
often the timing of assessments in relation to treatment was not 
stated. Often the samples consisted of a cross section of patients 
who had undergone mastectomy over the previous few years. Thus 
some patients would have been seen shortly after surgery, but 
others not until months or years later. The psychosocial effects 
of a serious illness like breast cancer could be expected to vary 
with time. The mixing of results from different time periods makes 
it hard to distinguish the early and late consequences of 
treatment.
Few studies had control groups. To what extent are control groups 
needed?
Certain experiences —  for example loss of the breast —  are 
virtually unique to breast cancer. Thus controlled studies might 
be unnecessary to understand matters such as feelings of 
mutilation, phantom sensations and problems with prostheses.
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The need for control groups Is much clearer In studies concerned 
principally with mood disturbance and social dysfunction, which 
occur also in people not suffering from breast cancer. Even so, 
careful interviewing (for example in work of Bard and Sutherland22 
or of Peck33 34) may be sufficient to show causal connections 
between psychosocial upset and treatment for breast cancer. 
Control groups could give a spurious air of respectability, for 
example in a postal questionnaire study too superficial in 
content. However, absence of control groups causes serious 
difficulty in Judging the extent of psychosocial morbidity.
(3) Inadequate methods of assessment.
Assessments of psychosocial morbidity need to be valid and 
reliable. Perhaps the simplest form of validity is face validity. 
The questions asked have to be relevant and comprehensive. At 
another level, if a criterion of validity can be defined, the 
assessments should be sensitive and specific. In practice there 
are no absolute criteria of psychosocial morbidity; the ”gold 
standard” of validity is usually taken to be the administration of 
a reliable interview schedule by an experienced psychiatrist or 
other suitably trained professional. Put another way, validity 
becomes partly a matter of consensus opinion. On this basis 
sensitivity and specificity have practical meaning only when 
another method of assessment —  for example a questionnaire —  is 
compared with the results of an observer interview.
Much of the research described above fell down on several of these 
criteria. Some of it was superficial in content, failing to tap 
relevant information. Even in studies where interviewing was good,
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the reliability of information obtained was not considered. Where 
questionnaires were used, generally their reliability was not 
checked and since they were not validated against observer 
assessments, sensitivity and specificity were unknown.
In spite of these limitations, what conclusions can be drawn from 
the "mainly qualitative” studies?
Firstly, the discovery of a breast lump might induce feelings of 
shock, depression and anxiety along with fears of death and 
mutilation. Mastectomy might cause depression, anxiety, 
irritability, anger or guilt. Occasionally depression might be 
very severe or chronic, with or without ideas of —  or even actual 
—  suicide. By its mutilating effect mastectomy might damage 
feminine self-concept. Sexual difficulties might lead to marital 
problems, including rejection by the husband. On the other hand 
improvement in marital and sexual relationships was sometimes 
reported. Loss of the breast might cause serious problems with 
dressing, aggravated by an inadequate prosthesis. Embarrassment 
might lead to social withdrawal.
Most of the studies in which post-operative radiotherapy was 
mentioned suggested that it increased psychological distress. The 
effect of chemotherapy on mood was unclear.
The studies reviewed so far did not allow a precise statement on 
the extent of the morbidity, although clearly not all women were 
seriously affected. Whether certain subgroups of women were prone
to morbidity was largely unknown. Opinion was divided as to
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whether morbidity was greater in older or in younger women. Bard 
had found that dependent personalities were prone to morbidity, 
but his concept of dependence was complex.23 He also found a 
relationship between Cornell Medical Index scores and
"invalidism", too weak to be of practical value.24 Impressionistic 
research suggested that morbidity was higher in women who were 
badly adjusted generally, but hard evidence was lacking. The 
duration of the morbidity was also unclear. What evidence there 
was suggested that mastectomy was not usually associated with 
major mood upset in the long term. However, some research 
suggested that problems with body image and sex might be 
long-lasting.
Other psychological effects included concerns about possible 
recurrence of the cancer and death. Innocent aches and pains might 
wrongly be attributed to recurrent cancer, causing anxiety. There 
was disagreement as to whether loss of the breast or possible 
death was the main cause of morbidity.
The stress associated with breast cancer might lead to the use of 
mental defence mechanisms. Denial of the presence of cancer 
appeared to be the commonest mechanism. Although it might prevent 
or reduce psychological morbidity, it might also cause delay in 
seeking treatment.
Mainly Quantitative Studies
During the 1970’s, the need for more clearly defined, reliable 
studies was increasingly recognised; some of the earlier reports
in this period described psychological problems in the period
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prior to breast surgery.
Studies focusing on pre-operative morbidity
One such study was the paper by Katz and colleagues (1970) 
entitled "Stress, distress and ego defenses —  Psychoendocrine 
response to breast biopsy."45 Thirty women awaiting breast biopsy, 
of whom 22 proved to have cancer, were studied. Whether or not 
these patients were consecutive was not stated. Nineteen came from 
a hospital clinic and the remainder from private physicians. The 
methods of quantifying distress were somewhat unusual, though 
previously documented. The authors used a score of "defensive 
adequacy." Defensive adequacy had three components: affect,
functional disruption, and impairment of defensive "reserve". 
Affect was scored on a scale from -6 through 0 to 6. Negative 
scores denoted pleasant emotions, and positive scores unpleasant 
emotions. The other two components were scored from 0 to 6, higher 
scores meaning greater impairment. The three scores were then 
added together to form a "total psychiatric score." The authors 
also identified the patients* main defence mechanisms. Finally 
they measured hydrocortisone production, by injecting a tracer of 
hydrocortisone labelled with radioactive carbon 1U.
Interviews with the patients were tape recorded to allow 
assessments by independent raters. Inter-rater reliability proved 
to be satisfactory, but was lowest for defensive reserve. Although 
there were no control subjects, the authors thought that most of 
the women did not show significant defensive breakdown. This 
opinion was partly supported by the patients’ hydrocortisone 
production being within the normal range; there was a significant,
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albeit modest, correlation between levels of hydrocortisone 
production and total psychiatric scores. The main defence 
mechanisms identified were displacement, projection, denial with 
rationalization, hope and prayer, stoicism-fatalism, and a mixture 
of defences. The first two mechanisms mostly failed to protect 
against morbidity; denial with rationalization was a more 
effective defence, but led to delay in obtaining medical advice.
Although this paper showed careful attention to reliability, 
possible bias in the selection of subjects, the unusual method of 
quantifying psychiatric upset together with the absence of control 
subjects cause some difficulty in interpreting the results. 
However, the authors' comments to the effect that despite the 
threat posed by breast biopsy, many patients coped, seem 
reasonable. Likewise the defence mechanisms outlined are 
convincing —  unlike the ethical justification for giving 
radioisotopes, which the authors chose not to discuss.
A controlled study of psychological morbidity prior to breast 
biopsy was reported in 1975 by Schonfield.46 His main purpose was 
to show whether life experiences influenced the development of 
breast cancer. In consecutive Hebrew-speaking Israeli women, the 
Holmes-Rahe schedule of recent experience failed to show higher 
scores in 27 women who proved to have cancer than in 85 with 
benign disease. In fact the opposite trend was seen: the benign 
group scored significantly higher for recent events requiring 
major or minor adjustment. The patients also completed the 
Institute of Personality and Ability Testing (IPAT) anxiety scale. 
The cancer patients aged HZ or less showed a significant excess of 
anxiety compared with the benign group. Schonfield thought that
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this was because loss of the breast was more important to younger 
patients. Depression was not measured.
In 1975 Greer and his research group at the Faith Courtauld Unit 
for Human Studies in Cancer started to publish a series of papers 
based on 160 consecutive patients who underwent breast biopsy. 
This work was of major importance because the sample was unbiased 
and the researchers used reliable measures of morbidity, notably 
the Hamilton depression rating scale. The patients were 
interviewed preoperatively and then followed up for two years.
The first of these studies provided information on morbidity in 
the period prior to breast biopsy.47 Depression as measured by the 
Hamilton scale appeared to be about as frequent in the 91 patients 
who subsequently proved to have benign disease as in the 69 found 
to have cancer. It was seldom of clinical degree: only 3% of 
cancer patients and 2% of control subjects scored 20 or more on 
the Hamilton depression scale. A further li% of cancer patients and 
3% of controls scored between 16 and 20, which suggested to the 
authors a clinically mild depressive state. Ninety three per cent 
of cancer patients and 95% of controls scored from 0 to 15. 
Anxiety was not measured. However, the main purpose of this work 
was to examine patterns of emotional expression in patients with 
breast cancer compared with control subjects with benign disease. 
Drawing on the methodology of David Kissen, who had reported that 
men with lung cancer had poor outlets for emotional discharge,48 
Greer and colleagues found that women with breast cancer showed a 
longstanding personality trait of abnormal emotional expression. 
Compared with patients with benign disease, they showed abnormal 
expression or suppression of anger. Abnormal suppression was
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commoner than abnormal expression.
In a companion paper published in the same year, investigating 
delay in consultation, Greer and colleagues noted that denial of 
illness was prominent in women with breast cancer who delayed 
seeing their doctors.49 The findings of both these preoperative 
papers had obvious theoretical and practical relevance.
This early work of Greer and his co-workers can be criticised 
because the authors might not have been truly f'blind” to the 
diagnosis of cancer or benign disease, even though they did not 
seek out the probable diagnosis in advance. The cancer patients 
were older on average than those with benign disease. Also, in 
many cases, the patients' surgeons must have known the likely 
diagnosis. This knowledge might have been communicated verbally or 
non-verbally to the patients, and non-verbally from the patients 
to the researchers. In a paper on methodology, the authors 
themselves acknowledged that such biases could occur.50
Morbidity in general surgical samples
None of the above preoperative papers compared morbidity in 
patients undergoing breast biopsy with that in patients undergoing 
routine surgery. Some of the morbidity prior to breast biopsy 
might not have been due to the threat of breast cancer, but simply 
to the threat of being admitted to hospital and undergoing 
surgery. Several mainly qualitative studies had drawn attention to 
anxiety in general surgical patients. For example, fears of the 
anaesthetic, of pain after or even during surgery, and of death 
were described.51-54 In one study, however, it was suggested that
59
occasional patients might actually welcome surgery as a pleasant 
change from hard work and poverty.52
In the late 1960’s and early 1970’s quantitative studies of 
anxiety in general surgical patients were undertaken by 
Spielberger and his research associates. In one of the early 
studies to be published by that group, twenty six male patients 
undergoing major surgery (precise operations not stated) completed 
Spielberger's state-trait anxiety inventory (STAI) 18-24 hours 
before surgery, and again three to nine days after surgery.55 Mean 
anxiety state scores were significantly higher before surgery than 
post-operatively. Trait anxiety, reflecting a personality 
characteristic, did not change significantly. These results were 
confirmed in a larger series of 56 male patients by Auerbach, who 
included an extra assessment at 48 hours after surgery. State 
anxiety at 48 hours was only slightly less than before surgery; 
during convalescence there was again a marked decline.56 In a 
further study of 59 male surgical patients, Martinez-Urrutia 
obtained similar results.57
Subsequently, Chapman and Cox studied a mixed sex sample in which 
10 males and 34 females underwent routine abdominal surgery. 
(These patients in fact served as a control group for kidney 
donors and recipients.) The patients completed the STAI before 
surgery and on days one and three thereafter. Results for the 
abdominal surgery sample seemed to contradict Spielberger’s 
results; there was a trend on day one for anxiety and depression 
to be higher than on the day before surgery, and on day three 
these symptoms were of similar intensity as prior to surgery. Sex 
did not influence the results.58 However, the post-operative
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assessment of Chapman and Cox was at three days exactly rather 
than the three to nine days in Spielberger's study.55
Taken together, the results of these studies suggested that major 
surgery provoked excess anxiety before operation, but that anxiety 
did not decline immediately afterwards. Rather it fell (presumably 
to baseline levels) several days after operation.
Studies focusing on post-operative morbidity
In a further paper from the Faith Courtauld Unit, Morris, Greer 
and White (1977) followed up the 69 patients with cancer (stage I 
and II) and the 91 with benign disease for two years after 
operation.59 They measured mood (depression), and marital, sexual, 
interpersonal and work adjustment. Personality was measured with 
the Eysenck personality inventory. Depression (score of 10 or more 
on the Hamilton scale) occurred in 11 of 63 (17%) of cancer
patients at three months after operation. At 12 months the 
prevalence was 12 of 53 (23%) and at two years 10 of Zj.5 (22%). In 
patients with benign disease the corresponding prevalences were 
7/85 (8%), 10/75 (13%) and 5/65 (8%). The trend towards more
depression in the cancer patients compared with those with benign 
disease was not statistically significant except at two years.
There was also a trend towards more sexual problems in the cancer 
patients. At three months, 8 (18%) of the cancer patients
experienced changes for the worse, compared with U (6%) of those 
with benign disease. This difference was statistically 
significant, but by two years there were no significant
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differences: 10 (32%) of the cancer group reported changes for the 
worse, compared with 14. (27%) of the benign group. About a tenth 
of both groups reported changes for the better. The authors 
believed that some of these sexual difficulties reflected the 
problems of middle age rather than the effects of breast cancer. 
There were no significant changes in overall marital adjustment, 
but more cancer patients than benign controls reported a 
long-lasting improvement in interpersonal relationships. Work 
adjustment deteriorated in cancer patients, especially in the 
first three months after operation. Thereafter some improvement 
occurred, so that by two years 71% of the mastectomy group had 
regained their preoperative work status. There was no work 
deterioration in the benign group.
An interesting feature of this study was an attempt to classify 
patients* psychological responses to diagnosis. Five categories —  
denial, fighting spirit, stoic acceptance, anxious/depressed 
acceptance and helpless/hopeless —  were distinguished. These 
categories were not entirely stable over time: stoic acceptance 
became increasingly common.
Two predictors of morbidity emerged from this work. Patients still 
"stressed** by mastectomy at two years had higher preoperative 
scores on the Hamilton depression scale and on the neuroticism 
scale of the Eysenck personality inventory.
Certain comments can be made about this study. In their 
preoperative paper,47 Morris and Greer used a threshold of above 
20 to define moderate to severe morbidity on the Hamilton 
depression scale, and a score of 16 to 20 to define mild
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depression. In their postoperative paper,59 they reduced the 
threshold for depression to 10 or above. Had they continued to use 
a threshold of 20 or above, very little depression would have been 
evident, with no significant differences between cancer and 
control groups. This suggests that the depression reported in 
their post-operative paper was mild in degree and less than that 
seen in many psychiatric patients. Their use of the undefined term 
"stressed” seems in keeping with this view.
Also, the cancer and benign disease groups differed in age. The 
mean age of the cancer patients was 58 years, and that of the 
benign group li8 years. In theory, some of the observed differences 
might have been due to age rather than to breast cancer. To 
overcome this problem, the authors stated they used a technique of 
looking at change within each patient group, using patients as 
their own controls, and observing and comparing changes for better 
or worse in the two groups. However, this technique could not have 
removed an effect of age. Instead, the authors might have reported 
the association between age and morbidity in the cancer group and 
then in the benign group. Had an effect of age been demonstrated, 
the groups could have been analysed after subdivision by age.
The findings of Morris and colleagues on work adjustment and 
predictors of morbidity had been anticipated partly in a small 
study by Schonfield of H2 patients attending a radiotherapy 
clinic.60 These patients, of whom all had been in full time 
employment, suffered from several types of malignancy, but 18 had 
breast cancer. Nine patients (21%) had not returned to work by 
nine months after surgery; compared with those back at work they 
had shown at the time of radiotherapy significant morale loss and
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Impaired well-being on the Minnesota Multiphasic Personality 
Inventory, and high covert anxiety on the IPAT scale. However, 
numbers were too small for a specific statement about the patients 
with breast cancer.
The study of Maguire and his co-workers, reported in 1975 and 1976 
but more fully in 1978, used age matching to overcome the problem 
of age differences between cancer and control groups.61*63 
Reliable observer rating scales were used to assess several 
aspects of morbidity, notably depression, anxiety and sexual 
dysfunction. These scales were used by Brown and Harris in their 
classic studies of depression in women in London.6* The interviews 
in Maguire’s study were tape recorded to allow independent 
checking of ratings. Symptoms were classed as absent, mild, 
moderate or severe.
Two hundred and one women attending breast clinics were included 
in the study: consecutive patients due to undergo breast biopsy 
and a one in five sample of women who did not require biopsy. One 
hundred and seventeen proved to have cancer. Of these, 96 were 
interviewed at three to four months and one year after operation. 
The remainder had died, were too ill, had moved house or refused 
to be seen. Eighty of 8>k control patients with benign disease were 
seen at the same time intervals. Because of the differences 
between patients and control subjects with respect to age, social 
class and marital status, subsamples were taken: 75 cancer
patients aged 65 or less who were free from recurrent disease and 
50 patients with benign disease who matched those in the 
mastectomy sample for the variables cited. All but six of the 75 
cancer patients underwent simple or modified radical mastectomy.
6ti
Results foi? the preoperative period showed that after discovery of 
disease and prior to attending the breast clinic, a substantial 
minority of women in both groups experienced moderate to severe 
depression or anxiety. Anxiety of this degree occurred in 23% of 
those who proved to have cancer and 26% of those with benign 
disease. For depression the corresponding figures were 13% and 
12%. After the patients had attended the clinic, the prevalence of 
anxiety rose slightly to 27% in the cancer patients but fell to 
15% in patients with benign disease. Depressive symptoms showed a 
similar, less marked trend. Minor degrees of anxiety or depression 
were very common in all patients and also tended to fall in 
patients with benign disease after they had attended the clinic.
At both four and 12 months after surgery, there was significantly 
more anxiety and depression in cancer patients than in the benign 
control group. Twenty-one per cent of the cancer patients 
experienced moderate or severe anxiety at four months, and 19% at 
one year. For depression the corresponding figures were 27% and 
21%. In the control subjects the highest prevalence of morbidity 
was 12% for moderate to severe depression at four months. For 
clinical depression at one year, and clinical anxiety at both four 
months and one year, the prevalences in the benign group were all 
8%. In a preliminary report, Maguire had noted that morbidity was 
greater in younger cancer patients, but actual data to support 
this observation were not given.61
Sexual problems in the cancer patients were commoner than mood 
disturbance. At four months, 1X0% had moderate to severe sexual 
difficulties. At one year, the prevalence remained high at 33%. In
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"the benign group the corresponding percentages were 12% and 8%.
Sixty-two (85%) of the cancer patients underwent postoperative 
radiotherapy. The authors believed it might have contributed to 
psychiatric morbidity. Patients associated it with a worse 
prognosis, and some said it made them exhausted and even lower in 
spirits. Radiotherapy also seemed to induce anxiety. However, 
since only 13 patients did not receive radiotherapy, it was not 
possible formally to prove that mood disturbance was commoner in 
patients who had received radiotherapy than in those who had not.
The authors found that psychological and sexual morbidity was 
often unrecognised or untreated. It was suggested that specially 
trained nurses, social workers or volunteers might help these 
patients.
This was a well-designed and clearly written study. However, the 
results applied to patients aged 65 or less and free of recurrent 
disease.
"The fallacy in postmastectomy depression" was the sceptical title 
of a North American controlled study by Worden and Weisman 
(1977).65 The authors set out to examine whether depression was 
specific to loss of the breast per se, using a different control 
group from Morris or Maguire. They compared HO women with newly 
diagnosed breast cancer with 50 fresh cases of women with other 
cancers, namely Hodgkin's disease, malignant melanoma and cancer 
of the colon. Both groups appear to have consisted of virtually 
consecutive patients. Refusal to participate was said to be 
uncommon, but the number refusing was not given. The patients were
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seen on six occasions over* a period of six to eight months. Mood 
was measured by the profile of mood scales (POMS), and by a 
clinical rating. Other assessments included self-esteem, 
predominant concerns (health, religion, work, money, family, 
friends, self-appraisal, and existential concerns), coping 
strategies, and the degree to which problems had been resolved.
The results were perhaps surprising. Levels of depression were 
remarkably similar in the women with breast cancer and in those 
with cancer in other sites. Twenty per cent of patients with 
breast cancer were Judged to show the clinical syndrome of 
depression, lowered self esteem, increased health concern, and 
loss of energy, compared with 18% of women with other cancers. In 
both groups, those with lowered self esteem tended to show 
persistent health concerns, many social problems with difficulty 
in resolving them, and low ego strength. This pattern of results 
suggested a vulnerability to distress in general, rather than to 
mastectomy of itself. The authors believed that a specific 
postmastectomy syndrome occurred in a minority of women only.
These results formed part of a wider study of the psychological 
effects of a variety of cancers in 163 patients of both sexes.66 
In this wider study the following factors were found to be 
associated with vulnerability to emotional distress: pessimism, a 
past history of depression, family problems, marital problems, low 
social class, and having little support. Religious observance was 
associated with decreased vulnerability, possibly because of its 
correlation with being older, conventional and having strong roots 
in the community.
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In their mastectomy patients Worden and Weisman did not find body 
image problems to be common, but they did not ask about them 
unless prompted by the patients. This was to avoid biasing the 
results by suggesting that such problems might exist. Possibly 
this was a case of throwing the baby out with the bathwater. The 
research of Bard and Sutherland,22 of Morris &t ai59 and of 
Maguire62 strongly suggests that had specific enquiry been made, 
more patients would have voiced concerns about body image. Hence 
some of the morbidity of mastectomy might have been missed. 
However, Worden and Weisman pointed out that patients in the 
control group also reported body image problems due to 
lymphoedema, skin grafting or colostomy.
On the other hand, Ray (1977) in a careful study comparing 30 
matched pairs of patients who had undergone mastectomy or 
cholecystectomy 18 months to five years previously, specifically 
sought out the effects of breast loss.67 She interviewed these 
patients on a single occasion lasting up to two hours. They 
completed depression and anxiety scales developed by Costello and 
Comrey, a self-esteem scale devised by Rosenberg, and several 
other scales which measured social warmth, social abrasiveness, 
social attractiveness, introversion-extraversion and body 
cathexis. For the body cathexis scale the patients rated their 
physical attractiveness with respect to 15 body parts, the total 
score being the sum of the individual scores. Surprisingly, this 
scale did not include an item about breasts. However, Ray 
encouraged the patients to talk freely about the effect of their 
illness and mastectomy.
She found that the mastectomy group were significantly more
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depressed and anxious "than the cholecystectomy group, tended to 
have lower self-esteem and described themselves as more 
introverted in their behaviour. There were no significant 
differences on the other scales. Hay thought that her findings 
reflected concerns about both the loss of the breast and possible 
recurrence of cancer. Despite the lack of significant differences 
between groups on the body cathexis scale (which may have been due 
to the absence of items about breasts), Ray found that 16 of the 
30 in the mastectomy group were seriously concerned about 
disfigurement. They used terms such as ffno longer a full woman” or 
even described the operation as ”obscene”.
This study therefore suggested that mastectomy had a long term 
effect on mood as well as on body image, but the matched design 
could have led to slight bias. The cancer and control groups were 
matched for age and time since operation. Matching for age, which 
was performed because mastectomy patients are on average older 
than cholecystectomy patients, might have caused her mastectomy 
group to be younger than usual. Indeed the oldest mastectomy 
patient was aged only 65. The other selective factor in this study 
was exclusion of patients with recurrent disease or physical 
deformity. This illustrates a common methodological difficulty. 
Selection and matching performed for very good scientific reasons, 
namely precision and the avoidance of confounding factors, may 
limit the generality of the conclusions.
A partial explanation of the difference in body image problems 
reported by Worden and Weisman and by Ray may be found in the work 
of Polivy.68 Using a standard questionnaire, Polivy compared body 
image problems in three groups: mastectomy patients, patients
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found on biopsy to have benign disease and general surgical 
controls. The surgical control subjects showed little change in 
either body image or total self image. The benign group 
experienced a decline in body and self image immediately after 
surgery. The most interesting result was that the breast cancer 
patients reported no such decline until several months after 
mastectomy. Polivy attributed this delay in acknowledging body 
image problems to massive denial.
Polivy did not assess mood in this study, except to note that 
mastectomy patients expressed more fears of death or mutilation 
than the other groups. In a review article, however, she made the 
important observation that patients might deny not Just the 
presence of cancer, but also the presence of anxiety.69
The non-expression of anxiety was also noted in a study published 
by Margarey et al in 1977.70 This concerned the influence of 
psychosocial factors firstly on delay in reporting breast 
symptoms, and secondly on the practice of breast self-examination. 
Ninety consecutive women admitted to a hospital in New South 
Wales, Australia, for breast biopsy were interviewed on videotape. 
Ten of the videotapes were used, along with earlier data, for a 
pilot study to develop operational definitions of some HO 
psychological factors. These included the use of ego defence 
mechanisms, the extent of anxiety and depression expressed 
verbally and non-verbally, and interpersonal support received. On 
the whole the various measures proved reliable when the videotapes 
were rated by independent observers. The patients also completed 
the Spielberger Anxiety Inventory, Millimet’s Manifest Anxiety- 
Defensiveness Seal© and the depression scale of the Minnesota
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Multiphasic Personality Inventory. However, only U3 patients 
completed all the scales; no adequate explanation was given for so 
much missing data. Some of the videotapes were technically flawed 
and only 6H were available for the main study.
The data were examined by correlational methods, including 
multiple regression analyses. Unfortunately, the numbers of 
patients available for each analysis, and the actual levels of 
morbidity, were not reported. The authors found that Zl.3.4% of the 
variance in delay was explained by the use of denial and 
suppression, the non-use of intellectualization, the absence of 
anxiety reported verbally, the presence of anxiety shown 
non-verbally, and the presence of depression reported verbally.
In view of the seemingly large amount of missing data, the results 
should be viewed with caution. However, the relationship between 
delay and denial was similar to that previously noted by Greer,49 
and the absence of anxiety reported verbally by patients who 
showed anxiety was striking. This result together with Polivy’s 
observations69 suggested that in patients under threat of cancer, 
denial of anxiety might prevent the full extent of that symptom 
from being detected by rating scales.
Conclusions from the "mainly quantitative" studies
Pre-operative morbidity
Four papers discussed pre-operative morbidity.45'47 63 All agreed 
on its presence, but not on its extent. Pre-operative depression
as defined by Maguire and colleagues was much commoner than
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depression as defined by Greer and Morris. In the latter study, 
levels of morbidity appeared similar in patients with benign 
disease and those with cancer. In Maguire’s study, while morbidity 
was similarly high in the benign and cancer groups prior to 
attendance at the outpatient clinic, thereafter it was 
significantly lower in patients with benign disease. This result 
was partly in accord with that of Schonfield who showed that 
morbidity was higher in cancer patients (but only those aged H2 or 
less) than in patients with benign disease.
To some extent the differing results of these studies must have 
reflected varying design, patient selection factors, and 
definitions of morbidity. The one constant finding in the above 
three papers was that only a minority of patients experienced 
morbidity of clinical degree. This finding was also in accord with 
the fourth paper: the uncontrolled observations of Katz &t al. 
However, the size of this minority remained in some doubt, and 
none of these researchers showed whether patients about to undergo 
breast biopsy were more or less upset than those about to have 
routine surgery.
Po3t-operativ& morbidity
Post-operatively, agreement was greater. Having redefined clinical 
depression as a Hamilton score of 10 or above, Morris e£ al found 
that the prevalence of postoperative depression varied from 17 to 
23%.59 Maguire &t al found that the prevalence of moderate to 
severe depression varied from 21 to 27% and anxiety from 19 to 
21%.63 Worden and Weisman's figure for depression was 20%.65 So 
the prevalences of clinical symptoms, as defined by these authors,
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were similar: about a fifth to a quarter of patients being
affected. One could conclude, as for the pre-operative period, 
that morbidity of clinical degree affected only a minority of 
patients after mastectomy; and that the size of this minority 
depended partly on thresholds to define morbidity, and perhaps 
also on the influence of postoperative radiotherapy, which many 
patients on whom these figures were based received.
Both Maguire and Morris found that morbidity persisted beyond four 
months (respectively up to one year and up to two years) and Ray’s 
study suggested that depression and anxiety lasted up to five 
years.59 63 67
There was some disagreement about the extent of problems with body 
image, but probably up to half of patients were upset by 
disfigurement —  possibly more. The prevalence of sexual problems 
varied from 18% in the study of Morris e.t al to Zj.0% in that of 
Maguire et al. (However, the denominator in the latter study 
included only those who were sexually active and aged 65 or less.) 
Morris &t al thought that some of the sexual problems might 
reflect middle age rather than mastectomy.
Morris and colleagues found that work status was still impaired in 
nearly a third of patients at two years after mastectomy.
Predictors of morbidity
In the quantitative studies, about the only definite information 
on predictors of emotional morbidity was the finding of Morris et
al (published in fact shortly after work for this thesis began)
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that high pre-operative depression scores and high Eysenck 
neuroticism scores predicted those patients liable to be 
’’stressed” by mastectomy.59 However, Weisman’s finding in a mixed 
group of cancer patients (including breast), that vulnerability to 
morbidity was associated positively with pessimism, a past history 
of depression, family problems, marital problems, low social 
class, and having little support, but negatively with religious 
observance, is relevant.66 The qualitative studies had already 
suggested that women who were dependent and poor copers were prone 
to morbidity.
The effect of age on morbidity —  about which there had been 
disagreement in the qualitative studies —  was not examined in 
the quantitative studies, with one exception: Maguire’s
observation (not however supported by a formal analysis of data) 
that younger women were more liable to be distressed.61
Effects of further treatment after mastectomy
Only one further treatment —  postoperative radiotherapy —  was 
examined in the ’’mainly quantitative” research. Maguire et al. 
agreed with the ’’mainly qualitative” studies, that radiotherapy 
might increase emotional distress.61'63 Morris et al reported that 
radiotherapy did not influence morbidity at two years after 
mastectomy, but did not describe its more immediate effects.59
There were no quantitative studies in the literature on the 
psychosocial effects of other forms of postoperative treatment 
such as dophorectomy or adjuvant chemotherapy. There was little 
information on the effects of recurrent disease and its treatment.
Scope of this thesis
This review of the literature has highlighted several areas where 
knowledge was lacking or incomplete. Not all could be explored, 
given constraints on both clinical material and time, but 
information was sought in the following areas.
The psychosocial effects of further treatments: adjuvant
chemotherapy and postoperative radiotherapy.
Effects of recurrent disease.
In both the preoperative and postoperative periods:
Precise levels of morbidity, using both observer rating scales 
and self rating scales as a check on possible observer variation 
in defining morbidity.
Predictors of morbidity.
Finally, it was of interest to examine the performance of self 
rating scales in detecting psychosocial morbidity in patients 
undergoing treatments for breast cancer. Self rating scales, if 
satisfactory, could save both time and expense in future studies.
The precise questions asked have been stated in the Preface; the 
methods of addressing them are discussed in the next chapter.
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C H A P T E R  25: 
PATIENTS AND METHODS
Design of study
For* each of the questions asked in the Preface, the following 
comparisons were made among groups of patients.
(1) Does psychosocial morbidity prior to breast biopsy exceed that 
prior to routine surgery? VJhat factors independently predict 
morbidity?
Here psychosocial morbidity was compared in consecutive patients 
under the age of 70 awaiting breast biopsy with that in 
consecutive women aged under 70 awaiting elective cholecystectomy. 
The patients undergoing breast biopsy were subdivided into those 
proving subsequently to have cancer and those with benign disease. 
Within the breast biopsy groups, an attempt was made to find 
independent predictors of morbidity, using demographic and other 
data to be described later.
Elective cholecystectomy was chosen as a control operation because 
it was commonly performed on women of similar age to those 
undergoing breast biopsy. Other control operations, for example 
varicose veins and hernia repair, were considered, but rejected 
both because turnover of patients undergoing these operations was 
low and because the waiting time for admission was far longer than 
for breast biopsy.
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(2) What is the extent of psychosocial, morbidity in patients 
allocated to adjuvant chemotherapy, and how does it compare with 
the morbidity in patients receiving post-operative 
radiotherapy?
The starting point for this question was a randomized trial of 
adjuvant chemotherapy in stage II breast cancer.
(In stage I disease, the cancer appears to be confined to the 
breast. In stage II disease, it has spread to the axillary lymph 
nodes; although disease cannot be demonstrated elsewhere, 
micrometastases are very often present at the time of diagnosis. 
Adjuvant chemotherapy is intended to destroy these micrometastases 
before they enlarge and kill the patient.)
The design of this trial is shown in figure 2-1. Consecutive 
patients under the age of 70 with histologically proved stage II 
breast cancer underwent simple mastectomy and axillary clearance 
and were allocated at random to:
(i) a three week course of radiotherapy to chest wall and local 
lymph nodes;
(ii) a year’s course of adjuvant chemotherapy;
(ii) radiotherapy followed by chemotherapy.
The chemotherapy regime was based on that of Bonadonna in Italy,18 
except that all drugs were given intravenously. Cyclophosphamide 
(300 mg/m) methotrexate (ZiO mg/m) and 5-fluorouracil (600 mg/m) 
were administered at the outpatient clinic on days one and eight 
of consecutive 28 day cycles. Treatment was started within six
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weeks of mastectomy and continued until recurrence or for one 
year. Patients allocated to combined radiotherapy and chemotherapy 
began their course of radiotherapy four to six weeks 
post-operatively and chemotherapy was started four to six weeks 
after completion of radiotherapy.
Post-operative radiotherapy was conventional orthovoltage 
treatment: 15 fractions over three weeks to chest wall, axilla, 
infra- and supraclavicular fossae, and internal mammary region 
(average tumour dose 3.7 Gy).
This trial had been set up at the Victoria Infirmary in Glasgow by 
Mr C S McArdle and colleagues to examine the effect of adjuvant 
chemotherapy on quantity of both disease-free survival and overall 
survival in stage II breast cancer. A few patients at Gartnavel 
General Hospital who attended the oncology clinic of Professor K C 
Caiman also entered the trial. It was thought important to examine 
quality of survival as well as quantity.
(3) Does post-operative radiotherapy cause more psychosocial 
morbidity than, no further treatment?
Two groups in the chemotherapy trial received postoperative 
radiotherapy. Since patients with stage I cancer attending the 
Victoria Infirmary received no further treatment after mastectomy, 
they could serve as a control group to assess the psychosocial 
effects of radiotherapy. Ideally these patients on no further 
treatment would have had stage II cancer. An ideal sample was not 
available, since local opinion was that patients with stage II 
cancer should receive further treatment, but differing stages of
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disease could be allowed for1 in the interpretation of results. The 
only selection criteria for the stage I patients studied was that, 
like the stage II group, they should be a consecutive series, aged 
under 70 and free of second cancers.
(4) What is the. extent of morbidity in a general sample of 
patients with "early" breast cancer receiving several types of 
treatment, and what factors independently predict morbidity?
The inclusion of patients with stage I disease meant there would 
be a large group of consecutive patients with stage I or II breast 
cancer, receiving several treatments. The advantage of a large, 
general sample was that it would allow a fairly precise population 
estimate of the extent of morbidity in patients with "early” 
breast cancer, to compare with the results of other workers, and 
also would provide enough patients to examine predictors of 
morbidity. Results for patients at risk of psychological trouble 
would be more reliable and have wider application if derived from 
a general sample rather than from subgroups.
Control subjects without cancer were desirable to confirm whether 
morbidity in the cancer patients was higher than expected. 
Patients already seen prior to surgery could also serve as control 
groups after surgery: consecutive patients aged under 70 who,
following breast biopsy, were found to have benign disease; and 
consecutive women aged under 70 who had undergone elective 
cholecystectomy.
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(5) How well do 3elf rating scales perform in patients treated 
for breast cancer?
A sample of breast cancer patients with reasonably high 
prevalences of morbidity was needed to address this question of 
validity; but until prevalences were known, the precise sample 
could not be predicted. This matter is discussed below in the 
section on the statistical analysis of the validity study, and 
also in chapter 7.
Timing of psychosocial assessments
Pre-operative assessments took place on the afternoon or evening 
prior to the day of surgery.
The timing of postoperative psychosocial assessments was partly 
dictated by the design of the chemotherapy trial. Assessments were 
made at one, six, 13, 18 and 2k months after operation
(figure 2-1). This allowed morbidity to be measured prior to 
follow-up treatment, after radiotherapy, midway through the course 
of chemotherapy, shortly before completion of chemotherapy, and 5 
and 11 months after completion of chemotherapy. The cancer 
patients were interviewed at all these times. The original 
intention was to see the control patients with benign disease at 
the same time intervals. However, there was insufficient time 
available to carry out the many interviews required, and some 
patients with benign disease were not keen to be interviewed 
repeatedly. As a compromise they were seen at one, three and 13 
months. The cholecystectomy group was seen at three months only, 
by which time much of the physical recovery from surgery seemed
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likely to have occurred.
Patients on chemotherapy were reviewed as close as possible to day 
28 of each treatment cycle. This was the time in the cycle when 
physical toxicity was least, since about three weeks had elapsed 
since the previous injection. The purpose of this timing was to 
minimize confusion between physical and psychological symptoms. 
For a similar reason, radiotherapy patients were interviewed two 
to three weeks after completion of treatment.
Measures of morbidity used
The measurement of psychosocial morbidity in patients undergoing 
breast surgery and further treatment presented certain problems. 
Ideally, assessment of patients would have been blind, but 
treatment received could not be concealed from the interviewer. 
The possibility of tape-recording interviews, editing them in such 
a way that all references to further treatment were removed, and 
having the edited tapes rated by independent assessors was 
considered. However, it was rejected as impracticable. Despite 
this, observer assessments were considered essential, even if 
potentially biased. Self rating scales were also desirable, as a 
check on possible observer bias.
Observer scales
When the study was planned (1977). Dr Peter Maguire was asked for 
his advice on observer scales. The previous year he had published 
preliminary findings of his mastectomy study"-” In this
he had used the same scales (at that time unpublished) as
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Brown and Harris in "their study of the social origins of 
depression in womens Dr Maguire kindly provided the author with 
nine relevant scales and definitions of morbidity. These scales 
were subsequently published by Brown and Harris.** Since they had 
been used successfully both in women in the community and in women 
with breast cancer, they were the obvious choice. They are as 
follows:
depressed mood; 
fears/anxiety/worry; 
under activity; 
drive (appetite and sex); 
sleep;
socially unacceptable behaviour; 
effect on day-to-day routine; 
employment or housework/child care.
For most of the scales there were four possible ratings: 0=absent, 
l=mild, 2=moderate and 3=severe. However, the two drive scales 
(appetite and sex) had seven-point scales which allowed for 
ratings of increased drive as well as reduced drive.
Certain features of the present study affected the way in which 
these scales were used. Account had to be taken of the many 
physical symptoms likely to be experienced by patients receiving 
treatment such as chemotherapy. Some symptoms, for example loss of 
appetite or lack of energy, were potentially ambiguous because 
they could denote either psychological distress or physical 
malaise. For ratings of depression or anxiety, somatic symptoms
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such as gastro-intestinal dysfunction were discounted. On the 
other hand, the under activity scale normally referred only to 
symptoms of presumed psychological origin —  for example, 
depressive retardation. In patients receiving radiotherapy or 
chemotherapy, it might be impossible to know whether under 
activity was caused by change in mood or treatment received. Thus 
in the assessment of under activity the cause was ignored, and 
ratings could reflect symptoms of physical origin, psychological 
origin, or both. The same was true for ratings of day-to-day 
routine and of problems with employment and housework.
It seemed likely that few, if any, patients would report increased 
sex drive after mastectomy, and therefore the seven-point sex 
scale was changed to a four-point loss of libido scale. Maguire 
had changed this scale in the same way.61*63 To simplify matters 
further, the seven-point appetite scale was not used, so that all 
scales remaining had a range of 0-4. The original definitions of 
the scale points are given in Appendix 1.
Ratings of loss of libido were made only in married or cohabiting 
patients. Loss of libido was thought important in those without 
sexual partners, but would have been difficult to measure. 
Problems in measuring precise baseline levels of sexual desire led 
to a decision to include in ratings of loss of libido married 
patients who were no longer sexually active. Inevitably, a rating 
of zero in such patients might mean that sexual appetite, though 
unchanged, was low.
There were still rather many observer scales, and sleep ratings 
did not seem essential, except for the validity study (chapter 7).
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Otherwise they have not been included in the presentation of 
results. In the interests of clarity or brevity, the remaining 
scales are often referred to by alternative names, as follows 
(original names in brackets):
depression (depressed mood); 
anxiety (anxiety/fears/worry); 
lethargy (under activity); 
loss of libido (sex);
irritability (socially unacceptable behaviour); 
routine/social dysfunction (effect on day-to-day routine); 
work (employment or housework/child care).
Ratings covered the month prior to each assessment. A reliability 
study was conducted, comparing ratings of 16 patients by two 
observers: the author and his colleague Dr A F Cooper. The author
interviewed the first patient in the presence of Dr Cooper and
thereafter, for successive patients, the observers exchanged
roles. However, in the case of six patients the second observer 
could not be present. He therefore rated a tape recording of the 
other observer’s interview. Full details of the results obtained 
are given in Appendix 2. There were few disagreements between 
raters and none was greater than one scale point. The extent of 
agreement was assessed by the unweighted version of Cohen’s 
Kappa.71 The respective values of Kappa for depression, anxiety, 
irritability, loss of libido, lethargy, social dysfunction, 
(house)work and insomnia were 0.68, 0.7 U, 0.67, 1.0, 0.81, 0.85,
0.90 and 0.79. Inter-rater reliability was therefore satisfactory.
The above method almost certainly resulted in greater agreement
8>lX
than would have been obtained from separate interviews by the two 
observers. Separate interviews were tried in one patient, but 
afterwards she objected very strongly. Already very worried prior 
to breast biopsy, she was confused by being interviewed twice. The 
author believed it would have been unethical to pursue the matter 
further in these patients.
Observer assessments were also used for physical symptoms. A 
simple arbitrary physical symptom score was devised based on the 
presence or absence of several relevant symptoms in the month 
prior to assessment. These included anorexia, nausea, vomiting, 
irritation of mucous membranes, hair loss, complete alopecia, skin 
reaction, pain, arm swelling, and significant other symptoms. One 
point was allotted for each symptom present, and the score was the 
sum of the points. "Irritation of mucous membranes" included 
symptoms such as mouth ulcers and cystitis due to chemotherapy, 
and oesophagitis due to radiotherapy. An example of a 
"significant other symptom" would be dyspnoea caused by lung 
metastases.
In patients receiving post-operative treatment, the presence of 
conditioned reflex nausea and vomiting was noted. (Patients 
subject to treatment-induced nausea and vomiting often developed 
conditioned reflex symptoms in response to previously neutral 
stimuli such as the smell of the hospital, as will be described in 
later chapters.)
In Joint assessments of 12 patients the author and Dr A F Cooper 
both agreed completely as to the presence or absence of physical 
and conditioned reflex symptoms. This was hardly surprising, given
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■that the severity of individual symptoms was not recorded. Rating 
their severity would have been desirable, but the more detailed 
reliability study needed would probably have stretched the 
goodwill of the patients too far. In any case, summing the points 
for each physical symptom to provide an overall score gave an 
indication of the severity of physical problems.
Although formal standardized observer assessments were essential 
for reliability, by their very fixed nature they might miss 
important topics. Therefore, six months after surgery, cancer 
patients were asked open-ended questions. The questions were 
always the same: How do you feel about your illness? How do you 
feel about the mastectomy? How do you feel about your treatment? 
Immediate replies were recorded verbatim. In addition, patients 
who had received radiotherapy followed by chemotherapy were asked 
how the two forms of treatment compared. At any of the 
assessments, spontaneous comments were noted.
Self rating scales
Self rating scales (Appendix 3) had to be sufficiently sensitive 
to detect minor degrees of morbidity. Scales such as those of Beck 
and Zung, often used in patients with severe depressive illnesses, 
might not have been sensitive enough.72 73 The general health 
questionnaire74 was chosen because it had been widely used and was 
known to be valid and reliable in detecting morbidity in general 
practice and in outpatient clinics. Although likely to be suitable 
for patients with breast cancer, it had potential drawbacks.
Firstly, it contained somatic and social items. Cancer patients
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free of psychological symptoms might endorse these items solely on 
account of physical illness or physical treatment. As a result 
their scores on the questionnaire would increase and they might 
wrongly be classified as psychiatrically ill. This was known to 
occur in physically ill inpatients.75 Secondly, when the study was 
started the general health questionnaire did not provide separate 
scores for depression and anxiety.
However, it was clear that the problem of misclassification could 
be reduced by using the 36-item version of the general health 
questionnaire in which items concerned with physical illness had 
been removed. In the event this version was not used because new 
subscales of the general health questionnaire became available in 
1978, as detailed below.
To provide separate scores for depression and anxiety, an 
additional measure, the Leeds scales for the self assessment of 
depression and anxiety, was included.76 The general versions of 
the two Leeds scales were chosen as they were designed to measure 
the degree of depression and anxiety in patients with a variety of 
diagnoses. Most of the items in the Leeds scales were purely 
psychic in content, unlike many in the general health 
questionnaire.
The Leeds scales were modified slightly because they measured very 
recent mood, whereas the general health questionnaire measured 
mood over the previous few weeks. With the agreement of Dr Snaith, 
their designer, the wording of the Leeds scales was altered to 
x>@fer the previous few weeks. This was similar to the time 
period applied to the observer scales.
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A year after the study began, a version of the general health 
questionnaire was published containing four subscales derived by 
principal components analysis.77 The subscales were: somatic
symptoms, anxiety and insomnia, social dysfunction, and severe 
depression. All but the social dysfunction subscale had been 
validated against clinical assessments. The severe depression 
subscale contained items purely psychic in content, namely ideas 
of worthlessness, hopelessness and suicide; there were no somatic 
items. The anxiety/insomnia scale was mainly psychic in content, 
although arguably insomnia might sometimes be caused by physical 
complaints. However, it was clear that these subscales overcame 
many of the problems of misclassifying patients with purely 
physical complaints and they provided separate measures of 
depression and anxiety. They were used extensively in the data 
analysis.
There were recognised threshold scores to define morbidity for 
most of these self rating scales. The standard 60-item version of 
the general health questionnaire had scores ranging from 0 to 60, 
with a score of 12 or above to indicate clinically significant 
morbidity. However, this threshold was obtained from a general 
practice sample. Scores on each Leeds scale ranged from 0 to 18. 
For both depression and anxiety, the recommended threshold for 
clinical morbidity was a score of 7 or above.
There were no recognised threshold scores for the four subscales 
of the general health questionnaire. These were determined from 
comparisons of observer and self ratings obtained during the 
course of the study, as described in chapter 7- Threshold scores
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to define clinical morbidity were found to be: somatic symptoms 
6/7; anxiety and insomnia 6/7; social dysfunction 7/8; severe 
depression 2/3. The analysis to be reported in chapter 7 also 
suggested that the threshold score for the 60 item version of the 
general health questionnaire should be doubled to 2 ll for the 
detection of definite cases (observer depression or anxiety rating 
of two or more).
Two other self rating scales were used: the Eysenck Personality 
Inventory (EPI),78 and the Mill Hill synonyms test of verbal 
intelligence.79 There had been suggestions that cancer patients 
might differ in personality from the general population,5 80 and 
the influence of personality and intelligence on adjustment to 
cancer was of interest. Verbal intelligence rather than 
performance intelligence was measured since the former seemed less 
likely to be affected by physical problems caused by cancer or its 
treatment. Also, verbal intelligence seemed relevant for the 
understanding of cancer and its implications.
Patients normally completed the EPI (form A) at one month after 
surgery, and the Mill Hill scale at three months. The Mill Hill 
score was converted into an intelligence quotient according to the 
method of Peck.81 It was impossible to be certain that the EPI 
scores, especially the neuroticism score, would not be influenced 
by current mental state. The possibility of specifically asking 
patients to fill in the EPI to reflect their usual selves was 
considered. Kendell and DiScipio had found that such instructions 
reduced neuroticism and introversion scores in depressed 
psychiatric inpatients, when compared with the scores obtained 
without the instructions.82 However, changing the EPI in this way
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might have inhibited comparisons with other research on cancer 
P&tients in which no change had been made.59 83 Also, the breast 
cancer outpatients would not generally be so depressed as 
psychiatric inpatients. The instructions were left unchanged and 
in practice the majority of patients seemed to take the inventory 
to refer to their normal selves.
Proforma
A proforma was devised, covering basic information (for example 
age, social class, marital status, menstrual status, work status) 
plus certain other items which might influence morbidity (e.g. 
delay between finding the breast lump and attending the outpatient 
clinic, time on the waiting list, education, knowledge of family 
members or friends with breast cancer, past history of serious 
illness, past psychiatric history, religious observance, living 
alone). Details of the proforma and necessary definitions of items 
are given in Appendix ll. Several of these measures were fairly 
crude, but seemed likely to be reliable. Ideally a fuller 
assessment of personal and social functioning would have been 
made. For example, a measure of the intensity of religious 
conviction would have been better than defining religious 
observance merely by whether the patient attended church more than 
once a month. A good marriage or good social support might protect 
against morbidity, but valid and reliable assessment of the 
quality of marriage or social support would have been complex. The 
patients already had many questionnaires to fill in, and to 
maintain their co-operation the amount of information sought had 
to be limited.
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Location of interviews
In Maguire's study interviews took place in the patients' homes, 
to encourage free discussion.61'63 Likewise the author saw 
patients at home whenever possible. Home interviews proved to be 
essential for the regular follow-up of patients who otherwise 
would have been reviewed seldom or not at all in the outpatient 
department; their co-operation had to be secured. Interviews in 
hospital were often difficult because of lack of a suitable room 
or because the patients had to see other doctors or undergo tests. 
However, some patients had to be assessed at the hospital: for 
practical reasons, those seen prior to surgery; those who 
preferred to be seen at the hospital; and some of those who seemed 
to accept the study only if their surgeons approved there and 
then. Often great care was needed to ensure that the arrangements 
for interviews were adequate. Most interviews lasted about an 
hour, with a range from about half an hour to four hours.
Statistical notes
Numbers of patients required
There was no definite way of knowing the numbers of patients 
needed. In a comparison of two groups, knowledge of the standard 
deviation would allow calculation of the number of patients 
necessary to show a mean difference of clinically relevant size at 
a given level of significance.84 However, use of the standard 
deviation was open to question with skewed data such as general 
health questionnaire scores. Also, the definition of a clinically
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relevant: difference was very much a matter of opinion, though even 
a large difference in psychological morbidity seemed less 
important than, say, a 5% difference in long-term survival.
Size of postoperative stage II sample
In practice the critical factors influencing sample size were time 
available and the need to obtain, in the post-operative period, as 
many stage II patients as possible, since unlike the stage I 
patients they would be randomized into three smaller groups. The 
randomized trial of chemotherapy in stage II cancer had been 
running for nearly a year when the psychological study began, and 
over HO patients had been recruited. This suggested that over the 
following two years a further 80 stage II patients would enter the 
trial, and allowing for a few refusals, at least 70 of these would 
enter the psychological study. This would mean 20 or more in each 
of the three randomized groups. A psychologist with extensive 
statistical knowledge —  Mr Malcolm Adams —  advised that 20 
patients in each group was the minimum number required. In fact 
the "vanishing sample phenomenon" occurred. It took over three 
years, not two, for the 80 or so patients to materialise. With a 
two-year follow-up, this meant that data collection lasted more 
than five years.
Additional stage II sample
In anticipation of the problem of numbers, a further stage II 
sample was obtained. Forty-four patients who had already entered 
the chemotherapy trial were seen for the first time at 13 months 
after mastectomy, when many were completing a year's treatment.
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Although early interviews were missing in these patients, the 
information obtained proved valuable. It allowed a more precise 
estimate of the psychological effects of chemotherapy and helped 
comparisons of the performance of the observer and self rating 
scales.
Since the author was fully occupied collecting data prospectively 
from the time of surgery, he was unable to interview all the 
additional stage II patients. His colleague Dr A F Cooper very 
kindly saw most of them.
Size, of stage II sample receiving radiotherapy.
With a sample of around 70 stage II patients seen from one month 
onwards, at least 20 patients would be allocated to radiotherapy 
alone. However, a further 20 or so patients would receive 
radiotherapy followed by chemotherapy. Their chemotherapy would 
start after the three month assessment. Therefore, by combining 
the radiotherapy alone patients with those allocated to 
radiotherapy plus chemotherapy, at least Zj.0 patients could be 
assessed before and after radiotherapy. This would have the 
advantage of increasing statistical power in the comparison with 
stage I patients on no further treatment. The only drawbacks would 
be: (1) the radiotherapy plus chemotherapy patients would have to 
be excluded from the analysis at six months; (2) since patients in 
that group would know about the impending chemotherapy, 
conceivably their mood might thereby be affected.
In the light of the results obtained (chapters U and 5), the size 
of the radiotherapy sample was in fact doubled in this way.
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S i z e  o f  p o s t o p e r a t i v e  s t a g e  I  s a m p l e
Scrutiny of records showed that roughly equal numbers of stage I 
and II patients were treated over a given period. However a stage 
I sample equal to the stage II sample (over 70 patients) was too 
large to be followed up in the time available. A sample of H0 
stage I patients was therefore identified, which seemed large 
enough for comparisons with stage II patients receiving
radiotherapy. There would still be a consecutive general sample of 
80 or more patients with stage I or II breast cancer.
Size of control groups and of pre-operative cancer sample
There were far more patients with benign disease than with cancer. 
In theory a very large benign control group was possible, but
again there would have been insufficient time available for follow 
up. On the other hand patients with benign disease would be
younger than those with cancer, so that analysis of results by age
was indicated. Thus around HO control patients with benign disease 
seemed necessary, to allow them to be divided by age into 
subgroups of reasonable size.
For a similar reason, in the preoperative period, a sample of 
around HO patients with stage I or II cancer was aimed at. To 
achieve this aim without introducing selection bias, it seemed 
that the previously decided number of around HO patients with 
benign disease would have to be greatly exceeded. This was because 
benign disease was much commoner than cancer, and the diagnosis 
was often uncertain until after frozen section biopsy. In some
9 H
patients, however, younger age, the clinical nature of the lesion, 
or both, made a diagnosis of cancer most unlikely. Therefore, 
after obtaining the desired consecutive sample of Zj.0 patients with 
benign disease, the author decided to omit preoperative interviews 
in patients in whom cancer was improbable. This policy worked 
well; the number of redundant interviews of patients with benign 
disease was kept to a minimum and no case of cancer was missed.
For statistical reasons it subsequently proved necessary in the 
post-operative period to obtain a few more patients with benign 
disease. For practical reasons they had to be recruited 
pre-operatively. A further eight consecutive patients with benign 
disease were assessed before surgery and one month thereafter. 
Because of the pattern of results which was emerging (to be 
described in chapter 6), it was not thought necessary to follow up 
the final eight beyond one month.
The cholecystectomy patients were on average closer in age to the 
cancer patients than were the benign group. It was decided to 
study a sample of 30 consecutive patients being admitted for 
surgery.
Data analysis
Data analysis was governed by two main principles. The first was 
the avoidance of repeated significance testing, such that 
"significance” might arise by chance alone. The second was not 
losing relevant information in pursuance of the first. Several 
groups of patients were analysed over a two year period. A 
multi-group repeated measures analysis of variance seemed to have
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many advantages: comparisons amongst groups and within groups, 
measurement of interactions, statistical control by the use of 
covariates, and avoidance of spurious significance. The main 
drawback was the need for constant numbers within each group over 
time. Losses to follow-up occurred as a result of deaths and 
refusals. Deaths occurred mainly in the radiotherapy-alone group. 
Equal numbers over time could have been achieved only by excluding 
such patients, or by the dubious process of substituting group 
means for missing scores. Exclusion of patients who had died would 
have meant excluding them following relapse, a likely period of 
suffering. Hence important information would have been lost. 
Furthermore, much of the data was either of nominal type, or, if 
interval, markedly skewed. Thus violation of underlying 
statistical assumptions was possible.
Therefore, the alternative method of performing separate 
cross-sectional analyses for each time interval was chosen. As a 
result, no available data were left out. To reduce the risk of 
spurious statistical significance, analyses were confined largely 
to comparisons that were of clinical interest; the data were not 
"combed” for every significant difference. Where possible, tests 
which allowed for multiple comparisons were chosen.
Data in the chemotherapy trial were analysed on an intention- 
to-treat basis. All patients were included in the analysis of 
results regardless of whether they had relapsed or failed to 
complete chemotherapy. This was so that the results could guide 
practical decision-making by the clinician.
The main statistical tests used were as follows: for comparisons
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among groups, X2 tests, Fisher exact probability tests, one-way 
(parametric) analysis of variance, Kruskal-Wallis analysis of 
variance, t—tests and Mann-Whitney U-tests; for comparisons within 
groups, paired t-tests, McNemar’s X2 test for correlated 
proportions, Cochran’s Q. test, Friedman analysis of variance and 
the binomial test.85 Two-tailed tests were preferred, except 
where previous research strongly suggested the likely direction of 
a difference. Thus one tailed tests were used in comparisons of 
the psychosocial effects of radiotherapy with those of no 
additional treatment. Further details are given in the appropriate 
chapters.
Predictors of morbidity were determined by stepwise multiple 
regression analysis. Variable entry and removal were determined by 
the default criteria in the Statistical Package for Social 
Sciences (SPSS-X):86 a probability of 0.05 for variable entry and 
0.1 for variable removal. Plots of residuals were examined to 
check the adequacy of models, and transformations used if 
indicated. Results are reported as R2 and adjusted R2. R2 is the 
proportion of variation in a dependent variable explained by a 
combination of independent (predictor) variables. R2 varies from 0 
to 1; the higher its value, the more successful is prediction. 
Adjusted R2 is a more realistic estimate of the value of R2 which 
might be obtained in the population from which the sample was 
drawn.84 87
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Methods in the validity study.
Criteria of morbidity
In the validity study the aim was to compare the performance of 
the general health questionnaire, its subscales, and the two Leeds 
scales with valid criteria of morbidity.
In the absence of some physical or biochemical marker, the 
generally accepted criterion of "caseness" is the Judgement of a 
clinical psychiatrist or trained interviewer using a reliable 
interview schedule.80 In the present context, the definition of a 
"case" seemed arbitrary. If a patient enduring severe side effects 
from chemotherapy felt very depressed, would she be a "case" or 
would she be showing an entirely understandable reaction to 
enormous stress? Also, symptoms such as retardation which might 
aid case definition were ambiguous in patients with severe 
physical symptoms.
Consideration was given to applying well-known definitions of 
caseness which either were available when the study began or 
shortly afterwards: for example the Feighner criteria, or the 
Brown and Harris criteria.64 89 However, Feighner's definitions of 
caseness depended partly on ambiguous somatic symptoms, and would 
not have been suitable unless modified. Brown and Harris defined 
caseness by saying that "a psychiatrist would not be surprised to 
see [the woman] in an outpatient clinic". Caseness could be Judged 
by comparing with "anchoring examples" —  that is, typical case 
histories. However, more precise definitions seemed necessary in 
the present study. Given that definition of a case of depression
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or anxiety would have to concentrate on "psychic" symptoms, the 
simplest method seemed to be one based on degree of morbidity; the 
following working definitions were adopted.
To examine the validity of the 60-item and 28-item versions of the 
General Health Questionnaire an observer rating of 2 or more for 
depression or anxiety was chosen as the criterion for caseness 
(figure 2-2). This seemed appropriate for scales designed as 
non-specific case detectors. The observer under activity scale was 
used to validate the somatic symptoms subscale. In the patients 
studied the under activity scale was really a global estimate of 
fatigue rather than a direct measure of somatic symptoms, but 
seemed likely to reflect feelings of physical dysfunction. The 
observer depression scale was used to validate the severe 
depression subscale. On the under activity and depression scales, 
the criterion chosen for caseness was a score of 2 or above.
The other two subscales of the general health questionnaire 
measure anxiety/insomnia and social dysfunction. Although the 
former scale is often used as a measure of anxiety alone, strictly 
speaking it should be validated against ratings of both anxiety 
and insomnia. Therefore observer ratings of anxiety and of 
insomnia were summed to form a seven—point scale to validate the 
anxiety/insomnia subscale.
The impairment of day-to-day routine observer scale covers social 
dysfunction and so might have been used on its own to validate the 
social dysfunction subscale. However, the latter subscale contains 
items concerned with the performance of tasks or usual activities. 
Its content was thought to be reflected more accurately by
99
comparing it with combined observer ratings of day-to—day routine 
and of performance at work and household tasks. Thus to validate 
the social dysfunction subscale, scores on the impairment of 
day-to-day routine scale and the (housework/child care scale were 
summed to form a second seven-point scale.
On each of the combined observer scales, a score of 2 or above was 
again chosen to define caseness.
Validation of the two Leeds scales was more straightforward. An 
observer depression rating of two or above was used to validate 
the Leeds depression scale, and an anxiety rating of two or above 
for the Leeds anxiety scale.
Statistical methods in the validity study
Firstly, correlation co-efficients between observer ratings and 
self ratings were computed. Correlation coefficients are often 
used to estimate validity, although it is easy to obtain a 
statistically significant correlation co-efficient even if 
classification is poor. Since distributions of the data were 
skewed, Spearman non—parametric rank order co-efficients were 
preferred, although for comparison with other work, the Pearson 
co-efficients were sometimes also calculated. In practice the two 
co-efficients tend to give very similar results.
For a more precise estimate of the performance of the scales and 
subscales, sensitivities and specificities were calculated. During 
the course of the study, the method of receiver operating 
characteristic (ROC) curve analysis became increasingly popular as
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an elegant way of summarizing the effects on classification of 
different thresholds of morbidity.90-92 In chapter 7 the data are 
presented in this form. Used originally to examine observer 
variation in detecting radar signals, ROC curves are plots of 
sensitivity (on the y-axis) versus (on the sc-axis) the false 
positive rate (=1—specificity) for every possible threshold score. 
Thus an ROC curve shows the discriminating power of the 
questionnaire at every possible threshold of morbidity. If the 
discrimination is no better than chance, the ROC curve follows the 
straight line y=x rising diagonally from the origin. The area 
under this line is 0.5. If discrimination is better than chance, 
the curve is bowed upwards above the straight line. A perfect ROC 
curve would reach right up to the point on the y-axis where 
sensitivity is 100%, the false positive rate 0% and the area under 
the curve 1.0. In practice this ideal is not achieved. Examination 
of the ROC curve allows a decision to be made about the optimal 
threshold for morbidity for a given purpose.
Item analyses allowed a more detailed examination of the 
performance of the general health questionnaire. Goldberg has 
described the method in his Maudsley monograph.74 An item analysis 
shows how well each item of the questionnaire detects different 
degrees of morbidity. Certain items might prove to be redundant. 
If so, a modified version of the questionnaire might be considered 
for use in breast cancer patients.
An example of an item analysed by the method used by Goldberg is 
shown below. It shows the percentages of normals, of patients with 
mild symptoms and of cases with given GHQ scores. According to the 
usual method of scoring, a GHQ score of 2 or 3 means that the item
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is endorsed.
GHQ score Gradient
0 1 2 3
Have you been Normal 53 40 8 8
feeling run down Mild 9 35 57 — 57
and out of sorts? Case 6 6 50 38 88
This item performs well. Less than 10% of normals endorse it, most 
"cases” endorse it, while an intermediate number of patients with 
mild symptoms do so. The gradient is the difference between the 
percentages of normals and cases endorsing the item. For this item 
the gradient is therefore (88-8) = 80.
Ideally several degrees of morbidity rated by observers -- for
example absent, mild, moderate and severe —  would be 
differentiated by the items of the questionnaire. In practice 
observers may not be able to agree about all these categories. 
Thus in the original item analysis of the general health 
questionnaire Goldberg decided to use three categories only: 
absent, mild and severe. Patients falling between these categories 
were excluded. In the present study too few patients were 
available to allow exclusions. As in the example above, three 
categories of morbidity were used: absent, mild and "case.” "Mild” 
meant an observer rating of one, while ”case” was defined as an 
observer depression or anxiety rating of two or above. This method 
would not be expected to give as good discrimination as one which 
excluded patients who could not definitely be placed in a given 
group.
Since the Leeds scales are scored differently from the general 
health questionnaire, the above method of item analysis is not
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appropriate. Items in the Leeds scales were analysed by 
calculating the correlation coefficients between observer ratings 
of depression and anxiety and relevant items. This was the method 
used by Snaith &t cd. in the development of the Leeds scales.76
Ideally a validity study would be purpose designed, using a sample 
known to have a reasonable prevalance of morbidity —  for example 
30%. A low prevalence of morbidity might make the validity 
co-efficients unreliable. In the present work, the validity study, 
being an extension of the main study of the effects of different 
treatments, had to capitalize on existing data. Although previous 
work suggested that prevalences of 20% or more could be expected, 
it was soon apparent that levels of morbidity were often low. A 
sample of patients with adequate prevalences of depression, 
anxiety, somatic and social symptoms had to be found. In the event 
the sample which came closest to this requirement proved to be 
those stage II patients allocated to chemotherapy alone or 
combined with radiotherapy, at 13 months after operation, as will 
be described in chapter 7.
Effect of age on Leeds anxiety scores
A supplementary question which arose during the study will also be 
examined in chapter 7: the effect of age on Leeds anxiety scores. 
When designing the Leeds scales, Snaith and his colleagues began 
with a large pool of possible items. An item analysis was then 
undertaken to remove those correlated with demographic factors 
such as age and social class. Therefore the final versions of the 
two Leeds general scales should not have shown any correlations 
with age.
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However, in a cross-validation study, Snaith and colleagues found 
an unexpected, significant negative correlation between Leeds 
anxiety scores and age. On this basis they recommended that in 
comparing anxiety levels in different age groups, the scores of 
older patients should be weighted as follows: age <30, add 0 to 
score; age 30-39, add 1 to score; age Zj.0-49, add 2 to score; age 
50-59, add 3 to score; age 60+, add li to score. The authors 
suggested that people became less anxious as they grew older.76
Where allowance for age is necessary in this thesis, the age 
correction factor has not, however, been applied. In chapter 7 it 
is shown that in control subjects (benign breast and 
cholecystectomy) there were no significant correlations between 
age and uncorrected Leeds anxiety scores; indeed application of 
the correction factor led to significant positive correlations 
with age. Thus the age correction factor seemed of dubious 
validity —  perhaps not surprisingly since the significant 
negative correlation with age noted by Snaith and colleagues 
should not have arisen in the first place.
In subsequent chapters age is allowed for either by subdividing 
treatment groups by age, or by constructing matched pairs.
C H A P T E R  3 :
PSYCHOSOCIAL MORBIDITY PRIOR TO BREAST BIOPSY
The aims of the research reported in this chapter were: (1) to 
determine how specific to breast surgery is pre-operative 
psychological morbidity, by comparing women undergoing breast 
biopsy with those undergoing routine elective surgery; (2) within 
patients awaiting breast surgery, to identify those most 
vulnerable to emotional distress.
The selection of patients has been described in chapter two. Three 
groups of patients were studied: those undergoing frozen section 
biopsy who proved to have cancer; those who proved to have benign 
disease; and those awaiting elective cholecystectomy.
Interviews took place on the afternoon or evening prior to the day 
of surgery, but since the patients were also interviewed after 
surgery, scores obtained on the Eysenck personality inventory and 
the Mill Hill test of verbal intelligence were available for most 
of them. Where appropriate, these scores were also used in the 
analysis of results.
The cancer patients were older, on average, than those with benign 
disease. However, the two breast biopsy groups were not matched by 
age, since the resultant selected groups would not be 
representative samples of the populations from which they were 
drawn. Within the two breast biopsy groups, the relationship 
between age and ratings of psychological distress was examined. 
Comparisons were then made according to age group. Multiple 
regression analysis was used in the hope of identifying those
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breast biopsy patients most prone to psychological distress. In 
the cholecystectomy group, associations between physical symptom 
scores and ratings of psychological morbidity were explored.
RESULTS
Forty-three consecutive patients with benign disease and k8> 
consecutive patients with cancer were asked to participate in this 
part of the study. Four in the benign group were excluded (two 
refused, one did not speak English and one was mentally 
handicapped). Four cancer patients also refused (Appendix 5), 
leaving samples of 39 and kk respectively. A further eight 
consecutive patients with benign disease were subsequently 
recruited (this was done mainly to increase the size of the benign 
group after surgery —  see chapter 6). However, these extra 
patients gave a final sample of k7 in the benign group before 
surgery. Of 30 women awaiting elective cholecystectomy, none 
refused to take part.
Table 3-1 illustrates the age differences amongst the three 
groups. Mean age was lowest for patients with benign disease, 
intermediate for cholecystectomy patients, and highest for breast 
cancer patients. Otherwise demographic data for the three groups 
were similar. The benign group tended to have higher Eysenck 
personality inventory neuroticism scores than the other groups, 
though differences were not significant. There was no association 
between age and Eysenck neuroticism scores in any of the groups.
Table 3-2 shows the results of the observer scales prior to 
operation. Patients with benign disease were significantly more 
depressed and irritable than patients with cancer or gall-bladder
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disease. The benign group also tended to show more anxiety and 
loss of libido. The cholecystectomy group showed a trend towards 
greater lethargy than the other groups. Social dysfunction tended 
to be higher in the cholecystectomy and benign groups compared 
with the cancer group.
A similar pattern was seen on the self rating scales (table 3-3). 
Patients with benign disease were more anxious and depressed than 
the cancer or cholecystectomy patients, although the differences 
were not statistically significant. However, the cholecystectomy 
patients had significantly more somatic symptoms than the other 
groups. Both they and the benign breast patients showed more 
social dysfunction than the cancer patients.
The cancer and benign disease patients were then subdivided into 
two groups: those aged li5 or under and those aged U6 or above 
(tables 3-li and 3-5). Cancer patients aged U5 or under were very 
significantly more anxious, and showed significantly more loss of 
libido, than cancer patients aged U6 or above. They tended to be 
more depressed and irritable. In contrast, benign disease patients 
aged U6 or above tended to be more depressed and had significantly 
greater social dysfunction, than those aged U5 or under.
Mean physical symptom scores were 0.93 (range=0-4) for the
cholecystectomy patients, but only 0.07 and 0.09 for the cancer 
and benign groups respectively (p<.0001). Table 3—6 shows the 
nonparametric correlation coefficients between physical symptoms 
and observer and self rating scales in the cholecystectomy group. 
All correlations were positive. On observer ratings, correlations 
were significant mainly for scales with little or no psychic
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content. However, on self ratings, there was a significant 
correlation between physical symptoms and Leeds anxiety scores.
Prediction of morbidity
Several stepwise multiple regression analyses were performed in 
the breast biopsy patients. Independent variables were age, social 
class, marital status, work status, previous history of serious 
illness, previous psychiatric history (that is, having received 
psychotropic medication prior to discovery of breast disease), 
religious observance, education, time from discovery of breast 
lump to outpatient clinic, time on the waiting list, living alone, 
and knowledge of friends or relatives with breast cancer. The 
dependent variables were scores on the general health 
questionnaire, and on the Leeds depression and Leeds anxiety 
scales.
Analyses were performed first for patients with benign disease, 
but none of the independent variables predicted morbidity. 
Positive results emerged in the cancer group. Table 3-7 shows the 
correlation matrix for the Ml cancer patients. Time on the waiting 
list (mean=5.3 weeks) was the only variable associated with 
increased morbidity as measured by the general health 
questionnaire (r=0.3H; P=0.025). There were no predictors of Leeds 
depression scores. However, two variables independently predicted 
Leeds anxiety scores (table 3-8): age, and a previous history of 
having received psychotropic medication. Together, they accounted 
for a quarter of the variance (R2=0.25; adjusted R2=0.22; p<.003). 
Time on the waiting list just failed to reach significance as a 
third independent predictor of anxiety.
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SUMMARY OF RESULTS: CHAPTER 3
In patients awaiting cholecystectomy, somatic symptoms and social 
dysfunction were prominent, and there was a significant 
association between physical symptoms and anxiety.
Patients who proved to have benign disease had the highest levels 
of psychological morbidity. Social dysfunction was also prominent 
in this group.
Patients who proved to have cancer, considered as a whole, did not 
appear to have more symptoms than the cholecystectomy control 
group.
Within the cancer group, however, patients age U5 or less had 
high levels of psychological morbidity. Multiple regression 
analysis showed that a previous history of psychological upset 
made a further, independent contribution to pre-operative anxiety 
in the cancer patients.
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C H A P T E R  4 :
THE PSYCHOSOCIAL EFFECTS OF ADJUVANT CHEMOTHERAPY
In this chapter the psychosocial effects of adjuvant chemotherapy 
are compared with those of radiotherapy. Patients with stage II 
cancer were randomized to receive radiotherapy, adjuvant chemo­
therapy or radiotherapy followed by chemotherapy (figure 4-1).
RESULTS
Seventy-nine patients were invited to participate in this part of 
the study. Five (four in the combined radiotherapy/chemotherapy 
and one in the chemotherapy alone group) refused to do so 
(Appendix 5)* Of the 74 patients remaining, 24 were allocated to 
receive radiotherapy, 27 to receive chemotherapy and 23 to receive 
combined therapy. The treatment groups were similar in respect of 
age, social class, marital status and previous psychiatric history 
(table 4-1). During the course of the study, six patients refused 
further psychiatric interviews (table 4-2). A further six patients 
refused to continue chemotherapy but agreed to further interviews. 
Four patients developed local regional recurrence and 15 (20%) 
disseminated disease. Nine (38%) of the 24 radiotherapy patients 
had died by 24 months, compared with only six of 50 (12%) in the 
two chemotherapy groups (p<0.035* Table 4—3 gives sample sizes at 
each time interval after operation.
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Psychological symptoms
Prevalences of symptoms are shown as the percentages of patients 
scoring above threshold scores for morbidity. In the case of the 
observer scales, barcharts (figures 4-2 to 4-12) show the 
percentages with a score of one or above. Barcharts for the self 
rating scales show the percentages scoring above the relevant 
threshold for morbidity (these thresholds are discussed further in 
chapter 7)* The actual numbers of patients scoring above the 
threshold are also given, at the base of each bar.
The prevalences of depression, anxiety and behaviour upset 
(irritability) measured by the observer scales are illustrated in 
figure 4-2. The prevalences of depression and anxiety at one month 
following mastectomy in the radiotherapy-alone group were 33% and 
38% respectively, both falling to 14% at one year. The prevalences 
of anxiety and depression in the two chemotherapy groups were 
similar at one, three and six months. At 13 months, however, there 
was an excess of depression (p<0.1), and a significant excess of 
anxiety (p<0.05) in the chemotherapy groups.
At one month the prevalence of behaviour upset in the radiotherapy 
group was 13%, and 22% in both the chemotherapy groups. At one 
year, the prevalence in the radiotherapy group was only 5% 
compared with 25% and 27% in the two chemotherapy groups. This 
difference was nearly significant (p<0.07, using Fisher’s exact 
probability test with the two chemotherapy groups combined, 
because of small expected frequencies).
At 18 months, prevalences of depression, anxiety and irritability
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fell in the two chemotherapy groups, but there was an apparent 
increase in morbidity in the radiotherapy-alone group. However, 
examination of individual scores showed that virtually all the 
morbidity in that group occurred in patients with systemic 
relapse. All five patients with systemic disease scored positively 
for depression or anxiety, compared with none of the disease-free 
survivors (p<0.001). Only one of the five was still alive at 24 
months.
Figure 4-3 shows the prevalences of morbidity as measured by the 
60-item general health questionnaire and two of its subscales —  
anxiety/insomnia and severe depression. Figure 4-4 shows 
prevalences on the Leeds depression and anxiety scales. The 
pattern is similar to that seen on the observer scales. There were 
no significant differences among groups up to six months after 
surgery. At 13 months on the 60-item general health questionnaire, 
on the anxiety/insomnia subscale and on the Leeds anxiety scale, 
there was a trend towards more morbidity in the two chemotherapy 
groups compared with the radiotherapy group, though differences 
were not significant. However, on both the severe depression 
subscale and the Leeds depression scale, there was a significant 
excess of morbidity in the two chemotherapy groups (using Fisher's 
exact probability test with data from the two chemotherapy groups 
combined, because of small expected frequencies).
In the second year, prevalences measured by the self rating scales 
generally fell. There was no clear rise in morbidity in the 
radiotherapy group at 18 months, but two of the five radiotherapy 
patients with systemic relapse had felt too ill to complete self 
rating scales.
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Somatic and social problems
Figure ZJ.-5 shows the observer* ratings of under activity, routine 
upset and work/housework problems. The pattern on all three scales 
is similar. At one and three months after operation, there were no 
significant differences among groups. At both six and 13 months, 
morbidity in the radiotherapy group was lower than in the two 
chemotherapy groups. On the routine upset scale, these differences 
were statistically significant. In the second year, morbidity in 
the chemotherapy groups lessened. However, at 18 months in the 
radiotherapy group, there appeared to be a slight peak in
morbidity, similar to that seen on the observer depression, 
anxiety and behaviour scales.
Results of the somatic and social dysfunction subscales of the
general health questionnaire are shown in figure li-6. As with the 
observer scales, there were no significant differences among
groups up to three months. At six months, the radiotherapy 
patients tended to show more morbidity relative to the other 
groups than they did on the corresponding observer scales.
However, at 13 months, results were similar to the observer 
scales: both chemotherapy groups experienced more morbidity than 
the radiotherapy group. Using 3 by 2 X2 tests, these differences 
were not significant, but when the results for social dysfunction 
were re-analysed by Kruskal-Wallis analysis of variance, the 
differences were significant at less than the 5% level. In the 
second year morbidity was mostly lower than during the first year.
113
Loss of libido
In figure ZJ.-7 loss of libido is seen "to be similarly distributed 
among the three treatment groups.
Results for larger cohort of patients
Since an additional series of stage II patients had been seen for 
the first time at 13 months, it was of interest to merge it with 
the preceding sample to provide results for a larger group of 112 
patients. Table H-U. shows the demographic data for the additional 
patients and table ZJ.-5 the new sample sizes at the three time 
intervals during the second year.
Results for the larger cohort are shown in figures H-& to U-12. On 
the whole they confirmed those from the smaller cohort. Results at 
13 months for the 60-item general health questionnaire and for the 
observer under activity scale became statistically significant.
Population estimate of degree of morbidity associated with 
chemotherapy.
The larger sample gave an opportunity to estimate the theoretical 
extent of morbidity in the population from which it was drawn. 
Since the two groups allocated to chemotherapy were, by one year, 
essentially similar, they were merged for this purpose. Of 76 
patients allocated chemotherapy alone or after radiotherapy, 15 
(20%) scored 2 or more on the observer depression scale. The 95% 
confidence intervals were 11-29%. The proportions classified as 
depressed by both the severe depression subscale of the general
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health questionnaire and the Leeds depression scale were 
identical: 28%, with 95% confidence intervals of 18-38%.
So in round terms around a quarter of patients intended to 
complete chemotherapy at 13 months after operation were clinically 
depressed. This percentage would have been marginally higher had 
those patients not completing chemotherapy been excluded.
In the radiotherapy alone group, the prevalences of depression 
were very low at 13 months: 6% of 36 patients scored 2 or more on 
the observer scale; none scored above the threshold on the severe 
depression subscale and only 3% above the threshold on the Leeds 
depression scale. These prevalences were too low to allow the 
calculation of valid confidence intervals. (For example, the ”95% 
confidence intervals” for 6% of a sample of 36 were -2% to lZj.%.)
Further information on levels of morbidity, based on a sample of 
mixed stage I/II patients, is given in Chapter 6.
Conditioned reflex symptoms.
In the cohort of patients allocated chemotherapy (alone or after 
radiotherapy) who were first seen at 13 months after mastectomy, 
it was found that several had felt sick or vomited before, their 
injection of chemotherapy. After repeated drug-induced nausea and 
vomiting, they had begun to feel sick or vomit in response to 
previously neutral stimuli, such as the sight or smell of the 
hospital and medical equipment such as syringes or needles. As 
will be discussed further in chapter 8, these symptoms appeared to 
arise from a classical Pavlovian conditioning process. In the
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cohort first seen at 13 months, the occurrence of conditioned 
reflex symptoms was not recorded systematically and figures for 
their prevalence would probably be an underestimate. However, the 
stage II patients seen prospectively from one month onwards were 
always asked about conditioned reflex symptoms; the prevalences 
reported below should therefore be accurate.
Three months after operation two patients who had received
radiotherapy alone and three receiving chemotherapy alone were 
experiencing conditioned reflex nausea without vomiting.
Thereafter this problem ceased in patients who had received
radiotherapy alone. At six months in both groups allocated to 
chemotherapy 15 of 46 (33%) patients had conditioned reflex nausea 
and six (13%) conditioned reflex vomiting. At 13 months, in those 
46, the prevalence of conditioned reflex nausea and vomiting had 
risen considerably, the corresponding figures being 27 (59%)
(p<.002) and 16 (35%) (p<.01). Furthermore, conditioned reflex
symptoms persisted beyond cessation of treatment. At 18 months,
11 of 41 (27%) had conditioned reflex nausea and three (7%)
conditioned reflex vomiting. Even at 24 months, seven of 39 (18%) 
still had conditioned reflex nausea.
As in the cohort first seen at 13 months, the conditioned stimulus 
was most often something in the hospital environment, but anything 
associated with the administration of chemotherapy might 
subsequently of itself induce nausea or vomiting. One woman 
vomited when she saw a member of the clinic staff in a shop. Other 
stimuli included clothes worn or perfume used whilst attending for 
treatment, or the mere thought of treatment. Where possible 
patients sought to avoid experiencing such stimuli again. A year
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after completing treatment, a 31-year-old patient talked of her 
"sick coat” She had worn it during treatment, but now it was 
hidden at the back of her wardrobe, to stop her feeling sick 
again. Another patient who had completed chemotherapy tried to 
remove what she experienced as the nauseous smell of the hospital 
from some of her clothes by washing them repeatedly. After her 
attempts had failed she threw the clothes away.
Physical symptom scores
Physical symptom scores among groups (table H-6) were similar up 
to three months after operation, but at six and 13 months were 
significantly higher (pc.001) in the two chemotherapy groups. At 
18 months the trend was reversed (p<0.1), reflecting systemic 
relapse in the radiotherapy-alone group.
Relationship between mood and physical symptoms
To what extent were the anxiety and depression of chemotherapy 
associated with physical symptoms? This question was examined in 
the HO patients who actually completed the chemotherapy course. 
Inclusion of the six who did not finish treatment (and who 
experienced very few dysphoric or physical symptoms) would have 
obscured the meaning of any correlations found. Table H-7 shows 
the Spearman correlation coefficients between ratings of mood and 
physical symptoms in these HO patients at 13 months after
mastectomy. Coefficients were first calculated for the total
physical symptom score and then for the commoner individual
physical symptoms, namely nausea, vomiting, irritation of mucous
membranes, and alopecia.
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There were modest positive correlations between all ratings of 
mood and the total physical symptom score, and also between mood 
and nausea. None was statistically significant. However, 
correlations between ratings of mood and vomiting, and between 
mood and irritation of mucous membranes, tended to be larger and 
several were significant. In contrast, correlations between 
ratings of mood and alopecia were all negative. Indeed the 
negative correlation between observer anxiety and alopecia was 
Just significant at the five per cent level.
Relationship between mood and conditioned reflex symptoms
There were several positive correlations between mood and 
conditioned reflex symptoms (table ZJ.-8). For conditioned nausea 
the correlations were larger than for conditioned vomiting. All 
but one of the correlations with nausea, but only one of those 
with vomiting, were significant.
An association between mood and conditioned reflex symptoms might 
merely reflect two other associations: that between mood and
physical symptoms; and the inevitable association between 
conditioned reflex symptoms and physical symptoms (conditioned 
symptoms being dependent on pre-existing nausea and vomiting). A 
comparison was therefore made between the nine patients who had 
nausea or vomiting without any conditioned reflex symptoms, and 
the 29 patients who had nausea or vomiting combined with either 
conditioned reflex symptom (tables H-9 and ZJ.-10).
Table ZJ.-10 shows that despite the small numbers, there was a
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strong trend for the patients who had conditioned reflex symptoms 
to have greater mood disturbance than those who did not. This 
trend was statistically significant for the Leeds depression and 
anxiety scales. The two groups did not differ significantly in 
age. (In chapter six it will be shown that there was a significant 
negative correlation between age and morbidity at 13 months,)
Other correlates of conditioned reflex symptoms.
Thus both mood and the length of time on treatment were related to 
conditioned reflex symptoms. Were any other patient variables 
significantly associated with liability to conditioned reflex 
symptoms? A search for additional correlates, by cross-tabulations 
and breakdown of demographic and other background data (see 
proforma) with conditioned reflex nausea and vomiting was 
negative. In particular, no relationship could be shown with 
Eysenck Personality Inventory scores. The mean (SD) Eysenck 
neuroticism score in patients without conditioned symptoms was 9.3 
(H.7); in those with conditioned symptoms it was 8.9 (5.7). For
extraversion the corresponding figures were 10.9 (2.7) and 11.1 
(3.6).
Other correlates of mood disturbance.
Mood disturbance in patients receiving chemotherapy was associated 
positively with physical symptoms, except for hair loss. What 
other factors influenced liability to mood disturbance?
The examination of this question is deferred until chapter 6, 
where predictors of morbidity at 13 months after mastectomy are
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examined in a larger sample of 79 stage I and II patients. (The 
multiple regression analyses reported in chapter 6 show that the 
main independent predictors of morbidity at 13 months were age, 
Eysenck neuroticism scores, previous scores on the questionnaires 
measuring mood, and treatment with chemotherapy.)
Patients' opinions of their treatment.
The patients’ responses to the question ’’How do you feel about 
your treatment”, recorded verbatim at the six month assessment, 
are given in Appendix 6. Clearly there were more adverse comments 
about chemotherapy than about radiotherapy. One patient stated 
that chemotherapy was the worst thing that had ever been thought 
up. She said that the clinic had been nicknamed ’’Belsen" because 
chemotherapy made people look like the victims of a Nazi 
concentration camp.
Patients in the combined radiotherapy/chemotherapy group were 
asked to compare the two forms of treatment. All but two of the 23 
patients were already in no doubt that the adverse effects of 
chemotherapy were worse than those of radiotherapy (p<.001 —  
binomial test). Of the two patients who did not think that 
chemotherapy was worse, one said that the two treatments were 
about equal and the other that radiotherapy was worse. By 13 
months, however, the latter patient had become depressed and 
reversed her previous opinion about the two treatments.
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Other observations.
A few patients on chemotherapy reported that they felt low for a 
few days after each injection. This feeling did not always last 
long enough to qualify for a depression rating of 1.
Chemotherapy was the only treatment to induce suicidal thoughts, 
which usually occurred at the point in the treatment cycle when 
physical toxicity was maximal. Such thoughts were not persistent. 
With the exception of one patient with a long history of 
endogenous depression antedating mastectomy, no patient required 
admission to a psychiatric ward.
Several patients reported that in the days preceding each visit to 
the chemotherapy clinic they became anxious because they feared 
further conditioned reflex symptoms.
On the other hand some patients derived a sense of security from 
the fact of getting treatment and regular check-ups at the clinic. 
For that reason, some had mixed feelings about stopping treatment.
While loss of libido was not significantly different among the 
three treatment groups, three patients on chemotherapy reported 
unaccustomed pain on intercourse which they related to the 
treatment. This problem seemed to stem from the adverse effect of 
chemotherapy on mucous membranes. Two patients reported anxieties 
about contraception, being afraid they might conceive a child 
malformed by chemotherapy.
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SUMMARY OF RESULTS: CHAPTER 4
Psychosocial symptoms were assessed over* two year*s in a randomized 
trial of three forms of treatment following mastectomy for Stage 
II breast cancer. The treatments were: (1) three weeks of
radiotherapy; (2) one year of adjuvant cyclophosphamide, 
methotrexate and 5-fluorouracil; (3) radiotherapy followed by 
chemotherapy. Analysis of the results on an intention-to-treat 
basis showed no appreciable differences among groups in 
depression or anxiety at one, three and six months after 
operation. However, at six months significantly more patients 
allocated to chemotherapy reported disturbance of their daily 
routine.
At 13 months, patients who had been allocated to chemotherapy 
(alone or after radiotherapy) showed significantly more 
depression, anxiety and social dysfunction than control patients 
treated with radiotherapy alone. About a quarter of patients in 
the two chemotherapy groups were clinically depressed. Conditioned 
reflex nausea and vomiting increased markedly during the second 
six months of chemotherapy, and persisted for up to a year 
thereafter.
Mood disturbance was significantly more likely to occur in 
patients subject to drug-induced vomiting and irritation of mucous 
membranes, However, alopecia was not associated with increased 
mood disturbance. There was a positive association between mood 
upset and conditioned reflex nausea and vomiting.
Mood disturbance also seemed linked to systemic recurrence of 
cancer.
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C H A P T E R  5 :
THE PSYCHOSOCIAL EFFECTS OF POSTOPERATIVE RADIOTHERAPY
In "this chapter* the psychosocial effects of radiotherapy after* 
mastectomy are investigated. Psychosocial morbidity in patients 
with stage II breast cancer who received post—operative 
radiotherapy was compared with that in patients with stage I 
cancer who received no further treatment after mastectomy.
In chapter 2 it was pointed out that to increase statistical 
power, the stage II patients who received radiotherapy and those 
who received radiotherapy followed by chemotherapy were merged for 
comparison with the stage I patients. A possible drawback was that 
morbidity in the radiotherapy followed by chemotherapy group might 
have been affected by knowledge of impending chemotherapy. 
However, the results reported in chapter H showed that at one and 
three months, morbidity did not differ significantly in the 
patients who received radiotherapy alone and those who had 
chemotherapy in addition. Therefore it seemed Justifiable to merge 
the groups in this way, and to refer to the combined group as the 
"radiotherapy group". Obviously, the patients who went on to 
receive chemotherapy had to be excluded from the analysis after 
the three month assessment.
RESULTS
Forty-three stage I and 51 stage II patients were invited to 
participate in this section of the study. Four in each group 
refused to do so (Appendix 5). Table 5-1 shows that the 
demographic and other background data for the two groups were
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similar.
Tables 5-2 and 5-3 show the scores on the observer and self rating 
scales at one and three months after operation for patients 
allocated to radiotherapy or to no further treatment. At one 
month, prior to treatment, there were only minor differences 
between the two groups, none of which was significant. At three 
months, patients who had completed radiotherapy two to three weeks 
previously showed significantly higher observer scores for 
lethargy (p<0.001) and routine upset (social dysfunction) (p<0.04) 
than those not so treated. They also scored significantly higher 
on the general health questionnaire p<0.04) and on its somatic 
symptoms subscale (p<0.05). They tended to score higher on the 
social dysfunction subscale (p<0.07).
At six months, observer ratings showed that the marked trend 
towards excess lethargy in patients who had received radiotherapy 
was maintained (table 5-4). These patients scored higher on the 
general health questionnaire (p<0.04) and on the somatic symptom 
subscale (p<0.04) (Table 5-5). Neither observer nor self ratings 
demonstrated any excess of anxiety or depression in the 
radiotherapy group.
By 13 months, the trend towards excess lethargy and somatic 
symptoms in patients treated with radiotherapy had stopped. 
Although there were no significant differences between groups on 
any of the scales, there was a slight trend towards more anxiety 
and depression in patients not given radiotherapy.
Physical symptom scores (Table 5-6) were similar at one month
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after operation, but at three months were markedly higher in the 
radiotherapy group (p<0.001). Thereafter there were no significant 
differences between the groups.
To determine whether psychological morbidity in the radiotherapy 
group at three months was associated with physical symptoms, 
Spearman correlation coefficients between ratings of morbidity and 
physical symptom scores were calculated (table 5-7). All but one 
of the coefficients were positive, but only three approached 
significance on two tailed tests: those with behaviour upset, with 
the somatic symptom subscale of the general health questionnaire, 
and with the social dysfunction subscale. All three were 
significant using one tailed tests. However, the scatter gram of 
the physical symptom score with behaviour upset showed that the 
positive correlation was largely due to the influence of a single 
outlying point, namely a patient with a behaviour score of 2 and a 
physical symptom score of 6. There were no such influential points 
in the scattergrams of physical symptoms with somatic symptoms and 
social dysfunction. Thus there was no convincing relationship 
between physical symptoms and ratings of mood; rather, physical 
symptoms seemed to be associated with somatic and social 
dysfunction.
Conditioned reflex symptoms
Two patients who had felt sick during radiotherapy experienced 
conditioned reflex nausea on re-entering the treatment centre. In 
both patients this symptom was mild and short-lived; neither had 
conditioned reflex vomiting.
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Patients' opinions of their treatment.
The verbatim reponses of the radiotherapy patients to the 
question, ’’How do you feel about your treatment?’* are given in 
Appendix 6. Five of 23 patients described radiotherapy as having 
been ’’very severe”, ’’very unpleasant”, ’’very rough”, ’’horrible” 
and ’’terrible”.
Some patients told the author that they had been frightened by the 
radiotherapy machine. Two stated they could never go through the 
treatment again. A few had been distressed by seeing patients with 
advanced cancer. One patient feared radiotherapy might cause 
long-term physical harm.
However, at least half of the 23 had no particular complaints 
about their treatment. Reassurance by the radiographers seemed to 
have allayed the fears of some of them. One patient said she felt 
insecure after completing her treatment because she was no longer 
getting frequent check-ups. Psychological upset associated with 
radiotherapy was mostly short lived but occasionally resulted in 
increased ratings of anxiety at three months.
Most non-radiotherapy patients interpreted their lack of 
post—operative treatment favourably, but there were exceptions. A 
few became anxious in the context of not receiving further 
treatment. For example, one patient feared her illness was too 
serious to Justify any further intervention. She experienced acute 
anxiety leading to a panic attack which she interpreted as a sign 
of metastatic disease. Unlike the radiotherapy patients, she 
attended the outpatient clinic only every six months and several 
weeks elapsed before she was reassured.
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SUMMARY OF RESULTS: CHAPTER 5
Psychosocial morbidity was compared in 47 patients who received 
post—operative radiotherapy and 39 who received no further 
treatment after mastectomy.
One month after operation, prior to radiotherapy, there were no 
significant differences between the two groups on any of the 
measures of psychosocial morbidity.
At three months, patients who had completed radiotherapy had 
significantly more somatic symptoms and social dysfunction than 
those not so treated. At six months the radiotherapy group 
continued to show more somatic symptoms. A year after operation, 
there were no significant differences between groups.
Several patients receiving radiotherapy were seriously upset by 
their treatment. While somatic symptoms were the main problem, 
some patients experienced anxiety, usually short-lived. This 
anxiety was not associated with physical symptoms and appeared to 
stem partly from environmental factors in the radiotherapy 
department. However, occasional node negative patients, who were 
seen infrequently after surgery, were not reassured in the absence 
of post operative treatment and also became anxious. Overall, 
results failed to confirm that depression and anxiety were 
commoner in patients who received radiotherapy than in those who 
received no further treatment.
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C H A P T E R  6 :
MORBIDITY IN A STAGE I/II SAMPLE: ITS EXTENT AND PREDICTION
In this chapter psychosocial morbidity is examined in more detail 
in a consecutive sample of 90 patients with stage I or II breast 
cancer. This more general sample comprised firstly: 39 patients 
with stage I cancer, who served as the control group for the 
radiotherapy study reported in chapter 5; secondly, 51 patients 
with stage II cancer. The latter group consisted of the first 5 1  
of the 74- patients in the chemotherapy study reported in chapter 
H. The final 23 of the 7& were excluded because after the first 5 1  
the author had stopped recruiting new patients with stage I 
cancer. If the final 23 had been included, the sample would not 
have been drawn from a truly consecutive series of patients with 
stage I/II breast cancer.
The aims of the more detailed analysis were:
(1) To obtain more precise estimates of the levels of morbidity 
over a two-year period. This would allow comparisons with the 
results of other researchers who had studied samples of stage I 
and II breast cancer.
(2) To seek factors contributing independently to morbidity in 
this group. An association between chemotherapy and psychological 
morbidity has already been shown. If other factors contributed to 
morbidity, patients liable to problems could perhaps be 
identified.
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Handling of control groups.
Before these analyses, a decision was necessary on how to allow 
for the age differences between the cancer patients and those with 
frsnign or gall bladder disease, already noted in chapter 3 
(pre-operative results). In particular, the age difference between 
the cancer and benign groups was unexpectedly large (difference 
between means = 15*9 years). Although the method of analysis by 
age could be different from that reported in chapter 3 —  the 
benign group was now a control group instead of an experimental
group --- it was thought important to avoid any method which
selected a biased subsample of the cancer patients. Such bias 
would obscure estimates of levels of morbidity. Subject to this 
constraint, two main methods were considered for the cancer/benign 
comparison.
The first was to examine the effect on age in the cancer and 
benign groups separately, by scattergrams and correlation 
coefficients, and make appropriate allowance for the results 
obtained. The second was by constructing matched pairs, a method 
which would increase statistical sensitivity. To avoid bias in the 
cancer group, this matching could be done by selecting only from 
the benign group.
However, no final decision was made until some preliminary 
analysis had been undertaken. The original pre-operative sample of 
patients with benign disease had comprised 39 patients. Of these 
3& agreed to be seen at one and three months, and 30 at 13 months.
Firstly, levels of morbidity in the benign group were compared at
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"the three assessments (tables 6-1 and 6-2). On all measures there 
were no significant differences in morbidity with time. Next the 
correlation coefficients between age and and the various measures 
of morbidity were calculated (table 6—3). None of these was 
significant, except for an isolated correlation between age and 
the observer rating of (house)work problems. These results 
suggested: (1) a single assessment in the benign group would have 
been sufficient; (2) since mood disturbance in the benign group 
did not vary with age, depression and anxiety in cancer patients 
of any age could be compared with that in the benign group.
However, the latter conclusion was not altogether Justified 
because the age difference between the benign and cancer patients 
was so large. There were few patients aged over 50 in the benign 
group, and since a majority of cancer patients were aged over 50, 
a comparison between them and the benign group was of dubious 
validity. The same problem (too few older patients in the benign 
group) also affected attempts to construct matched pairs by 
selecting patients solely from the benign group.
One solution would have been to recruit more patients with benign 
disease, but to allow enough matches for the older cancer 
patients, a very large sample would need to have been screened. So 
a compromise solution was adopted. The cancer patients were split 
into those aged 50 or above (n=59) and those aged under 50 (n=31). 
A further eight consecutive patients with benign disease were 
recruited, giving a total of U2 at one month after surgery. It was 
then possible to extract from the H2 a subsample of 31 patients 
which matched the cancer patients aged under 50 for age, social 
class and marital status. Matching was exact for marital status,
130
within five years for age, and within one point on the Registrar 
General’s 5-point scale for social class.
This solution meant there were no matches for the older cancer 
patients. However, the subdivision of the cancer patients by age 
meant that the older cancer patients could be compared with the 
younger cancer patients.
Since the cholecystectomy patients were closer in age to the 
cancer patients, it seemed reasonable simply to establish that 
within the cholecystectomy group there were no significant 
correlations between age and morbidity (table 6-4.) and then 
compare that group as it stood with the cancer patients. (The 
correlation coeffient for age with Leeds depression scores (0.37) 
approached significance, with a probability of 0.06. However, 
inspection of the relevant scattergram showed that the coefficient 
was inflated by a single outlying point; correlations for the two 
other measures of depression were negligible.)
Results for the cancer group.
Of the 90 cancer patients who agreed to help with this part of the 
study, 11 died and 11 refused further follow-up over the two 
years. One of the 90 was unavailable at the one-month interview 
but was included subsequently. On two occasions, patients felt too 
ill to complete self-rating scales. The 51 patients with stage II 
disease received post-operative radiotherapy (n=17), a year’s 
course of adjuvant chemotherapy (n=22) or a combination of both 
(n=12); the 39 with Stage I disease received neither.
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The mean (SD) age of the 90 cancer patients was 53*7 (10.4) years. 
Sixty-nine (77%) were married, 2 (2%) divorced, 13 (.2.11%) widowed 
and 6 (7%) never married. Thirty-four (38%) were drawn from social 
classes I and II, 44 (ti9%) from social class III and 12 (13%) from 
social classes IV and V. Twenty-one (23%) gave a history of 
treatment for nervous complaints from their general practitioner, 
and a further 5 (6%) reported previous treatment by a
psychiatrist. Demographic data for the benign and cholecystectomy 
groups have already been given in chapter 3.
Overall morbidity in the cancer patients.
Results were first calculated to show the proportion of all cancer 
patients with clinical depression and anxiety (namely observer 
ratings of two or above) at all assessments (table 6-5)* No more 
than 8% of patients were clinically depressed or anxious at any 
time in the two years after mastectomy, with the exception of 
clinical anxiety at one month (15%)* Likewise the upper 95% 
confidence limits never exceeded 14%, except for 22% in the case 
of anxiety at one month. Clinical morbidity was very low in the 
second year.
Minor morbidity (observer ratings of 1) was common. The 
prevalences of minor depression at 1, 3* 6, 13. 18 and 2.11 months 
were respectively 32%, 24%, 13%. 20%, 15% and 13%. For minor
anxiety, the corresponding figures were 21%, 19%, 19%, 27%, 19% 
and 13%.
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Effects of age on morbidity,
Table 6-6 shows results of all the observer* scales at one month. 
Here the cancer patients are subdivided into those aged under 50 
(n=31, mean age=Zll.6) and those aged 50 or above (n=58, mean 
age=60.2). The former group is compared with 31 matched control 
subjects with benign disease.
Psychological symptoms —  depression, anxiety and irritability —  
were significantly commoner in cancer patients aged under 50 
compared with the control subjects with benign disease and also 
compared with cancer patients aged 50 or above. Loss of libido was 
more severe than mood disturbance, being especially common in 
younger cancer patients. However, about a fifth of married
patients aged 50 or above reported total loss of sexual appetite
following mastectomy.
The pattern of results for non-psychic symptoms, namely under 
activity, change in daily routine (social dysfunction) and 
problems with work and household tasks was different. Whilst the 
younger cancer patients had more problems than the matched
controls, there were no significant differences between the two
cancer age groups. The older cancer patients showed a trend 
towards more serious problems with work and household tasks.
Results of the self rating scales at one month (table 6-7) were 
similar to those of the observer scales. On the 60-item General 
Health Questionnaire, the cancer patients aged under 50 scored 
significantly higher than the matched controls, and higher than
the older cancer patients. The same pattern of scores (high
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morbidity in the younger cancer patients compared with the matched 
controls and compared with the older cancer patients) occurred on 
the Leeds depression scale and on both measures of anxiety. 
Differences for anxiety were statistically significant, or nearly 
so, using two-tailed tests.
Results of the social dysfunction subscale also resembled closely 
the observer findings. The younger cancer patients scored very 
significantly higher than the benign group but both groups of 
cancer patients had high scores.
At three months (tables 6-8 and 6-9), the younger cancer patients 
continued to score significantly higher on measures of depression 
and anxiety, compared with the older cancer patients, but again 
there were no significant differences for non-psychic symptoms 
(under activity, routine and work upset, and somatic symptoms). 
Loss of libido was significantly commoner in younger cancer 
patients.
These tables also show morbidity in the cholecystectomy group. On 
the whole levels of depression and anxiety in this group were 
lower than in the younger cancer patients, and comparable with 
levels in the older cancer group.
At six months (tables 6-10 and 6-11) the pattern was similar to 
that at three months, although for purely psychic symptoms, 
differences between the younger and older cancer patients were 
significant only on the observer depression and the Leeds anxiety 
scale. There was also a significant excess of somatic symptoms in 
the younger cancer patients.
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The effect of age on several of the measures of morbidity was 
still evident at 13 months (tables 6-12 and 6-13)- There was a 
trend towards more depression in the younger cancer patients. The 
cancer patients aged under 50 showed significantly more anxiety 
than those aged 50 or above. However, there were no clear 
differences in symptoms of clinical degree (observer ratings of 2 
or above). Sexual problems, though less common than at one month, 
remained an important source of morbidity.
The full results at 18 and 2/i months, subdivided by age, are shown 
in tables 6-1/i to 6-17. At 18 months (tables 6-1/1. and 6-15) all 
measures of depression or anxiety, except the Leeds depression 
scale, continued to show a strong trend (significant or nearly so) 
towards greater morbidity in the younger patients. However, by 2/i 
months this trend was confined to measures of anxiety.
Unlike depression and anxiety, loss of sexual appetite continued 
to be prominent in the second year after operation. At 18 months 
in married patients, 23% of those aged under 50 and 10% of those 
aged 50 or above reported moderate to severe loss of libido; at 2/i 
months the corresponding figures were 21% and 10%. The first of 
these age differences was statistically significant.
Effects on employment.
At the time of mastectomy, 36 of the original 90 patients had paid 
employment (2/i full-time and 12 part-time). The extent to which 
they resumed work is shown in table 6-18. The category "full 
hours” refers to those patients who had resumed, or virtually
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resumed, their usual pre-operative working hours. "Reduced hours" 
refers to patients whose usual working hours were cut 
substantially (for example, by half).
The full hours category includes certain patients on chemotherapy 
who were usually off work on their injection day, and often the 
following day. Generally employers helped them by rescheduling 
work to fit in with the twice monthly chemotherapy injections, and 
overall their working time was little affected, if at all. It 
seemed best to include them in the full hours category.
Table 6-18 shows that by 6 months, most patients had resumed work, 
and of these only a few had had to reduce their normal working 
hours substantially. At 18 and 2ll months, about four fifths of 
patients were working, none with reduced hours. One patient was 
not working because her employer’s factory had closed down, and 
another who for some time had been thinking of giving up work 
decided to do so after her operation. Otherwise, it was clear that 
treatment for breast cancer had directly caused loss of work.
Independent predictors of morbidity at 13 months
Several stepwise multiple regression analyses were performed to 
determine more precisely the factors contributing independently to 
morbidity at one year. The independent variables included age, 
social class, marital status, work status, previous history of 
serious illness, previous psychiatric history, religious 
observance, education, intelligence, knowledge of friends or 
relatives with breast cancer, follow-up treatment received and 
scores on self rating scales at one month after operation. The
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dependent variables were scores on the General Health 
Questionnaire, on its subscales, and on the Leeds depression and 
anxiety scales at one year. Seventy-nine patients completed these 
scales. The correlation matrix is shown in table 6-19.
Table 6-20 shows the results of the multiple regression analyses 
obtained using the default criteria in the Statistical Package for 
Social Sciences (SPSS-X). In these analyses the variables were 
untransformed, with a probability of 0.5 for variable entry and 
0.1 for variable removal. The main predictors of morbidity at one 
year after mastectomy appeared to be scores on the self rating 
scales at one month, Eysenck neuroticism scores, age and treatment 
with chemotherapy. Prediction seemed best for depression and 
anxiety.
However, inspection of plots of residuals showed that for the 
60-item general questionnaire and two of its subscales (somatic 
symptoms and severe depression), the distribution of the residuals 
deviated from normality (figures 6-1 to 6-3). During the study it 
had become apparent that scores on the 60-item GHQ and these two 
subscales often had a positive skew. This was especially so in the 
case of the severe depression subscale.
The anxiety/insomnia and social dysfunction subscales usually had 
distributions quite close to normality, but the distribution of 
residuals for the social dysfunction subscale was not ideal 
(figure 6-4).
Accordingly, the regression analyses for the 60-item general 
health questionnaire and the somatic symptoms, severe depression
137
and social dysfunction subscales were repeated after 
transformation of the dependent variables. For the 60-item 
questionnaire and its somatic symptoms subscale, scores were 
transformed by adding one and then calculating the Naperian 
logarithms. (Adding one avoided the problem of the logarithm of 
zero.) The behaviour of the residuals improved (figures 6-5 and 
6-6).
In the case of the severe depression subscale, standard 
transformations (square root, addition of one followed by taking 
Naperian logarithms, common logarithms or reciprocals) had only a 
marginal influence on the distribution of the residuals. However, 
a more extreme transformation, namely taking the fourth root, 
seemed reasonably effective (figure 6-7).
The peaked distribution of residuals for the social dysfunction 
subscale was also somewhat resistant to standard transformations; 
the least unsatisfactory was adding one and taking Naperian 
logarithms (figure 6-8).
The results for the regression analyses using the transformed 
dependent variables are given in table 6-21. On the whole the 
transformations improved the models. In the case of the 60-item 
general health questionnaire, three extra predictive variables 
(Eysenck neuroticism, treatment with chemotherapy and verbal 
intelligence) entered the equation, and the proportion of variance 
explained almost doubled. An extra variable (treatment with 
chemotherapy) also entered the equation for social dysfunction, 
though the increase in variance explained was small. There were no 
new variables in the equation for somatic symptoms, but again a
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slight increase in variance explained. Results for the severe 
depression subscale were essentially unchanged.
The final regression equations are set out in table 6-22. The 
coefficients for the independent variables were positive, with two 
main exceptions: those for age and social class. However, in the 
equation predicting the 13 month Leeds depression score, there was 
a counter-intuitive negative sign in front of the one month GHQ-60 
score. Likewise in the equation for the 13 month severe depression 
score, the one month Leeds anxiety score had a negative sign. 
These two negative signs occurred despite adequate tolerances for 
the relevant independent variables. In both cases they were the 
last variables to enter the equation and their omission would have 
had only a minor effect on the variance explained. Inspection of 
residual plots and partial plots for the final equations suggested 
there were no serious violations of the assumptions of homogeneity 
of variance and linearity in the models.
These analyses therefore confirmed that the consistent predictors 
of psychosocial morbidity continued to be the ratings of morbidity 
at one month, Eysenck neuroticism scores, age and treatment with 
chemotherapy.
SUMMARY OF RESULTS: CHAPTER 6
Psychosocial morbidity was examined in 90 consecutive patients 
aged under 70 with Stage I or II breast cancer. In the two years 
after mastectomy, the prevalences of depression and anxiety of 
clinical degree were low: under 10%, except for clinical anxiety
at one month (15%). Confidence intervals showed that the
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prevalences of clinical morbidity in the population from which the
sample was drawn were probably under 15%, except that anxiety at
one month might have been as high as 22%. However, cancer patients 
aged under 50 showed significantly higher prevalences compared 
with cancer patients aged 50 or above and compared with matched 
control subjects with benign breast disease. Social and work
problems were common at all ages. Sexual problems were more severe 
than mood disturbance. Patients at risk of mood disturbance one 
year after operation could be predicted by combinations of age, 
Eysenck neuroticism scores, self ratings of mood at one month 
after operation, and whether or not they were receiving
chemotherapy.
mo
C H A P T E R  7:
PERFORMANCE OF THE SELF RATING SCALES
This chapter contains an analysis of the performance of the self 
rating scales used in this study: the general health questionnaire 
and its subscales; and the Leeds general scales for the self 
assessment of anxiety and depression. These scales are compared 
with observer ratings.
As outlined in chapter 2, a sample with reasonably high 
prevalences of morbidity (depression, anxiety, somatic symptoms 
and social dysfunction) had to be found. The sample closest to 
this ideal was the series of stage II patients (reported in 
chapter 4) who were completing (or were intended to complete) 
chemotherapy at 13 months after operation.
There were 45 patients allocated to chemotherapy alone or combined 
with radiotherapy who had been followed up prospectively from one 
month onwards and who completed self rating scales at 13 months. 
However, an additional 30 similar patients had been assessed for 
the first time at 13 months, mostly by Dr A F Cooper, allowing a 
total sample of 75 to be used.
RESULTS
The mean age (SD) of the 75 patients was 51.2 (11.0) years. Fifty 
(67%) were married, 2 (3%) separated or divorced, 10 (13%) widowed 
and 13 (17%) never married. The social class distribution was: I — 
2 (3%); II - 26 (35%); III - 36 (48%); IV - 7 (9%); V - 4 (5%). 
Nineteen (25%) reported previous treatment for psychological
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symptoms by their* general practitioner, and a further 3 (Zj.%) had 
been treated by a psychiatrist. Forty-eight of the 75 patients 
were interviewed by the author and 27 by Dr A F Cooper.
Results for the general health questionnaire
Table 7-1 shows the Spearman rank-order correlation coefficients 
between observer scores and the general health questionnaire and 
its subscales.
Figure 7-1 shows the Receiver Operating Characteristic (ROC) 
curves for the 60-item and 28-item general health questionnaire 
scales. Since the ROC curves are bowed considerably above the 
diagonal, both versions of the questionnaire performed much better 
than chance. The areas under the curves, found by counting 1mm 
squares on graph paper, were 0.97 (60-item) and 0.98 (28-item).
Since ROC curves are subject to sampling variation, standard 
errors were calculated for the plotted points. Each point has two 
standard errors, one in the horizontal plane and the other in the 
vertical plane.88 Some of the percentages corresponding to these 
points (for example 0% and 100%) were either too small or too 
large for meaningful standard errors. However, examples of more 
valid standard errors were 9.0% in the vertical plane and 3.7% in 
the horizontal plane for the point where sensitivity was 87% and 
false positive rate 8%. Likewise where sensitivity was 80% and the 
false positive rate 3%, the standard errors were 10.7% (vertical) 
and 2.2% (horizontal). The other standard errors which could 
reasonably be measured were of similar size. Standard errors in 
the vertical plane were larger than those in the horizontal plane
1U2
because the sample of cases (15) was smaller1 than that of
non-cases (60).
Some of the sensitivities and specificities corresponding to these 
ROC curves are shown in tables 7-2 and 7-3. On the General Health 
Questionnaire 60-item scale, with a threshold score of 12 or above 
to define morbidity, sensitivity was 100% but specificity only 76%
(table 7~2). Doubling the threshold score to 24 or above caused
the sensitivity to fall to 87% but the specificity to rise to 97%.
For the 28-item version of the General Health Questionnaire 
(table 7-3) doubling the threshold score to 10 or above gave the 
best discrimination between cases and non-cases.
Figures 7-2 and 7-3 show the ROC curves for the four subscales of 
the General Health Questionnaire. Although the curves deviate
considerably from the diagonal, those for the somatic symptoms 
subscale and the social dysfunction subscale seem less close to 
the ideal than those for the anxiety/insomnia or severe depression 
subscales. The areas under the ROC curves were 0.82 (somatic 
symptoms), 0.90 (anxiety/insomnia), 0.85 (social dysfunction) and 
0.81 (severe depression).
Table 7-4 shows sensitivities and specificities corresponding 
to the ROC curves for the subscales. As defined by the observer 
ratings, there were 22 cases of under activity (somatic symptoms), 
23 of anxiety and insomnia, 27 of social dysfunction and 14 of 
depression. A cut-off score of 6/7 discriminated between cases and 
non-cases on both the somatic symptoms subscale and on the anxiety 
and insomnia subscale. The cut-off score for the severe depression
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subscale was 2/3, and for "the social dysfunction subscale 7/8. For 
both the anxiety/ insomnia and severe depression subscales, 
sensitivity and specificity were satisfactory. For the other two 
subscales specificity was somewhat low, and could not be improved 
without losing sensitivity.
Item analysis of the general health questionnaire
The full item analysis of the general health questionnaire is set 
out in Appendix 8. Three items were found to be poor 
discriminators among groups. They were numbers 5 (’’pains in 
head”), 6 (’’tightness or pressure in head”) and 19 (’’frightening 
or unpleasant dreams”).
It was also clear that many items did not discriminate very well 
between normal patients and those with minor morbidity. If poor 
discrimination is defined arbitrarily as a difference of less than 
10% in the proportions of normals and those with minor morbidity 
endorsing a given item, then in 21 items discrimination was poor. 
These items were the three already cited plus numbers 8 (’’afraid 
of collapse in public place”), 21 (’’mananging to keep busy and 
occupied”), 27 (’’managing as well as most people in your shoes”), 
31 ("feeling warmth and affection for those near to you”), 32 
("finding it easy to get on with people”), 34 ("afraid to say 
anything to people in case you made a fool of yourself”), 36 
("capable of making decisions about things”), 38 ( dreading
everything you have to do”), 40 ("couldn’t overcome your
difficulties”), 46 ("able to face up to your problems”), 48 
("feeling people were looking at you”), 52 ("life entirely 
hopeless"), 53 ("hopeful about own future”), 54 ("reasonably
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happy, all things considered”), 57 (’’thought of the possibility 
that you might make away wih yourself”), 58 (’’couldn’t do anything 
because your nerves were too bad”) 59 (’’wishing you were dead and 
away from it all") and 60 (’’found that the idea of taking your 
life kept coming into your mind”).
This list includes five of the seven items of the severe 
depression subscale. The remaining items in the list did not seem 
to show a particular pattern, except that several concerned 
relationships with other people.
Eight items were endorsed by more than 10% of normals. These were 
numbers 1 ("perfectly well and in good health”), 2 (”in need of a 
good tonic”), 7 ("been able to concentrate on whatever you’re 
doing"), 9 ("having hot or cold spells”), 10 ("perspiring 
(sweating) a lot"), 15 ("been feeling mentally alert and wide 
awake"), 16 ("feeling full of energy") and 22 ("taking longer over 
the things you do"). Only the last two of these were endorsed by 
more than 15% of normals.
Differentiation between normals and cases was better. Only 13 
items (numbers 5, 6, 13, 19, 31, 34, 48, 51, 52, 56, 57, 58 and 
60) had gradients of less than 40. These items included six of the 
seven in the severe depression subscale. However, all items of the 
severe depression subscale had a gradient of at least 20, and four 
had a gradient of more than 35*
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Results for Leeds scales
Table 7-5 shows sensitivities, specificities and false positive 
rates for the Leeds depression and anxiety scales. As defined by 
observer ratings, there were 14 cases of depression and seven of 
anxiety. The recommended cut-off score of seven or above for both 
scales did not need to be changed.
Table 7-6 shows several correlation coefficients: observer ratings 
of depression with Leeds depression total score and with Leeds 
depression items; observer ratings of anxiety with Leeds anxiety 
total score and with Leeds anxiety items. All coefficients were 
highly significant.
For depression the correlation coefficient with the item on 
appetite was low. For anxiety the correlations with the items on 
anxiety out of the house and with palpitations ("butterflies") 
were also low.
Effect of age on the Leeds anxiety scale.
In chapter 2, Snaith's recommendation that in comparing Leeds 
anxiety levels in different age groups, the scores of older 
patients be weighted, was discussed. In all the results presented 
so far, unweighted Leeds anxiety scores were used. In chapter 6, 
where the effect of age on morbidity was examined, the pattern of 
the unweighted Leeds anxiety scores closely resembled that of the 
two other measures of anxiety: observer ratings and the
anxiety/insomnia subscale of the general health questionnaire. For 
that, reason alone it seemed better not to use the age correction
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factor.
However, a stronger reason was that in both control groups after 
surgery, the correlations between age and unweighted Leeds anxiety 
scores were not significant. In the benign group at one and three 
months, the values of Spearman’s rho were 0.06 (n=4 2) and 0.04 
(n=34). In the cholecystectomy group at three months, the value 
was 0.11 (n=26). After the scores had been weighted by the age 
correction factor, the three coefficients all became significantly 
positive: respectively 0.34 (p<0.03), 0.34 (p<0.05) and 0.45
(PC0.03).
SUMMARY OF RESULTS: CHAPTER 7
The performance of the General Health Questionnaire as a case 
detector was assessed in 75 patients allocated to chemotherapy for 
early breast cancer. The questionnaire and its subscales were 
found to be valid when compared with observer ratings. The 
misclassification rate of the 60-item version of the questionnaire 
was lowest when the standard threshold score for clinical 
morbidity was doubled to 24. It was lowest for the 28-item version 
when the threshold score was doubled to 10. Suggested threshold 
scores for clinical morbidity for the subscales are: anxiety and 
insomnia subscale 6/7; severe depression subscale 2/3; somatic 
symptoms subscale 6/7; and social dysfunction subscale 7/8.
The performance of the Leeds general scales for the self 
assessment of depression was also examined in the same patients. 
The recommended threshold scores (6/7 for both depression and 
anxiety) appeared to be satisfactory.
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CHAPTER S:
DISCUSSION AND CONCLUSIONS
Morbidity prior to breast biopsy
The results reported in chapter 3 lend some support to the belief 
that breast biopsy patients are more vulnerable than general 
surgical patients to pre-operative morbidity. It was notable, 
however, that patients with cancer, considered as a whole, did not 
seem more anxious or depressed than control patients who had 
undergone cholecystectomy. Patients with benign disease appeared 
to be the most distressed. However, when cancer patients were 
subdivided by age, a marked excess of anxiety was evident in those 
patients aged Z15 or less. Multiple regression analysis confirmed 
the strong negative relationship between age and anxiety in cancer 
patients, and showed that a previous history of psychological 
upset made a further, independent contribution to pre-operative 
anxiety.
Some of these results were unforeseen. While anxiety was 
anticipated in both the cancer and benign groups, the author 
expected firstly that it would be of lesser degree in patients 
with benign disease, of whom fewer faced a definite threat of 
early death; and secondly that in both groups anxiety levels would 
be higher in younger patients, for whose families premature death 
would be especially serious. The finding that in the benign group 
anxiety was high and did not decline with age suggested that a 
proportion of this anxiety was not due to admission for breast 
biopsy, but to some other characteristic of the patient sample.
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The benign group was a consecutive series of patients with benign 
lumps, and was likely to have been adequately representative of 
patients presenting with benign lumps to their general 
practitioners, who could be expected to refer all of them to 
outpatient clinics. However, a bias towards anxiety in patients 
attending clinics could have occurred if these patients possessed 
personality traits such as anxiety or hypochondriasis which would 
render them more liable to notice lumps or to consult their 
doctors. A high Eysenck neuroticism score would be in keeping with 
this view. A less likely explanation would be that the patients 
were not self-selected and that there was an association between 
benign breast disease and anxiety due to factors other than 
knowledge of a breast lump. Conceivably, neuro-endocrine factors 
in the hypothalamus or pituitary might predispose to both benign 
breast disease and anxiety. Alternatively, anxiety through a 
neuro-endocrine mechanism might actually increase the size of 
benign breast lesions and make them clinically apparent.93
The variable results of some of the early controlled studies have 
been discussed fully in chapter 2. Greer and Morris found similar 
levels of depression in patients found to have cancer and those 
with benign disease. Anxiety was not measured. However, in a more 
recent study of similar patients, Morris &t aL, using the 
Spielberger self rating scale, showed that anxiety was slightly 
higher in patients with benign disease (n=13) than in patients 
with cancer (n=21).9* In the cancer group, anxiety was notably low 
in younger patients —  the exact opposite of the results of the 
present study. The authors suggested that a greater threat to life 
and a greater awareness of cancer among younger patients might 
provoke the psychological defence of denial, so that anxiety would
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net be manifest. However*, they thought this explanation was 
unlikely, since it was not clear* why denial should only occur* in 
younger* cancer* patients. But equally ther*e seems no reason why the 
low anxiety in the present series of older cancer patients should 
have been due to denial.
Maguire et al found that in the period between attendance at the 
outpatient clinic and breast biopsy, distress was significantly 
higher in cancer patients than in those with benign disease. 
Schonfield found an excess of anxiety only in those cancer 
patients aged H2 or less.46 63
On the other hand, in a series of 56 consecutive patients 
Wirsching (1982) found that anxiety was significantly higher in 
patients with benign disease than in those with cancer, the cancer 
group experiencing little or no anxiety.95 In the same year 
Gottesman and Lewis reported that mean pre-operative scores for 
depression and anxiety were virtually identical in 15 patients 
with early breast cancer and 15 women undergoing elective 
surgery.96 The results of these two studies resemble those of the 
author.
Of interest is the recent finding of Hughes et al that patients 
attending a breast clinic and proving to have benign disease had 
experienced an excess of depression in the previous year, compared 
with those with cancer and also when compared with the general 
population.93 Depression in their benign group was associated with 
recent life events and social difficulties. The authors concluded 
that the somatic complaints of patients with benign breast disease 
might be secondary to psychiatric disorder. The present results
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are consistent with this finding. The benign group, like theirs, 
also showed a trend towards excess social dysfunction.
The positive associations between physical symptom scores and 
ratings of psychosocial morbidity in the cholecystectomy group 
require comment. Correlations between symptoms such as vomiting or 
pain and, for example, lethargy are to be expected since all are 
associated with chronic cholecystitis. The significant correlation 
between physical symptoms and general health questionnaire scores 
might also be due, at least in part, to the many somatic and 
social items in the questionnaire. However, the significant 
association between physical symptoms and Leeds anxiety scores 
cannot be so explained because there are no somatic items in that 
scale. It is possible that anxious patients are more liable to 
report nausea, vomiting and pain, but it is more likely that 
physical symptoms provoke anxiety. Certain patients reported 
spontaneously that bouts of pain made them frightened. Hence 
physical distress may have contributed to some of the anxiety 
prior to admission for gall-bladder surgery. This possibility 
seems to have received little attention in previous research.97 98 
Anxiety due to physical distress would decrease differences in 
anxiety scores between cholecystectomy and breast biopsy patients, 
since the breast biopsy patients experienced negligible physical 
upset. In keeping with previous work, a few cholecystectomy 
patients expressed fears of the anaesthetic or other physical 
procedures, and two were afraid they might have cancer; but 
malaise and fatigue were much more striking clinically than 
anxiety or depression.
Thus results in the pre-operative period were not entirely
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clearcut. However, manifest ps, r- .^ gjsiv^ rQa
awaiting biopsy of malignant lesy zr-a -c+a, :e*sa comrney ciiak -aaa 
sometimes been supposed. Despite m e  :rrojye~. iecmm prccac ura 
which may provoke more anxiety than m e  .-.eedla ’*icDsy wlncn .is 
replacing it," most cancer patients aged o^ /er 115 (numerically a
large group) did not report serious morbidity, in the minority --
those aged 45 or less —  it remains to be confirmee whether needle 
biopsy would reduce the marked excess of anxiety.
Results for the benign group supported the belief that: gatiiSents 
presenting with benign breast disease may be especially JisSHfe-to 
psychological morbidity. If so, these patients might not be an 
ideal control group in the post-operative period.
The cholecystectomy control group, chosen because it would provide 
reasonable numbers of female patients who had not been on the 
waiting list for a prolonged period, was imperfect. Although these 
patients were regarded as "cold” cases, the degree to which 
several of them would experience malaise and pain was not 
anticipated; pain may have increased anxiety slightly. However,,,no 
group would be ideal in controlling for the effects of routine 
surgery.
Psychosocial effects of adjuvant chemotherapy
Whether adjuvant chemotherapy actually achieved its aim of 
improving survival was until recently uncertain. A meta—analysis 
of the results of clinical trials of adjuvant chemotherapy in some 
10000 patients has now shown that it reduces early deaths in 
postmenopausal patients by about one sixth and in pi-enienopaubal
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patients by about one third.100 Clearly, however, the effect on 
survival is modest; many patients die despite the treatment. Hence 
its psychosocial effects continue to be relevant.
Recent 'reports on the psychosocial effects of chemotherapy
When this thesis was started, there were no published reports on 
the psychological effects of adjuvant chemotherapy after 
mastectomy. Preliminary results of the thesis, showing a 
significant excess of depression in chemotherapy patients a year 
after surgery, were published in abstract form in 1979 and 
1980.101 102 Subsequently, two randomized controlled studies from
the United Kingdom, likewise providing a single estimate of 
morbidity during treatment, also suggested that adjuvant 
chemotherapy was associated with increased emotional 
distress.103 104
Palmer and colleagues found that nine of 2U (37%) patients who had 
completed a six month course of five-drug chemotherapy reported 
severe disruption to their lives compared with two of 21 (9%) 
receiving the single agent chlorambucil. Twenty-nine per cent of 
those who had received the five-drug combination said that the 
treatment was unbearable or could not be gone through again.103 
Maguire and colleagues Judged that 20 of 26 (77%) patients
receiving cyclophosphamide, methotrexate and 5-fluorouracil (CMF) 
for one year had experienced anxiety or depression compared with 9 
of 18 (50%) having no treatment, and that of 15 receiving
melphelan, four (27%) had experienced anxiety and five (33%) 
depression.104 Some of these patients, who were assessed by 
reliable interview methods at three and 12—18 months after
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mastectomy , received psychiatric treatment during a counselling 
project. It is not entirely clear whether the results obtained 
were based on the three month assessment, when the patients would 
still be receiving chemotherapy, or on that at 12-18 months, when 
treatment would be complete —  or, indeed, whether the results 
were calculated in some other way. These two studies caused doubts 
to be expressed as to whether adjuvant chemotherapy could be 
justified.103 103
In the United States, adjuvant chemotherapy has been more widely 
adopted as routine treatment. Probably for that reason, 
quantitative controlled studies of its psychological effects were 
lacking until very recently.10 However, in an uncontrolled study 
based on a single structured interview, Meyerowitz and colleagues
(1979) noted that in 50 breast cancer patients undergoing adjuvant 
treatment with CMF, up to 80% experienced emotional distress, and 
up to 88% behavioural disruption, in five life areas: marriage and 
family, sex, financial situation, general activity level and 
work-related activity level.106 In a follow-up study of 35 of 
these patients, the authors found that patients took on average 
6.k months to ’’return to their old selves”.107
A more recent uncontrolled study of similar patients by Knobf 
(1986) also suggested that distress persisted beyond treatment. Of 
78 patients (a selected sample drawn from private oncology 
practices and from a university hospital clinic) those who had 
finished treatment were more upset by loss of the breast and about 
the uncertainty of survival than those still receiving 
chemotherapy. Knobf suggested that a delayed reaction to loss of 
the breast and a loss of security from receiving treatment might
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be responsible.100 Some support for this opinion comes from the 
early results of a controlled study by Cassileth and colleagues 
(1986) comparing self-rated anxiety levels in 68 mastectomy 
patients randomised to CMF plus prednisolone (CMFP), or to 
observation only. Assessments over one year showed no significant 
differences between the two groups, but there was a trend towards 
higher anxiety levels in patients not given adjuvant treatment. 
The authors thought that allocation to observation only might 
induce anxiety, whilst active treatment might have a placebo 
effect.109 The results are not altogether comparable with other 
studies of the psychological effects of CMF, since steroid 
hormomes may affect mood, and levels of depression were not 
reported. However, the trend towards anxiety in patients given no 
further treatment is similar to that found in Maguire’s 
chemotherapy study104 and consistent with the results for the 
stage I patients reported in chapter 5.
One other study from the United States seemed to suggest that 
morbidity in patients with breast cancer treated with adjuvant 
chemotherapy was low. Silberfarb and colleagues (1980) reported 
that early morbidity in such patients was less than in those 
treated with radiotherapy. The authors wondered if chemotherapy 
might induce psychological morbidity at a later stage in 
treatment.110 However, reliable conclusions cannot be drawn from 
this study because the chemotherapy sample comprised only seven 
patients.
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Conditioned reflex symptoms
Recently conditioned reflex nausea and vomiting have also been 
described by North American researchers.111-1^  However, before 
this work is discussed, a question arises: were the pre—treatment 
nausea and vomiting experienced by patients in the present study 
genuine conditioned reflex symptoms?
These symptoms only occurred after a variable duration of 
post-treatment nausea or vomiting. They became more frequent with 
repeated exposure to chemotherapy injections, but less frequent 
after chemotherapy was stopped.114 Sometimes they generalized to 
stimuli outwith the hospital, for example the smell of organic 
chemicals similar to those used in the hospital. They could occur 
in response to the thought of treatment. These patterns fit with 
classical Pavlovian conditioning:115 the unconditioned stimulus 
being the administration of CMF (leading to nausea or vomiting) 
and the conditioned stimulus being anything Just before its 
administration —  usually the sight or smell of the immediate 
surroundings. Second order conditioned stimuli and generalization 
are a natural sequel.
However, it could be argued that anticipatory nausea was merely a 
manifestation of anxiety rather than a conditioned response. But 
the author found that patients seemed able to distinguish between 
the kind of nausea they might experience in response to anxiety, 
and the kind of anticipatory nausea they recognised was peculiar 
to chemotherapy treatment, and took account of this in recording 
conditioned symptoms.
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In the first of the North American reports, Neese and colleagues 
studied patients receiving chemotherapy for lymphomas. They found 
that the prevalence of conditioned reflex nausea was related to 
dose and duration of chemotherapySubsequently, Morrow studied 
225 patients receiving several regimes of chemotherapy for a 
variety of cancers. Anticipatory nausea or vomiting occurred in 
47, a prevalence of 21%.112 Morrow used the word ’’anticipatory” 
rather than ’’conditioned reflex” to avoid implications about 
cause, but thought that a conditioning mechanism was likely. 
Multiple regression analysis showed that independent predictors of 
conditioned reflex symptoms were: the severity of post-treatment 
nausea and vomiting; the length of time from the treatment pulse 
to the point at which post-treatment symptoms were most severe; 
and treatment with cisplatin. In contrast to the results of Neese 
and colleagues, and those of the author, Morrow believed that if 
patients developed conditioned reflex symptoms, they would do so 
within four months of starting treatment.
One recent study has described conditioned reflex vomiting in 
patients receiving CMF for breast cancer. Wilcox and colleagues 
compared the incidence of this symptom in patients randomized to 
low dose and high dose CMF in a clinical trial.113 They found that 
59% of 22 patients on high dose CMF had anticipatory vomiting 
compared with only 14% of 29 on low dose CMF. The pooled incidence 
was therefore 33%. Those who developed post-treatment vomiting 
before the fourth cycle of treatment were significantly more 
likely to develop conditioned reflex symptoms eventually. 
Anticipatory vomiting was commoner when post—treatment vomiting 
was severe. However, not all patients entering the clinical trial 
were included by the authors and symptoms were recorded
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retrospectively, based on notes made by clinic staff. Thus the 
incidences reported may not be strictly accurate.
Comment on the present study: psychosocial effects of chemotherapy
In the present study, repeated assessments over two years allowed 
a detailed review of the psychosocial cost of CMF. There were no 
significant differences among treatment groups up to three months 
after mastectomy, but by six months patients on chemotherapy alone 
or in combination had suffered more upset to their daily routine 
than those treated with radiotherapy alone, and conditioned reflex 
symptoms were common. Those receiving combined therapy were 
already almost unanimous that chemotherapy was the more unpleasant 
treatment.
Adjuvant chemotherapy had its main psychosocial impact during the 
second half of intended treatment. Depression, anxiety, social 
dysfunction and conditioned reflex symptoms peaked at one year, 
even though over a tenth of patients did not complete CMF. 
Conditioned reflex symptoms continued beyond the first year. 
Depression may also have persisted in minor degree. However, most 
patients allocated chemotherapy escaped systemic relapse in the 
second year. Unlike the radiotherapy-alone patients, they were 
spared much of the emotional and physical distress associated with 
recurrent disease.
(Although in the radiotherapy group patients with recurrent cancer 
were significantly more distressed than those free of disease, a 
precise estimate of the morbidity due to recurrent disease would 
require a larger patient sample. However, Silberfarb and
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colleagues, comparing patients with breast cancer at three phases 
of the disease —  initial treatment, first recurrence and final 
illness —  found a significant excess of depression at first 
recurrence compared with the other two phases.110 More recently, 
Hopwood has reported that at least a third of patients presenting 
with advanced breast cancer may have psychological morbidity 
amenable to treatment.116)
The peak of psychological morbidity during the second half of CMF, 
and some of the after-effects, could almost certainly be prevented 
if courses of treatment were restricted to about six months. Since 
Bonadonna and colleagues have shown recently (1985) that six 
months of adjuvant CMF is probably as effective as 12,117 there seems 
little justification at present for longer courses of CMF.
Several questions remain unanswered. While psychological morbidity 
could be greatly reduced by shortening courses of chemotherapy, it 
is unclear whether the lifetime psychological cost to the patient 
due to adjuvant chemotherapy would thereby become similar to that 
due to radiotherapy alone. The precise lifetime cost could only be 
determined by indefinite follow-up of a very large series of 
patients. Much would depend on the varying effects and timing of 
relapses, further treatments and deaths after the first two years. 
These matters are complex. Although the present study and that of 
Silberfarb and colleagues110 show, not surprisingly, that 
recurrent disease is distressing, treatment given for systemic 
relapse may sometimes reduce morbidity. Thus Baum and colleagues
(1980) found that chemotherapy given for systemic relapse enhanced 
well-being, despite physical toxicity, provided remission 
occurred.118 The psychological effects of chemotherapy may vary
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according to the stage of disease at which it is prescribed.
Significantly more patients died in the radiotherapy-alone group 
compared with the two chemotherapy groups. Given that the object 
of the study was to determine the psychosocial cost of allocation 
to follow-up treatment, those who believe that death is not the 
end of experience might want to consider metaphysical questions: 
does death stop any further suffering? Is it better to be dead 
than miserable from chemotherapy?
Such questions can only be considered theoretically (one could 
hardly employ a medium as research assistant!) If it were assumed 
that the dead patients all had "average ratings of morbidity", 
including them in the analyses would not change the results —  the 
analyses would be valid as performed. If they were assumed to have 
no morbidity whatsoever (the after-life either being non-existent 
or consisting of eternal happiness), the results might be 
different but not the conclusions since there would still be less 
morbidity in patients allocated to radiotherapy alone compared 
with the chemotherapy groups. Only if it were assumed that after 
death the radiotherapy-alone patients had suffering above average 
might the conclusions be different.
These considerations might seem farcical, but death and its 
meaning were treated very seriously by some of the patients. Two 
women in the radiotherapy alone group who knew they were dying 
told the author that they had lost their religious faith. Others 
re-examined their beliefs about death and after-life.
At a more tangible level, the study did not address the
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psychosocial cost of chemotherapy to the patients' families. There 
could be no doubt that family members were often upset by the 
effects of chemotherapy on the patients, and sometimes also by 
seeing them die despite a year of arduous treatment. But whether 
the total amount of morbidity in the relatives of those treated 
with chemotherapy would be higher than in the relatives of those 
treated with radiotherapy (who tended to die sooner) is unclear. 
In theory this question, at least, is answerable, but practical 
measurement would be difficult.
Mechanisms whereby psychological morbidity developed.
What features of the chemotherapy regime caused patients to become 
depressed or anxious? The design of the study does not allow 
formal scientific answers, but there are certain pointers.
Depression and anxiety were associated with certain physical 
symptoms, especially vomiting and irritation of mucous membranes. 
This association might be interpreted in several ways. Firstly, 
patients with mood disturbance might be more likely to notice, 
experience or report physical symptoms. Secondly, unpleasant 
physical symptoms might induce reactive mood change. Thirdly, 
physical symptoms and mood change might have a common cause, 
namely the metabolic changes induced by chemotherapy. Chemotherapy 
might affect the brain either directly or through some 
intermediate metabolic disturbance. In either case the mood change 
would be endogenous.
The first explanation —  increased sensitivity to physical 
symptoms —  does not seem an important mechanism. If mood change
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made patients more likely to report physical problems, one would 
have to explain why they should report vomiting and irritation of 
mucous membranes but not hair loss.
However, it would not be surprising if vomiting and irritation of 
mucous membranes —  both very unpleasant symptoms —  induced 
reactive mood change. Some patients said that post-treatment 
vomiting was emotionally upsetting. Alopecia also seems 
sufficiently unpleasant to induce mood change; yet the two were 
not positively related. But mostly the patients were warned about 
hair loss, which unlike vomiting is not debilitating, and good 
wigs were provided.
(There was a single negative association between hair loss and 
mood, significant at the five per cent level, which is hard to 
explain, but possibly in the context of many significance tests, 
it was really a chance finding.)
Conditioned reflex symptoms also seemed to be a source of 
distress, greater than that associated with nausea or vomiting 
alone. Conditioned reflex symptoms and their relation to mood are 
discussed more fully below.
Was there any pointer to metabolically-induced mood change? 
Occasionally patients reported feeling depressed in the days 
immediately after each injection. Although this could be 
interpreted as a depressive reaction to attending the clinic, 
these patients seemed to recognise that this mood change had a 
different quality compared with how they ordinarily felt when 
depressed. This suggested it had an organic basis. Recently Devlen
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and colleagues have reported a similar finding in patients 
receiving chemotherapy for malignant lymphoma; they also thought 
an organic mechanism might have been responsible.119
How might chemotherapeutic agents induce organic mood change?
The basic metabolic principles of CMF therapy are reasonably 
clearcut. After conversion to active metabolites, cyclophosphamide 
acts as an alkylating agent which probably exerts its effect by 
cross-linking, within cells, the two strands of deoxyribose 
nucleic acid (DNA). It may also damage DNA in other ways. 
Methotrexate inhibits the synthesis of folic acid, while 
5-fluorouracil, a fraudulent pyrimidine, interferes with nucleic 
acid synthesis. Hence cell proliferation is inhibited in three 
different ways. However, the detailed metabolism of these drugs is 
complex, and much is not understood.120
The induction of vomiting by these drugs —  a subject which has 
been studied in some detail —  illustrates some of this metabolic 
complexity. Firstly, the three drugs vary not only in their emetic 
potency —  cyclophosphamide being the most potent, followed by 
5-fluorouracil and then by methotrexate —  but also in the onset 
time and the duration of vomiting. Secondly, there are several 
neural pathways (probably involving several neurotransmitters) 
whereby these drugs stimulate the vomiting centre in the brain 
stem. Their action on the vomiting centre cannot be explained 
solely in terms of stimulation of the chemoreceptor trigger zone 
(on the surface of the medulla at the area postrema) and 
subsequent transmission of impulses via dopaminergic neurones to 
the vomiting centre. Other inputs to the vomiting centre for
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example, from the gut and from the forebrain, may be relevant. 
Histamine, cholinergic substances and enkephalins may be 
implicated as neurotransmitters in the emetic actions of cytotoxic 
drugs. Furthermore, additional pathways must exist to mediate 
nausea and its autonomic accompaniments.121
Given the seemingly wide range of actions of cytotoxic drugs and 
their metabolic derivatives in the brain stem and elsewhere, it is 
easy to imagine that they might somehow upset neurotransmitters 
concerned with mood, albeit perhaps indirectly. Brain stem 
disturbance due to encephalitis or motor neurone disease is a 
well-recognised cause of emotional lability. However, large 
numbers of neurotransmitters are now recognised.122 Their 
potential interactions are so complex that it is extremely 
difficult to make any definitive statement on the neurochemical 
basis of mood, farless speculate on how chemotherapy might upset 
the balance.
Nonetheless, methotrexate is known to have a direct effect on 
brain cells. Although only 1-2% of plasma methotrexate enters the 
brain, depletion of folic acid has been found in the brain cells 
of both humans and animals treated with prolonged low-dose metho­
trexate.120 Deficiency of folic acid has been linked to depression 
in humans, although the direction of the association and its 
specificity to depression rather than to other psychiatric 
illnesses must remain in some doubt.123-126
Other organic mechanisms may be relevant, for example the release 
of cell breakdown products into the circulation. More recently, 
Dykes and her colleagues have shown, in the same chemotherapy
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trial which was the basis of this thesis, that there was an excess 
of certain viral infections in the patients treated with 
chemotherapy.177 Subclinical viral infection could cause 
depression.
Treatment with CMF also depresses ovarian function.105 117 
Hormonal disturbance might upset mood either metabolically or 
psychologically in that premenopausal patients knew that their 
periods had stopped and might not return. This might partly 
explain why psychological morbidity tended to be greater in 
patients aged under 50.
Although many of the above comments are speculative, both 
endogenous and reactive factors seem relevant to mood change 
associated with adjuvant chemotherapy. Their precise nature and 
contribution are very hard to disentangle, and must be the subject 
of future research.
The relation between mood and conditioned reflex symptoms
There appeared to be an association between mood and conditioned 
reflex symptoms which was independent of the corresponding 
physical symptoms. Patients with conditioned reflex nausea or 
vomiting showed greater mood disturbance than those with 
drug-induced nausea or vomiting but no conditioned reflex 
symptoms. However, this result has to be viewed with some caution. 
Since the severity of drug-induced nausea and vomiting was not 
recorded, the patients with conditioned reflex symptoms might have 
had more severe drug-induced symptoms than those without 
conditioned reflex symptoms. In this case the true association
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would be that between mood and severity of drug-induced symptoms.
Indeed the studies of Morrow and of Wilcox and colleagues,112 113 
quoted above, showed that conditioned reflex symptoms were more 
likely if post-treatment nausea or vomiting was severe. 
Nonetheless, an independent association between mood and 
conditioned reflex symptoms is not ruled out in the present study. 
Some patients were very upset by conditioned reflex symptoms 
which, unlike the corresponding drug-induced symptoms, seemed to 
them to imply the social stigma of being mentally unsound. Also, 
some clearly became anxious in anticipation of conditioned reflex 
symptoms.
Patients often had mixed feelings about attending the chemotherapy 
clinic. On the one hand they sought, and often obtained, 
reassurance about their disease from the clinic staff; but on the 
other hand the same staff also administered the very unpleasant 
treatment. This may have been a source of emotional conflict. In 
some ways their position is analagous to that of the dogs in 
Pavlov’s laboratory who were rewarded with food after seeing an 
circle but got nothing after seeing an elipse. When the circle and 
the elipse were progressively altered until the dogs could not 
distinguish between them —  that is, the stimulus was ambiguous —  
they showed great distress.115 Clinic staff may have become an 
ambiguous stimulus for the patients, though there must be some 
doubt about extrapolating from experimental neuroses in dogs to 
humans.
Overall, it seems that conditioned reflex symptoms probably had at 
least some direct effect on mood. However, underlying mood
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disturbance might affect susceptibility to conditioned reflex 
symptoms, and a combination of mechanisms is possible.
It was of interest that there was no relation between Eysenck 
personality inventory scores and liability to conditioned reflex 
symptoms. Eysenck once maintained that introverts were more 
readily conditioned than extraverts.128 However, in the light of 
criticism by other researchers, he later modified this theory: 
introverts would condition more readily than extraverts provided 
three requirements were met. Firstly, a partial (intermittent) 
reinforcement schedule should be used. Secondly, the unconditioned 
stimulus had to be weak. Thirdly, the interval between the 
conditioned and unconditioned stimulus had to be less than half a 
second.129 These provisos attempted to take account of relative 
differences in postulated "excitation” and "inhibition” in the 
brains of introverts and extraverts. In the present study, the 
first of these requirements may partly have been met because some 
patients attended the hospital for checks without necessarily 
receiving chemotherapy. Probably the third requirement was met but 
not the second because an injection of drugs seems a strong 
stimulus.
However, the lack of association between introversion and 
conditioned reflex nausea and vomiting tends to confirm that 
Eysenckfs earlier theory needed qualification.
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Psychosocial effects of radiotherapy
In chapter 2 it was concluded that studies prior to 1978 strongly 
suggested that radiotherapy after mastectomy was associated with 
increased psychological morbidity. More recent research has tended 
to confirm this finding. Forester and colleagues studied 200 men 
and women undergoing radiotherapy for a variety of tumours.130 
They did not say how many had cancer of the breast. About half
were treated by the betatron -- a large noisy machine -- while the
rest were treated by the much quieter linear accelerator. 
Dysphoric mood as measured by Spitzer’s Schedule for Affective 
Disorders was marked in both groups initially. Thereafter it 
became less in those treated by the linear accelerator but 
increased in the betatron group. Differences in diagnosis between 
groups did not account for this result; as in the study of Peck 
and Boland, reported in chapter 2, the patients were frightened of 
the betatron.
More directly relevant is the paper of Holland and colleagues who 
studied 20 patients undergoing six weeks of radiotherapy after 
mastectomy for stage II breast cancer.131 There were no control 
subjects, but detailed assessments of mood were made before 
treatment, during treatment and towards its completion. Depression 
and hostility were found to increase significantly during 
treatment —  as in Forester’s patients treated by the betatron. 
Anxiety about mutilation decreased significantly. The authors 
thought that the increase in dysphoria in their patients might be 
due to factors other than the treatment machine. They suggested it 
might be a reaction to the side effects of treatment, such as 
anorexia and fatigue, or else stem from the prospect of no longer
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being reassured from receiving treatment and being monitored 
closely by the clinic staff, after completion of radiotherapy.
Shortly afterwards Silberfarb and colleagues published a paper 
(already referred to in the discussion on chemotherapy) of which 
the main purpose was to compare morbidity at different stages of 
breast cancer: primary treatment, first recurrence and final
illness.110 However, It of the primary treatment group received 
post-operative radiotherapy. The authors reported that the 
radiotherapy patients experienced distress specific to that 
treatment (for example from being forced to confront cancer by 
attending the radiotherapy centre).
These papers and some of the research cited in chapter 2 therefore 
suggested that radiotherapy might induce morbidity in the 
following ways: (1) via frightening machines; (2) by physical side 
effects; (3) by forcing patients to think about cancer or to 
contemplate lack of continuing support after treatment. However, 
support during treatment might reduce morbidity.
Comment on the present study: effects of radiotherapy
In the present study the first and third of these mechanisms 
clearly operated in some patients; but there was no convincing 
connection between the side effects of radiotherapy and mood.
The design of the study also enabled the psychological effects of 
the prospect of radiotherapy to be assessed. One month after 
mastectomy, more than a third of all patients reported depression, 
anxiety or social dysfunction, and well over half some degree of
169
lethargy or inability to work. However, there were no significant 
differences on any of the measures of psychosocial morbidity 
between those patients who were due to receive radiotherapy and 
those who were not. Knowledge of impending treatment did not seem 
to cause excess morbidity.
Although the findings reported in chapter 5 leave no doubt that 
the ensuing radiotherapy caused psychological morbidity in a 
minority of the patients studied, there was at three months no 
significant excess of depression or anxiety in the radiotherapy 
group compared with the no treatment group. However, at three 
months (two to three weeks after completing treatment) almost two 
thirds of the radiotherapy group were found on observer ratings to 
have been lethargic over the previous few weeks, compared with
less than a third of the control group. Nearly half of the
radiotherapy patients had experienced routine upset compared with 
Just over a third of those who did not receive radiotherapy.
Results of the self rating scales were in keeping with those of
the observer ratings.
There were likewise no significant differences in depression or 
anxiety at six and thirteen months. Whilst the available sample of 
patients treated with radiotherapy was smaller from six months 
onwards, it was of sufficient size to demonstrate that a 
significant excess of somatic symptoms persisted at six months.
Could the excess of somatic symptoms observed at three and six 
months in patients treated with radiotherapy have been a 
psychological rather than a physical effect of treatment*? While 
psychological stress might induce somatic symptoms even in the
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absence of overt depression or anxiety, there seems no reason why
patients treated with radiotherapy should be any more likely to
manifest psychological stress as somatic symptoms than patients 
not so treated. Thus the excess of somatic symptoms probably had a 
physical basis. For similar reasons, the excess of social
dysfunction noted at three months in radiotherapy patients seems 
unlikely to have been psychogenic. Nearly all the radiotherapy 
patients had to travel to hospital five days every week and often 
to restrict other activities because of physical symptoms. That 
their daily routine was disrupted is hardly surprising.
Since patients treated with radiotherapy all had Stage II cancer, 
whilst those not so treated had Stage I cancer, results might 
conceivably reflect severity of disease rather than treatment with 
radiotherapy. However, this possibility seems unlikely. Stage II 
disease might affect patients in two main ways. Firstly, the
patients might realise that their disease had a relatively poor 
outlook. Secondly, there is a remote chance that an excess of 
micrometastases could alter mood physiologically. In either case, 
increased depression or anxiety would seem likely. Yet in spite of 
this potential bias, no excess of psychological morbidity was
found in Stage II patients.
The failure to show that radiotherapy induced an excess of 
depression or anxiety at any time in the first year after
operation was unexpected. Could it have been due to inadequate
statistical power? Conceivably, larger samples might have shown 
differences, but results suggest that any such differences would 
have to be small. Because the hypothesis tested was that
radiotherapy would induce more psychological morbidity than no
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further treatment, one-tailed significance tests were used. These 
are twice as sensitive as two-tailed tests. Moreover, the tests 
picked up the differences in somatic and social symptoms fairly 
consistently, but never any differences in depression or anxiety. 
This suggests that if there were any real differences in mood they 
would be less important than those in somatic or social 
dysfunction. Continuing somatic discomfort up to six months after 
operation did not appear to induce significant emotional upset in 
the radiotherapy patients, despite suggestions that fatigue 
induced by radiotherapy might be an important source of emotional 
distress.63 13*
Another possible reason for the lack of differences in mood might 
be the timing of assessments. The three month observer 
assessments, which covered the preceding month, did not normally 
include the first week of the radiotherapy course. Ideally, an 
extra assessment a few days after radiotherapy had started, and a 
corresponding assessment in the no further treatment group, would 
have been made; but it is very doubtful if the patients, 
especially those in the control group, would have tolerated being 
seen more often. Furthermore, the self rating scales covered the 
previous "few weeks". From the comments patients made while 
filling in these questionnaires, it was clear that fear at the 
beginning of radiotherapy was sometimes reflected in the three 
month general health questionnaire and Leeds scores.
The most plausible explanation for the lack of differences in mood 
may be anxiety associated with not receiving further treatment. 
Occasional stage I patients feared that mastectomy alone might be 
an inadequate treatment. In contrast, certain radiotherapy
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patients seemed to gain a sense of security from the mere fact of 
getting further treatment. The patients who did not receive 
radiotherapy were seen infrequently at the surgical outpatient 
clinic. While many attended the hospital a few days after 
discharge to have stitches removed or have a prosthesis fitted, 
usually their next appointment was not until six months after 
mastectomy. Unlike the radiotherapy patients, they had little 
opportunity to be reassured by professional staff in the weeks 
after operation. Had a mastectomy nurse counsellor been available, 
they might have shown less morbidity than the radiotherapy 
patients.
The absence of an appreciable excess of depression or anxiety in 
those treated with radiotherapy should not detract from the fact 
that up to half the patients found that radiotherapy was a very 
unpleasant form of treatment which caused persisting somatic 
symptoms and temporary social disruption. On this basis, and given 
that its only function is to prevent local recurrence, there is a 
strong case for careful thought before radiotherapy is prescribed 
after mastectomy. A recent survey of surgical practice showed that 
some surgeons were more likely than others to prescribe 
radiotherapy.132 Thus sometimes it may be given more as a routine 
than as a result of careful individual assessment of the risk of 
local recurrence and of the patient’s wishes after informed 
discussion of the treatment options.
Moreover, strictly speaking the results obtained apply only to a 
three week course of radiotherapy after mastectomy. An excess of 
depression or anxiety might have emerged had the course of 
treatment been longer —  as in the study of Holland al.130 In
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patients treated by breast conservation, a five or six week course
of radiotherapy is usual, the total dose being higher -- about
5000 rads.133 In the recent Cancer Research Campaign trial of 
breast conservation, Fallowfield and her colleagues thought that 
such radiotherapy might have caused mood disturbance.134 (These 
authors also commented that patients in the conservation group 
sometimes became anxious because they feared that the conserved 
breast had not been adequately treated.) Caution is also needed in 
extrapolating the results of the present study to radiotherapy 
given for other types of cancer, where the dose of radiotherapy 
might again be different. Furthermore, mood may be influenced not 
just by the treatment per se, but also by the patients1 beliefs 
and expectations, by the treatment setting and by relationships 
with the clinic staff.
Levels of morbidity
The results reported in chapter 6 showed that levels of depression 
and anxiety of clinical degree (ratings of 2 or 3) in the mixed 
stage I/II sample were lower than expected —  generally less than 
half those reported in the early British and American controlled 
studies of similar patients,59 63 64 and less than the more recent 
figure of 18% obtained by Hughes in an uncontrolled study.135 
Examination of confidence intervals showed it was very unlikely 
that the prevalences of clinical depression or anxiety would have 
exceeded lk% in the population from which the sample was drawn, 
except in the period immediately after operation, prior to any 
further treatment.
Could the low prevalences of depression and anxiety have been due
m
to factors other than treatment for breast cancer? Although this 
study used the same observer scales as that of Maguire,63 ratings 
might have been conservative, despite satisfactory reliability. 
However, morbidity assessed by the self rating scales was also 
low. The upper age limit (69) in the present study was higher than 
in that of Maguire (65). Thus relatively more patients with low 
scores were included. There were few areas of marked social 
deprivation in the catchment area of the hospital. There may have 
been little background morbidity associated with social problems.
In view of these low prevalences, two recent reports are of 
interest. The first, in the United States, was by Bloom and her 
colleagues of the Psychological Aspects of Cancer Study Group.136 
In a large multicentric study, patients with early breast cancer, 
patients with benign breast disease, cholecystectomy patients and 
healthy women were assessed on four occasions over a year. The 
authors concluded that their mastectomy patients experienced more 
post-surgical distress than the control subjects, but that the 
results did not support the belief that mastectomy was followed by 
severe psychiatric sequelae in psychologically healthy women. 
Patients with a previous history of having used major psychoactive 
drugs, those with recurrent breast cancer or concurrent physical 
illness and those whose physicians did not give approval were 
among those excluded from the study. The main purpose of some of 
these exclusions was to avoid factors which might confound the 
specific effects of breast cancer and its treatment.
Detailed comparisons between the present study and that of Bloom 
and colleagues are limited because of this large proportion of 
exclusions, and because the measures of morbidity (derived by
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principal components analysis) were different. The multivariate 
analyses used by Bloom and her co-workers had the advantage of 
reducing the chances of spurious statistical significance, but the
derived scales -- for example "psychopathology" (mainly paranoid
and obsessional symptoms) and "psychosocial impairment" 
(depression and social rSle) —  do not correspond to the usual 
clinical concepts. Indeed Bloom and colleagues stated that the 
statistical analysis of their data reduced accuracy in determining 
the status of an individual patient.
The second report was Dean’s study in Edinburgh.137 Dean, using 
Spitzer’s Research Diagnostic Criteria, found that three months 
after operation 17.7% of her mastectomy patients had minor 
depressive disorder but only 9.7% major depressive disorder, 
whilst at one year the corresponding percentages were 18.2% and 
k.5%. Anxiety was even less prevalent: at three and 12 months 
general anxiety disorder was present in only 0.9% and li.5% of 
patients respectively. Minor depression was significantly commoner 
than in a matched community sample, but there were no significant 
differences for major depression. The clinical case rate, 
determined by Dean’s own Judgment that the patient was clinically 
ill plus fulfilment of either the Research Diagnostic Criteria for 
major depressive disorder or the Feighner criteria for depression 
or anxiety, was 10% at three months and 5% at 12. Dean thought 
that the lower rates compared with earlier British studies were 
probably due to differing diagnostic criteria, but did not rule 
out a genuinely lower prevalence in her East of Scotland sample. 
She suggested that morbidity might have been low because her 
patients had undergone a two-stage diagnostic procedure which 
allowed preoperative counselling.
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However, the prevalence of clinical morbidity in the author’s West 
of Scotland sample was very similar to that observed by Dean, 
despite the one-stage frozen section procedure. Like Dean, the 
author found that few of the patients regarded themselves as 
psychiatrically ill. While occasionally severe, symptoms of 
clinical degree were usually short-lived, lasting weeks rather 
than months, unless reactivated by prolonged chemotherapy or 
recurrent disease. The main exception was loss of sexual interest, 
which tended to persist. The prevalences of serious sexual 
problems in the patients were much higher than those for 
depression and anxiety. Both Maguire and Dean also found that 
sexual problems were conspicuous after mastectomy.63 137
Subdivision of the cancer patients by age showed that 
psychological and sexual morbidity as measured by many of the 
scales were significantly commoner in patients aged under 50. This 
confirms Maguire’s clinical impression, based on an unselected 
sample, that morbidity was higher in younger patients.61 The 
findings of previous researchers —  that morbidity was either 
unassociated with or positively associated with age —  may well 
have resulted from selective sampling and unstandardized methods 
of assessment.22 30
In the present study it is not certain to what extent the effect 
of age on mood —  in particular anxiety —  was specific to 
treatment for breast cancer. Levels of anxiety, especially in the 
second year, were often so low that they may largely have 
reflected baseline levels in the community. In a recent review, 
Kay reported that the prevalence of anxiety in older people in the
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community was lower than in younger people.*" Had there been 
enough older control subjects in the present study, the 
specificity of the age effect might have been clearer. However, in 
the light of the results reported in chapter 3, patients with 
benign disease may not be an ideal control group and it might be 
better to use a random community sample.
Whilst sexual problems were very prominent in younger cancer 
patients, a substantial minority of older cancer patients reported 
severe loss of libido. It might be thought that loss of libido in 
older patients was due to age rather than to the effects of 
treatment for breast cancer. Again the dearth of older patients 
with benign disease prevented a matched comparison with the older 
cancer group. Morris and colleagues found that a surprisingly 
large proportion of middle-aged patients with benign breast 
disease experienced sexual difficulties over a two year period.59 
However, in the older cancer patients the loss of interest in sex 
was usually sudden. The patients often attributed it to mutilating 
surgery, although other factors such as further treatment 
(radiotherapy or chemotherapy) or the feeling that sex was not 
very important in the context of cancer were sometimes relevant. 
It would be unreasonable to conclude that treatment for breast 
cancer had no causative effect on sexual appetite in the older 
patients. Even if loss of libido would have occurred eventually in 
this group, treatment for breast cancer must have brought it 
forward in time.
For social and work problems, there were no consistent differences 
between younger and older patients. Since the older cancer 
patients had fewer psychological symptoms than the younger cancer
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patients, they may have had fewer social difficulties of psychic 
origin. However, they appeared to take longer to recover 
physically from surgery and follow-up treatment. This may explain 
why there were no clear differences between the age groups.
It could be argued that the results would have been different had 
the patients been treated by breast conservation or mastectomy and 
reconstructive surgery rather than by mastectomy alone. Although 
such techniques may confer very important advantages such as 
greater freedom with clothes and avoidance of feelings of disgust 
when undressing, the evidence that they actually reduce 
depression, anxiety and sexual problems appears to be 
conflicting.134 139*U3 Dean showed that breast reconstruction 
with a simple subpectoral prosthesis reduced psychological 
morbidity at three months after surgery, though not at a year.133 
However, published work has so far failed to show that breast 
conservation reduces depression or anxiety.134 i4o-u3 certainly 
the prevalences of serious mood disturbance in the author’s 
patients could not have been very much lower, especially in the 
second year after surgery, and suggest that most patients cope 
amazingly well, even if the surgical procedure is not ideal.
Prediction of morbidity
The multiple regression analyses showed that morbidity at a year 
could be predicted independently by factors such as age, Eysenck 
neuroticism, scores on self rating scales at one month and 
treatment with chemotherapy. That younger patients with previous 
evidence of emotional lability were vulnerable fits with common 
sense.
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Two results were less expected. Verbal intelligence emerged as a 
significant independent predictor of the (transformed) 60-item 
general health questionnaire score. Possibly higher intelligence 
leads to mood upset because of greater insight into the uncertain 
future in breast cancer. Social class was associated with social 
dysfunction, but the direction of the association was interesting. 
Higher social class was correlated with greater social 
dysfunction. Women of higher social class might be more socially 
inhibited by mutilating surgery, or alternatively more ready to 
report the social effects of the operation. However, since each of 
these results emerged in only one of the equations, they should be 
treated with caution, unless confirmed in another series of 
patients.
Indeed all the predictive factors require validation in other 
samples, even though the use of adjusted R2 rather than R2 makes 
some allowance for sampling variation. But age, one month mood 
scores, Eysenck neuroticism and treatment with chemotherapy 
emerged repeatedly in the analyses, Such internal consistency 
suggests they may be true predictors. Furthermore, some of the 
findings of other researchers are similar. Morris and colleagues 
found that morbidity was predicted by preoperative Eysenck 
neuroticism scores and ratings of depression;59 more recently 
Hughes showed that it was predicted by scores on the 60-item 
General Health Questionnaire.195 Dean (1987) found that the 
patients* preoperative mental state independently predicted 
morbidity 3 months after operation, along with further treatment 
received and the quality of the patient*s marital relationship.137
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The percentages of variance explained by the predictive equations, 
although very reasonable for this type of data, do not allow the 
exact identification of those patients likely to be helped by 
interventions such as counselling.144'147 However, extra vigilance 
in the follow-up of younger cancer patients with high scores on 
measures of psychological morbidity around the time of operation, 
especially if they are receiving chemotherapy, seems prudent.
The validity study,
Criteria of validity: severity of illness
The ad hoc criteria of caseness used in this study, and the 
reasons for their use, have been described in chapter 2. On the 
face of it, the definitions of caseness were different from those 
used by Brown and Harris,64 but was this really so?
For a woman to qualify as a "case", Brown and Harris stipulated 
that "a psychiatrist would not be surprised to see [the woman] in 
an outpatient clinic”. To be fudged a (non-specific) "case” in the 
present study, a score of 2 or 3 for either depression or anxiety 
was needed. However, most cases scored 2. The author would not 
have been surprised if some patients scoring 2 had been referred 
to a psychiatric clinic. Indeed on occasion they were so referred. 
Seldom was the severity such that in-patient care might have been 
indicated. Patients scoring 1 could usually function reasonably 
well despite symptoms, rather like some of the borderline cases of 
Brown and Harris. Examples of ratings are given in appendix 7*
So the range of psychiatric illness seen in the present study
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tended to be less than that in psychiatric practice, and probably 
of comparable degree to that observed by Brown and Harris in women 
in the community.
Comparisons with the self rating scales
The results of the validity study suggested that the general 
health questionnaire functioned reasonably well in patients 
undergoing chemotherapy following mastectomy. For the 60-item 
version of the questionnaire, a higher threshold score of at least 
20 seemed necessary to identify definite cases, and for the 
28-item version, a threshold of at least 10. There seemed to be 
little to choose between the performance of the two versions.
The threshold of 10 or above for the 28-item questionnaire was 
close to that obtained by Bridges and Goldberg (12 or above) in 
neurological inpatients.92 These patients were also subject to 
somatic and social symptoms and so the threshold appropriate for 
general practice had to be raised.
The anxiety/insomnia and the severe depression subscales appeared 
to perform adequately with the suggested threshold scores. The 
other two subscales (somatic symptoms and social dysfunction) 
performed fairly well. However, the threshold for the somatic 
symptom subscale should be viewed with some caution since the 
validating criterion was not a direct measure of somatic symptoms.
Goldberg originally derived these subscales by principal 
components analysis. He validated three of them against observer 
ratings, but had no observer ratings to compare with the social
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dysfunction subscale, and did not suggest threshold scores.77
However, one recent study has provided threshold scores for two of 
the subscales of the general health questionnaire: anxiety/
insomnia and severe depression. For the former subscale Aylard and 
colleagues suggested a score of 5 or above as the threshold for 
definite morbidity.148 This is 2 points lower than the author’s of 
7 or above. Their threshold score for definite morbidity on the 
severe depression subscale (Zj. or above) is only 1 point above the 
author’s. As they emphasised, however, it is unrealistic to expect 
a sharp distinction between health and pathology.
That some of the thresholds were close to those of others 
suggested that the observer ratings were reasonably accurate. 
However, there was one interesting discrepancy between observer 
and self ratings. Despite a careful interview one patient denied 
any psychological symptoms, and therefore was given observer 
ratings of zero. She also restricted discussion of her illness. 
Yet on the general health questionnaire, she endorsed many items 
concerned with psychological distress. When asked about this, she 
obliquely but convincingly acknowledged she had experienced the 
symptoms she had endorsed. Thus she was really a ’’false false 
positive.’’ The conventional rule that the performance of a self 
rating scale is Judged by the ’’gold standard” —  administration of 
a reliable interview schedule by an experienced psychiatrist —  
was in this case turned on its head: the ’’gold standard” was the 
self rating scale, not the observer rating. Denial of illness and 
psychological symptoms face to face but not on paper may be 
uncommon, but the extent to which it occurs in patients with 
cancer should be investigated further. In a study of another
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subject where denial is prominent, namely alcoholism, Lucas and 
colleagues found that patients admitted to a greater consumption 
of alcohol when interrogated by a computer than when interviewed 
by a psychiatrist!149
Recently (1988), in a paper describing the development of 
computerized assessments for minor psychiatric disorder, Lewis et 
al have commented: ”.... using a human interviewer introduces the 
problem of inter-observer variation.... In the traditional 
validity study, a questionnaire is compared with an interview, 
regarded as an error free 'gold standard/ Disagreement between 
interview and questionnaire is then an inevitable result of using 
an interview as the criterion in a validity test that assumes it 
is error-free. It is, therefore, difficult to sustain the argument 
that questionnaires, such as the GHQ, are less valid or accurate 
at detecting minor psychiatric disorder because they are 
self-report."150 On this basis the traditional comparison of a 
self rating scale with an observer assessment is an unduly severe 
test of validity.
Comments on the item analysis
Although the results discussed above pointed to the validity of 
the standard general health questionnaire and its subscales in the 
patients studied, an improved version might have been possible 
based on the items which were found to be the best discriminators 
of psychological morbidity.
The expectation that patients with purely physical problems might 
endorse somatic and social items, causing them to be poor
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discriminators of psychological upset, was partly confirmed. Three 
items in the somatic symptoms subscale (1,2 and 9) were endorsed 
by over 10% of normals. One item in the social dysfunction 
subscale (22 —  talking longer over things) was endorsed by 22% of 
normals. Item 16 (lack of energy) was endorsed by 25% of normals, 
but is not part of the 28-item questionnaire or the subscales.
Two items in the somatic symptoms subscale (5 and 6, concerned 
with pains, tightness and pressure in the head) were endorsed by 
too few patients in any category to be good discriminators of 
psychological morbidity. Overall, therefore, items in the somatic 
symptom subscale could not be thought of as a good case 
discriminators. However, four items in the social dysfunction 
subscale were good discriminators, consistent with GoldbergTs 
observation that social items may compare favourably with the more 
traditional ones (measuring depression or anxiety directly).74
The item analysis seemed disappointing in that about half of the 
60 items were poor discriminators of differing degrees of 
psychological morbidity. However, this result has to be seen in 
context. As noted in chapter 2, the item analysis could not have 
been expected to give as good discrimination as one which excluded 
patients with intermediate degrees of disturbance. Furthermore, 
the range of severity in the sample studied was smaller than in 
that studied by Goldberg to select items for the original general 
health questionnaire.74 Goldberg had three grades of severity: 
normal, mild and severe. His mild cases were drawn from a 
psychiatric outpatient clinic, the definition of severity being: 
"mildly ill —  needs some psychiatric help. Quite all right as an 
out-patient." Goldberg’s severe cases had to be in-patients on the
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disturbed admission ward of a mental hospital.
The mild cases in the present study were not usually in need of 
psychiatric help and often had little or no impairment of their 
day-to-day functioning and relationships with other people. Hence 
one could not expect them always to endorse items concerned with 
problems in interpersonal relationships and daily functioning. 
Most "cases” had ratings of 2 (moderate) rather than 3 (severe), 
and only one, with a history of endogenous depression antedating 
mastectomy, was admitted to a psychiatric ward. Thus only a small 
percentage of "cases" would have been expected to endorse items 
concerned with severe disturbance, for example those in the severe 
depression subscale. Viewed in this context, the questionnaire 
performed surprisingly well. Better discrimination would be likely 
in samples with a wider range of disturbance.
Technicalities aside, the existing questionnaire and its subscales 
worked well in practice. The results of chapter 5 (psychosocial 
effects of radiotherapy) showed that the subscales of the general 
health questionnaire discriminated successfully between, on the 
one hand, somatic symptoms and social symptoms and, on the other 
hand, depression and anxiety. Also, in chapter k (effects of 
chemotherapy) the severe depression subscale gave results very 
similar to those of the Leeds depression scale.
Hence it seems premature to recommend a shorter version of the 
questionnaire for cancer patients on the basis of the item 
analysis. Results from any item analysis are subject to sampling 
variation. Other, larger samples might give different results. 
Furthermore, if all the apparently poor items were excluded, most
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of the items measuring severe depression would disappear. The 
range of the questionnaire might thereby be restricted such that
it would not detect severe depression -- a problem which should
not be missed even if uncommon in a given patient population. 
Finally, as Snaith has observed, there is already a surfeit of 
scales;151 careful analysis of the performance of existing scales 
in varying circumstances should precede the creation of new 
scales.
So unless further item analyses in larger and more heterogeneous 
samples of cancer patients under many different conditions (for 
example, at different stages of disease and with different 
treatments) showed a consistent pattern of poor discrimination, 
then the existing questionnaire and its subscales seem a better 
option than a modified questionnaire. Although the results were 
for patients treated for breast cancer, the questionnaire and its 
subscales would seem likely to perform adequately in patients 
receiving similar types of treatment for early cancers in other 
sites. What then is the best way of using the existing 
questionnaire?
The 28-item version of the questionnaire, which contains all four 
subscales, may be preferable to the 60-item version because cancer 
patients often have to undergo many investigations, may tire 
easily and so be unable or unwilling to concentrate for long. If 
either version were the sole means of identifying cases, it might 
be best to opt for specificity by using a high threshold score and 
thereby improving classification. However, a high threshold may 
not be desirable in cancer patients free of physical symptoms 
because sensitivity might be reduced. If comparisons of mood were
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to be made between cancer patients with few physical symptoms and 
those with many, the anxiety/insomnia and severe depression 
subscales, which avoid ambiguous somatic symptoms, could be 
analysed separately. The thresholds for these subscales should not 
need changing according to the presence or absence of physical 
symptoms (although this would need formal proof).
On the other hand if trained interviewers were available a good 
strategy might be to leave the standard 60-item and 28-item 
thresholds unchanged —  i.e. to opt for sensitivity. The burden of 
interviewing could thereby be much reduced with little risk of 
missing cases, regardless of the presence of physical symptoms.
The heeds scales
Both Leeds scales seemed to perform adequately with the standard 
threshold of seven or above, despite the possible influence of 
physical symptoms. This result is not altogether surprising since 
neither Leeds scale is heavily loaded with items liable to be 
endorsed by patients with purely physical distress. The Leeds 
scales have been largely superceded by the Hospital anxiety and 
depression (HAD) scales, in which such items have been 
deliberately avoided.152
General comments
The Leeds scales (and probably also the closely related Hospital 
Anxiety and Depression scale) would therefore seem a good option 
to measure mood in cancer patients. The general health 
questionnaire has the advantage of additional measures of somatic 
and social dysfunction. However, scales specifically designed for
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cancer patients, or at least for those with physical illness, 
might be a better option. Several such scales have been developed 
in recent years —  for example the PAIS (psychosocial adjustment 
illness) scale, the Rotterdam scales, and purpose-designed 
linear analogue scales or diary cards.118 153-155 i\j0t all have been 
comprehensively validated, but such scales are likely to cover 
more topics relevant to cancer patients. Scales borrowed from 
other contexts do not measure items such as the reaction to an 
operation scar. However, an argument in favour of scales validated 
in other contexts (for example, psychiatry, general practice or
medical clinics) is that the scores obtained by cancer patients --
provided that they can be shown to be valid —  can be compared 
with the levels of morbidity which have become familiar in these 
other contexts. Hence it may be easier to Judge the severity of 
symptoms in cancer patients. Perhaps the best solution in cancer 
patients is to include both general scales (with items applicable 
to nearly everybody) and specific scales (with items especially 
relevant to cancer patients) —  provided, of course, that the 
patient is not over-burdened with questions.
Clearly self rating scales have limitations such as the ability of 
patients to complete them. (In cancer patients this problem may 
stem from severe physical illness rather than severe psychiatric 
illness.). Even fit patients need careful explanation of the 
purpose of the scales, encouragement to complete them and careful 
checking that they have done so. However, self rating scales have 
the advantage of freedom from observer bias in an area of medicine 
where the nature of the treatment can seldom be disguised from the 
investigator. Since they also cost much less than observer 
interviews, they have a valuable place in the assessment of the 
cancer patient.
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Conclusions
Psychosocial morbidity has been emphasised in several 
circumstances; before breast biopsy (in patients with benign 
disease and in younger cancer patients); during chemotherapy 
(especially the second six months of treatment); to a lesser
extent during radiotherapy; and after recurrence of cancer.
However, e common factor which has emerged in both the present 
study and in the work of others104 100 100 is that not
receiving further treatment may provoke anxiety. The mere fact of
receiving treatment may have a placebo effect, which may 
counteract any adverse psychological effects of that treatment. 
Such a placebo effect may have offset the anxiety due to a 
three-week course of radiotherapy, but was clearly insufficient to 
counteract the adverse psychological effects of a year of
intensive chemotherapy.
The placebo effects of receiving treatment merit greater attention 
in future research. It would be useful if they could be recorded 
formally and quantified. They may well vary from one treatment 
centre to another, depending on the degree of support available. 
Since many trials of cancer treatments have to be multicentric, 
there is an excellent opportunity to find out whether this is so. 
The placebo effects may also vary with the stage of the disease; 
this too could readily be Investigated. It should not be difficult 
to compare, say, the psychosocial effects of radiotherapy given 
immediately after breast surgery to prevent local recurrence with 
those of radiotherapy delayed until recurrence. In the latter case 
radiotherapy might be more reassuring than frightening.
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Studies comparing the psychosocial effects of the oestrogen- 
receptor blocking agent tamoxifen with those of other 
postoperative treatments might also help to clarify the placebo 
effect. Tamoxifen appears to be well tolerated, without obvious 
harmful psychological effects. If so, it becomes a placebo, 
psychologically speaking. It would be especially interesting to 
discover if morbidity in stage I patients treated with tamoxifen 
was less than in those on no further treatment.
Further work is theoretically desirable to clarify and quantify 
the mechanisms —  both physiological and psychological —  whereby 
treatments such as radiotherapy and chemotherapy induce 
psychological morbidity. However, the problems of designing 
adequate scientific experiments to disentangle the various 
mechanisms would be enormous or even impossible both practically 
and ethically. Research to provide even partial answers would 
almost certainly take years, by which time more effective and less 
toxic anti-cancer treatments would probably be available.
Rather than spend money on understanding precisely the 
pathophysiology of depression associated with the present-day CMF 
regime, it would seem better to spend it developing anti-cancer 
drugs without emetic potential. Failing that, money would be well 
spent on developing drugs to abolish the almost universal 
post-treatment nausea and vomiting. Conditioned reflex symptoms 
would then disappear completely. Since the results reported 
suggest that some of the mood disturbance stems from nausea and 
vomiting (especially if accompanied by conditioned symptoms), 
depression and anxiety would probably decrease also. Not only
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would there be great benefit for nearly all patients, but the r61e 
of nausea and vomiting in inducing mood disturbance would become 
clearer.
However, nausea and vomiting remain common. From a practical 
standpoint, how might the psychosocial morbidity associated with 
postoperative treatments be reduced, using existing knowledge?
Reducing the psychosocial morbidity of postoperative treatments
Several suggestions have been made. In controlled experiments, 
behavioural methods have successfully reduced the prevalence and 
severity of conditioned reflex nausea and vomiting. The 
techniques, all of which involve learning to relax, include: 
systematic desensitization; hypnosis with guided imagery 
(descriptions of pleasant, tranquil scenes); progressive muscle 
relaxation training with guided imagery; and biofeedback with 
muscle relaxation training and guided imagery.156 157 These are 
given once the patient has begun to develop conditioned symptoms. 
Ideally they would be given prophylactically before the onset of 
conditioned symptoms, but attempts to identify patients at risk 
have not had much success. Similar techniques would very probably 
be valuable in patients experiencing acute anxiety or panic under 
radiotherapy machines. With the increasing use of breast 
conservation, more patients are likely to undergo adjuvant 
radiotherapy.
Treatment with tetracyclic antidepressant drugs and cognitive 
therapy have been recommended to relieve depressive symptoms in 
cancer patients,158 155 but to what extent such treatment
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alleviates depression due specifically to chemotherapy is unclear. 
The value of counselling by nurses or other professionals is 
debatable,144-147 but psychological symptoms due to 
misconceptions about a particular treatment might be helped. In 
patients receiving no postoperative treatment, nurse counsellors 
might compensate for the absence of a placebo effect of treatment. 
Nurse counsellors are likely to use cognitive methods, even if not 
formally defined as such; adjuvant psychological therapy, 
developed by Greer’s research group, is more formally based on 
both cognitive and behavioural techniques.160 Further work is 
needed to determine the effect of these interventions on the 
morbidity of postoperative treatments.
However, such methods are unlikely to be effective in all 
patients, and moreover some of them require extra resources which 
often will not be forthcoming. The simplest way to avoid the 
morbidity of post-operative treatment is to reduce such treatment 
to the absolute minimum without compromising survival. (However, 
the possible placebo effects of receiving treatment should be kept 
in mind.) Postoperative radiotherapy could probably be omitted in 
many patients, though sometimes it will be impossible to predict 
the likelihood of local recurrence. The value of adjuvant 
chemotherapy in postmenopausal patients is small; in this group 
psychosocial morbidity should be preventable by prescribing 
tamoxifen instead.17 19 However, adjuvant chemotherapy remains 
valuable in premenopausal patients with positive axillary nodes;19 
in these patients, treatment should last no more than six months.
Finally, there is probably an irreducible minimum of psychological 
morbidity which will not disappear until fully effective cures
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become available. No one can totally remove the threat and sense 
of loss which treatment for breast cancer may induce, and indeed 
it may not be desirable to suppress normal grief reactions. The 
main aim must be to reduce unnecessary distress, by avoiding 
over-zealous treatment, and by directing support to those who wish 
it, need it and can be shown, by proper scientific evaluation, to 
be helped by it.
REFERENCES
1. De Moulin D. A short history of breast cancer. Boston:
Martinus Nijhoff, 1983:1-9.
2. De Mondeville H. La chirurgie de Maztre Henri, de MondeviVle.
Traduction contemporaine. Paris: Firmin Didot, 1897: volume 2, 
175-7.
3. De Moulin D. A short history of breast cancer. Boston:
Martinus Nijhoff, 1983:19.
1. Paul of jEgineta. The seven books of Paulus Mgtneta.
Translated by Francis Adams. London: Sydenham Society, 1811: 
volume 2, 79.
5. Leshan LL, Worthington RE. Personality as a factor in the
pathogensis of cancer: a review of the literature. Br J Med 
Psychology 1956;29:19-56.
6. Hunter J. The works of John Hunter FRS. Edited by Palmer JF.
London: Longman, Rees, Orme, Brown, Green and Longman, 1835: 
volume 1, 618-29.
7. Brodie BC. The works of Sir Benjamin Collins Brodte.
Collected and arranged by Charles Hawkins. London: Longman, 
Green, Longman, Roberts and Green, 1865: 256-70.
8. Velpeau A. A treatise on the diseases of the breast and
mammary region. Translated by Henry M. London, Sydenham 
Society, 1856:136.
9. De Moulin D. A short history of breast cancer. Boston:
Martinus Nijhoff, 1983:11.
10. Brodie BC. The works of Sir Benjamin Collins Brodie.
Collected and arranged by Charles Hawkins. London: Longman, 
Green, Longman, Roberts and Green, 1865:267-
11. Burney F. The journals and letters of Fanny Burney (Madame
d’ArblayJ. Edited by Hemlow J, Falle G, Douglas A, Bourdais 
de Charbonni^re JA. Oxford: Clarendon, 1975: volume 6,
596-616.
12. Velpeau A. A treatise on the diseases of the breast and
mammary region. Translated by Henry M. London, Sydenham 
Society 1856:511-91.
13. De Moulin D. A short history of breast cancer. Boston:
Martinus Nijhoff, 1933:15-
11. Keynes G. Conservative treatment of cancer of the breast. Br 
Med J 1937;ii:6!3-7-
15. McWhirter R. Simple mastectomy and radiotherapy in the
treatment of breast cancer. Br J Radiology 1955;28:128-39.
16. Baum M. The curability of breast cancer. Br Med J 1976;
i:139-12.
195
17. Anonymous (Editorial). Adjuvant tamoxifen in early breast 
cancer. Lancet l987;ii:191-2.
IS. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli 
L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, 
Veronesi U. Combination chemotherapy as an adjuvant 
treatment in operable breast cancer. New Engl J Med 
1976;294:405-10.
19. Consensus conference. Adjuvant chemotherapy for breast
cancer. JAMA 1985;254:3461-3.
20. Morris J, Royle GT, Taylor I. Changes in the surgical
management of early breast cancer in England. J Roy Soc Med 
1989;82:12-4.
21. Renneker R, Cutler M. Psychological problems of adjustment
to cancer of the breast. JAMA 1952;148:833-8.
22. Bard M, Sutherland AM. Psychological impact of cancer and its
treatment. IV. Adaption to radical mastectomy. Cancer 
1955;8:656-72.
23* Bard M. The use of dependence for predicting psychogenic 
invalidism following radical mastectomy. J Nero Ment Dis
1955;122:152-60.
24. Bard M, Waxenberg SE. Relationship of Cornell Medical Index
responses to postsurgical invalidism. J Clin Psychol
1957;15:151-3.
25. Quint JC. The impact of mastectomy. Am J Nursing 1963;
63:88-92.
26. Adsett CA. Emotional reactions to disfigurement from cancer
therapy. Canad Med Ass J 1963;89:385-91.
27. Eisenberg HSt Goldenberg IS. A measurement of quality of
survival of breast cancer patients. In: Haywood JL, Bulbrook 
RD eds. Clinical evaluation in breast cancer. London and 
New York: Academic Press 1966: 96-108.
28. Torrie A. Like a bird with broken wings. World Medicine
1970 April 7:36-47.
29. Shottenfield D, Robbins GF. Quality of survival among
patients who have had radical mastectomy. Cancer 1970; 
26:650-4.
30. Winick L, Robbins GF. Physical and psychological readjustment
after mastectomy. An evaluation of Memorial Hospitals PMRG 
program. Cancer 1977;39:478-86.
31. Craig TJ, Comstock GW, Geiser PB. The quality of survival in
breast cancer: a case control comparison. Cancer 1974;
55:1451-7.
32. Buis JG„ Jones IH, Bennett RC, Chan DPS. Women’s attitudes to
mastectomy for breast cancer. Med J Aust 1976;2:336-8.
196
33. Peck A. Emotional reactions to having cancer. Am J
Roentgenology 1972;114:591-9.
34. Peck A, Boland J. Emotional reactions to radiation treatment.
Cancer 1977;40:180-4.
35. Lyon JS. Management of psychological problems in breast
cancer. In: Stoll BA, ed. Breast cancer Management -- early
and late. London; Heinemann medical and year book medical 
1977:225-35.
36. Ervin CV. Psychologic adjustment to mastectomy. Medical
Aspects of Human Sexuality 1973:7:42-95.
37- Jamison KR, Wellisch DK, Pasnau RO. Psychosocial aspects of
mastectomy: 1. The woman’s perpesctive. Am J Psychiatry
1978;135:432-6.
38. Wellisch DK, Jamison KR, Pasnau RO. Psychosocial aspects of
mastectomy; 2. The man’s perspective. Am J Psychiatry 
1978;135:543-6.
39. Coblinger WG. Psychosocial factors in gynaecological or
breast malignancies. Hasp Physician 1977;10:38-40.
40. Bond MR. Chemotherapy in the treatment of advanced malignant
disease. Monographs in the surgical sciences 1967;4(l):l-67.
41. Boesen E, Davis W. Cytotoxic drugs in the treatment of
cancer. London: Arnold 1969:28-42.
42. Whitehead VM. Cancer treatment needs better anti-emetics
(letter). New Engl J Med 1975;293:199-200.
43- Burge PS, Richards JDM, Thompson DS, Prankerd TAJ, Sare M, 
Wright P. Quality and quantity of survival in acute myeloid 
leukaemia. Lancet 1975;11:621-4.
44. Priestman TJ, Baum M. Evaluation of quality of life in
patients receiving treatment for advanced breast cancer. 
Lancet 1976;i:899-901.
45. Katz JL, Weiner H, Gallagher TF, Heilman L. Stress, distress,
and ego defences. Psychoendocrine response to impending 
breast tumour biopsy. Arch Gen Psychiatry 1970;23:131-42.
46. Schonfield J. Psychological and life-experience differences
between Israeli women with benign and cancerous breast 
lesions. J Psychosom Res 1975;19:229-34.
47. Greer S, Morris T. Psychological attributes of women who
develop breast cancer: a controlled study. J Psychosom Res 
1975;19:147-53.
48. Kissen DM. Relationship between lung cancer, cigarette
smoking, inhalation and personality. Br J Med Psychology 
1964;37:203-16.
49. Greer S. Psychological aspects: delay in the treatment of
breast cancer. Proc Roy Soc Med 1974;67:470-3.
197
50. Greer Sf Morris T. The study of psychological factors in
breast cancer: problems of method. Soc Sci Med 1978;
12:129-34.
51. Deutsch H. Some psychoanalytic observations in surgery.
Psychosom Med 1942;4:105-15.
52. Blanton S, Kirk V. A psychiatric study of sixty-one
appendicectomy cases. Ann Surg 1947;126:305-14.
53. Carnevali DL. Preoperative anxiety. Am J Nursing 1966;
66:1536-9.
54. Ramsay M. A survey of pre-operative fear. Anaesthesia 1972;
27:396-403.
55* Spielberger CD, Auerbach SM, Wadsworth AP, Dunn TM, Taulbee 
ES. Emotional reactions to surgery. J Cons Clin Psychology 
1973;40:33-8.
56. Auerbach SM. Trait-state anxiety and adjustment to surgery. J
Cons Clin Psychology 1973;2:264-71.
57. Martinez-Urrutia A. Anxiety and pain in surgical patients. J
Cons Clin Psychology 1975;43:437-42.
58. Chapman CR, Cox GB. Anxiety, pain, and depression surrounding
elective surgery: a multivariate comparison of abdominal
surgery patients with kidney donors and recipients. J 
Psychosom Res 1977;21:7-15.
59. Morris T, Greer HS, White P. Psychological and social
adjustment to mastectomy: a two-year follow-up study. Cancer 
1977;40:2381-7.
60. Schonfield J. Psychological factors related to delayed return
to an earlier life-style in successfully treated cancer 
patients. J Psychosom Res 1972;16:41-6.
61. Maguire P. The psychological and social consequencies of
breast cancer. Nursing Mirror 1975;140:54-7.
62. Maguire P. The psychological and social sequelae of
mastectomy. In: Howells JG, ed. Modern perspectives in the
psychiatric aspects of surgery. New York: Bruner Maisels
Incorp., 1976:390-421.
63. Maguire GP, Lee EG, Bevington DJ, Kuchemann C, Crabtree RJ,
Cornell C. Psychiatric problems in the first year after 
mastectomy. Br Med J l978;i:963-5.
64. Brown GW, Harris TO. Social origins of depression: a study of
psychiatric disorder in women. London: Tavistock, 1978:
302-7.
65. Worden W, Weisman AD. The fallacy in postmastectomy
depression. Am J Med Sci 1977;276:169-75.
198
66. Weisman AD. Early diagnosis of vulnerability in cancer
patients. Am J Med Sci 1976;271:187-96.
67. Ray C. Psychological implications of mastectomy. Br J Clin
Psychology 1977;16:373-7.
68. Polivy J. Psychological effects of mastectomy on a woman’s
feminine self-concept. J Nerv Ment Dis 1977;164:77-87.
69. Polivy J. Psychological effects of radical mastectomy. Pub
Hlth Rev 1975;4:279-95.
70. Margarey CJ, Todd PB, Blizard PJ. Psycho-social factors
influencing delay and breast self-examination in women with 
symptoms of breast cancer. Soc Sci Med 1977;11:229-32.
71. Cohen J. Weighted Kappa: nominal scale agreement with
provision for scaled disagreement or partial credit. 
Psychological Bulletin 1968;70:213-20.
72. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory
for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
73- Zung WKA. A self-rating depression scale. Arch Gen Psychiatry 
1965;12:63-70.
74. Goldberg DP. The detection of psychiatric illness by
questionnaire. Maudsley monograph no. 21. London: OUP, 1972.
75. Maguire GP, Julier DL, Hawton KE, Bancroft JHJ. Psychiatric
morbidity and referral on two general medical wards. Br Med 
J 1974;1:268-70.
76. Snaith RP, Bridge GW, Hamilton M. The Leeds scales for the
self assessment of anxiety and depression. Br J Psychiatry 
1976;128:156-65.
77. Goldberg DP. Manual of the General Health Questionnaire.
Windsor: NFER Publishing Company, 1979.
78. Eysenck HJ, Eysenck SGB. Manual of the Eysenck personality
inventory. London: University of London Press, 1964.
79. Raven JC. Guide to using the Mill Hill vocabulary scale with
the progressive matrices scale. London: Lewis, 1958.
80. Kissen DM. The present status of psychosomatic cancer
research. Geriatrics 1969;24:129-37*
81. Peck DF. The conversion of progressive matrices and Mill Hill
vocabulary raw scores into deviation IQ’s. J Clin Psychol 
1970;26:67-70.
82. Kendell RE, DiScipio WJ. Eysenck personality inventory scores
of patients with depressive illnesses. Br J Psychiatry 
1968;114:767-70.
83. Coppen A, Metcalfe M. Cancer and extraversion. Br Med J
1963;11:18-9.
199
84. Armitage P. Statistical methods in medical research. Oxford: 
Blackwell Scientific Publications, 1971.
85. Siegel S. Nonparametric statistics for the behavioural
sciences. Tokyo: McGraw-Hill Kogakusha 1956.
86. Anonymous. User's Guide SPSS-X. New York: McGraw-Hill,
1983:601-21.
87. Norusis MJ. Advanced statistics guide. Chicago: Mcgraw-Hill/
SPSS Inc. 1983, 11-71.
88. Cooper JE, Copeland JRM, Brown GW, Harris T, Gourlay AJ.
Further studies on interviewer training and reliability of 
the present state examination (PSE). Psychol Med 1977;7: 
517-23.
89. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz
R. Diagnostic criteria for use in psychiatric research. Arch 
Gen Psychiatry 1972;26:57-63.
90. Metz CE. Basic principles of ROC analysis. Seminars in
Nuclear Med 1978;8:283-98.
91. Erdreich LS, Elisa TL. Use of relative operating
characteristic analysis in epidemiology. Am J Epidemiology 
1981;114:649-62.
92. Bridges KW, Goldberg DP. The validation of the GHQ-28 and the
use of the MMSE in neurological in-patients. Br J Psychiatry 
1986;148:548-53.
93. Hughes JE, Royle GT, Buchanan R, Taylor I. Depression and
social stress among patients with benign breast disease. Br 
J Surg 1986;75:997-9.
94. Morris T, Greer S, Pettingale KW, Watson M. Patterns of
expression of anger and their psychological correlates in 
women with breast cancer. J Psychosom Res 1981;25:111-7.
95. Wirsching M, Stierlin H, Hoffman F, Weber G, Wirsching B.
Psychological identification of breast cancer patients 
before biopsy. J Psychosom Res 1982;26:1-10.
96. Gottesman D, Lewis MS. Differences in crisis reactions among
cancer and surgery patients. J Cons Clin Psychol 
1982;50:381-8.
97. Hartsfield J, Clopton JR. Reducing presurgical anxiety: a
possible visitor effect. Soc Sci Med 1985;20:529-33.
98. Ray C, Fitzgibbon G. Stress arousal and coping with surgery.
Psychol Med 1981;11:741-6.
99. Gardecki TIM, Hogbin BM, Melcher DH, Smith RS. Aspiration
cytology in the pre-operative management of breast cancer. 
Lancet l980;ii:790-2.
100. Anonymous. Review of mortality results in randomised trials 
in early breast cancer (Editorial). Lancet 1984;ii:1205.
200
101. Cooper AF, McArdle CS, Russell AR, Smith DC. Psychiatric
morbidity associated with adjuvant chemotherapy following 
mastectomy for breast cancer. Br J Surg 1979;66:362.
102. Hughson AVM, Cooper AF, McArdle CS, Russell AR, Smith DC.
Psychiatric morbidity in disease-free survivors following 
radiotherapy and adjuvant chemotherapy for breast cancer: a 
2-year follow-up study. Br J Surg 198Q;67:370.
103. Palmer BV, Walsh GA, McKinna JA, Greening WP. Adjuvant
chemotherapy for breast cancer: side-effects and quality of 
life. Br Med J 1980;281:1594-7.
104. Maguire GP, Tait A, Brooke M, Thomas C', Howat JMT, Sellwood
R. Psychiatric morbidity and physical toxicity associated 
with adjuvant chemotherapy after mastectomy. Br Med J 
1980;281:1179-80.
105. Howell A, George WD, Crowther D, Rubens RD, Bulbrook RD, Bush
H, Howat JMT, Sellwood R, Hayward JL, Fentiman IS, Chaudary 
M. Controlled trial of adjuvant chemotherapy with 
cyclophosphamide, methotrexate, and fluorouracil for breast 
cancer. Lancet 1984;ii:307~ll.
106. Meyerowitz BE, Sparks FC, Spears IK. Adjuvant chemotherapy
for breast carcinoma: Psychosocial implications. Cancer
1979;43:1613-8.
107. Meyerowitz BE, Watkins IK, Sparks FC. Psychosocial
implications of adjuvant chemotherapy. A two-year follow-up. 
Cancer 1983;52:1541-5.
108. Knobf MK. Physical and psychologic distress associated with
adjuvant chemotherapy in women with breast cancer. J Clin 
Oncology 1986;4:678-84.
109. Cassileth BR, Knuiman MW, Abeloff, MD, Falkson G, Ezdinli EZ,
Mehta CR. Anxiety levels in patients randomised to adjuvant 
therapy versus observation for early breast cancer. J Clin 
Oncology 1986;4:972-4.
110. Silberfarb PM, Maurer LH, Crouthamel C. Psychosocial aspects
of neoplastic disease, I. Functional status of breast cancer 
patients during different treatment regimens. Am J 
Psychiatry 1980;137:450-5.
111. Neese R, Corli T, Curtis G, Kleinman P. Pretreatment nausea
in cancer chemotherapy: a conditioned response? Psychosom 
Med 1980;58:277-99.
112. Morrow GR. Prevalence and correlates of anticipatory nausea
and vomiting in chemotherapy patients. J Nat Cancer Inst 
1982;68:585-8.
113. Wilcox PM, Fetting JH, Nettlesheim KM, Abeloff MD.
Anticipatory vomiting in women receiving cyclophosphamide, 
methotrexate, and 5-FU (CMF) chemotherapy for breast 
carcinoma. Cancer Treat Rep 1982;66:1601-4.
201
11 4. Hughson AVM, Cooper AF. Psychological aspects of breast 
cancer and its treatment. Practitioner 1982;226:1129-35.
115* Pavlov IP. Selected works (trans. Belsky S). Moscow: Foreign 
Languages Publishing House, 1955:215-69.
116. Hopwood P. Measurement of psychological morbidity in advanced
cancer. In: Watson M, Greer S, eds. Psychosocial issues in
malignant disease. Oxford: Pergamon Press, 1983:35-10.
117. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C,
Zambetti M, Veronesi U. Ten-year experience with CMF-based 
adjuvant chemotherapy in resectable breast cancer. Breast 
Cancer Res Treat 1985;5:95-115.
118. Baum M, Priestman T, West RR, Jones EM. A comparison of
subjective responses in a trial comparing endocrine with 
cytotoxic treatment in advanced carcinoma of the breast. 
Eur J Cancer 1980;Suppl 1:223-6.
119. Devlen J, Maguire P, Phillips P, Crowther D, Chambers H.
Psychological problems associated with diagnosis and 
treatment of lymphomas. Br Med J 1987;295:953-7.
120. Powis G, Prough RA (eds). Metabolism arud action of anti­
cancer drugs. London: Taylor and Francis, 1987.
121. Borlson HL, McCarthy LE. Neuropharmacology of chemotherapy-
induced emesis. Drugs l983;23(suppl 1):8-17.
122. Mackay AVP. Neuropeptides and psychiatry. In: Granville-
Grossman K, ed. Recent Advances in Clinical Psychiatry, 
volume 5- Edinburgh: Churchill Livingstone, 1985:179-200.
123. Carney MWP. Serum folate values in 413 paychiatric patients.
Br Med J l967:±v:512-6.
124. Snaith RP, Mehta S, Raby AH. Serum folate and vitamin B12 in
epileptics with and without mental illness. Br J Psychiatry 
1970;116:179-83.
125. Shorvon SD, Carney MWP, Chanarin I, Reynolds EH. The
neuropsychiatry of megaloblastic anaemia. Br Med J 
1980;281:1036-8.
126. Coppen A, Abou-Saleh MT. Plasma folate and affective
morbidity during long-term lithium therapy. Br J Psychiatry 
1982;141:87-9.
127. Dykes EH, Sommerville RG, McArdle CS, Smith DC, Hole DJ.
Viral infection during chemotherapy for breast cancer. Br 
Med J 1985;290:1626-7.
128. Eysenck HJ. Extraversion and the acquisition of eyeblink and
GSR conditioned responses. Psychological Bull 1965; 
63:258-70.
129. Cook M. L&oels of personality. London: Holt, Rinehart and
Winston, 1984:61-78.
202
130. Forester BM, Kornfeld, DS, Fleiss J. Psychiatric aspects of
radiotherapy. Am J Psychiatry 1978;135:960-3.
131. Holland J, Rowland J, Lebovits A, Rusalem R. Reactions to
cancer treatment: assessment of the emotional response to 
adjuvant radiotherapy as a guide to planned intervention. 
Psychiatric Clin N America 1979;2:317-57-
132. Gazet J-C, Rainsbury RM, Ford FT, Powles TJ. Survey of
treatment of primary breast cancer in Great Britain. Br Med 
J 1985;289:1793-5.
133. Tobias JS. Radiotherapy and breast conservation. Br J 
Radiology 1986;59:653-66.
134. Fallowfield LJ, Baum M, Maguire GP. Effects of breast
conservation on psychological morbidity associated with 
diagnosis and treatment of early breast cancer. Br Med J 
1986;293:1331-4.
135. Hughes J. Emotional reactions to the diagnosis and treatment
of early breast cancer. J Psychosom Res 1982;26:277-83.
136. Psychological Aspects of Cancer Study Group. Psychological
responses to mastectomy. Cancer 1987;59:189-96.
137. Dean C. Psychiatric morbidity following mastectomy: pre­
operative predictors and type of illness. J Psychosom Res 
1987;31:385-92.
138. Kay D. Anxiety in the elderly. In: Noyes R, Roth M, Burrows
GD, eds. Handbook of anxiety. Volume 2: Classification,
etiological factors and associated disturbances. Elsevier 
Science Publishers,1988: 289-310.
139. Dean C, Chetty U, Forrest APM. Effects of immediate breast
reconstruction on psychological morbidity after mastectomy. 
Lancet 1983;i:459-62.
140. Sanger CK, Reznikoff M. A comparison of the psychological
effects of breast-saving procedures with the modified 
radical mastectomy. Cancer 1981;48:2341-6.
141. Steinberg MD, Juliano MA, Wise L. Psychological outcome of
lumpectomy versus mastectomy in the treatment of breast 
cancer. Am J Psychiatry 1985;142:34-9.
142. Schain W, Edwards BK, Gorrell CR, de Moss EV, Lippman ME,
Gerber LH, Lichter AS. Psychosocial and physical outcomes 
of primary breast cancer therapy: mastectomy vs excisional 
biopsy and irradiation. Breast Cancer Res Treat 1983;3: 
377-82.
143. De Haes JCJM, van Oostrom MA, Welvaart K. The effect of
radical and conserving surgery on the quality of life of 
early breast cancer patients. Eur J Surg Oncol 1986; 
12:337-42.
203
144. Gordon WA, Friedenbergs I, Filler L, Hibbard M, Wolf C,
Levine L, Lipkins R, Ezrachi O, Lucido D. Efficacy of 
psychosocial intervention with cancer patients. J Cons Clin 
Psychology 1930;48:743~59.
145. Maguire P, Tait A, Brooke M. Thomas C, Sellwood R. Effect of
counselling on the psychiatric morbidity associated with 
mastectomy. Br Med J 1980;281:1454-6.
146. Watson M. Psychosocial intervention with cancer patients: a
review. Psychol Med 1983;15:839-46.
147- Watson M. Counselling breast cancer patients: a specialist 
nurse service. Couns Psychology Quarterly 1988;1:23-32.
148. Aylard PR, Gooding JH, McKenna PJ, Snaith RP. A validation
study of three anxiety and depression self-assessment 
scales. J Psychosom Res 1987;51:261-8.
149. Lucas RW, Mullin PJ, Luna CBX, Mclnroy DC. Psychiatrists and
a computer as interrogators of patients with alcohol-related 
illness: a comparison. Br J Psychiatry 1977;151:160-7.
150. Lewis G, Pelosi AJ, Glover E, Wilkinson G, Stansfeld SA,
Williams P, Shepherd M. The development of a computerized 
assessment for minor psychiatric disorder. Psychol Med 
1988;18:737-45.
151. Snaith RP. Rating scales. Br J Psychiatry 1981;158:512-4.
152. Zigmond AS, Snaith RP. The hospital anxiety and depression
scale. Acta Psychiatr Scand 1983;67:361-70.
153. Derogatis LR. The psychosocial adjustment to illness scale
(PAIS). J Psychosom Res 1986;50:77-91.
154. Pruyn JFA, Maguire GP, De Haas JCJM. Two methods of measuring
some aspects of quality of life. In: Quality of life methods 
of measurement and related areas (Proceedings of the second 
EORTC workshop). Copenhagen: European Organisation for the 
Research and Treatment of Cancer, 1981:52-9.
155. Jones DR, Fayers PM, Simons J. Measuring and analysing
quality of life in cancer clinical trials. In: Aaronson NK, 
Beckmann eds. The quality of life of cancer patients. New 
York: Raven Press, 1987:41-61.
156. Morrow GR, Morrell C. Behavioural treatment for the
anticipatory nausea and vomiting induced by cancer 
chemotherapy. N Engl J Med 1982;5Q7:1476-80.
157. Redd WH. Control of nausea and vomiting in chemotherapy
patients. Postgrad Med 1984;75:105-13.
158. Tarrier N, Maguire P, Kincey J. Locus of control and
cognitive therapy with mastectomy patients: a pilot study. 
Br J Med Psychology 1983;56:265-70.
204
159. Maguire P. The recognition and treatment of affective
disorder in cancer patients. Int Peu Appl Psychology 
1984:33:479-91.
160. Greer St Moorey S. Adjuvant psychological therapy for
patients with cancer. Eur J Surg Oncology 1987;13:511-6.
161. Office of population censuses and surveys. Classification of
occupations. London: HMSO, 1970.
[GLASGOW
I UNIVERSITY 
[LIBRARY
205
PSYCHOSOCIAL EFFECTS OF TREATMENTS FOR BREAST CANCER: 
A TWO-YEAR FOLLOW-UP STUDY
Volume 2 (Figures, tables and appendices)
ANDREW VINCENT MARK HUGHSON, MB CHB, DPM, MRCPSYCH
A thesis in two volumes submitted for the MD degree of the 
University of Glasgow, based on research conducted in Glasgow at 
the Victoria Infirmary, Gartnavel General Hospital and the 
University Departments of Psychological Medicine and Clinical 
Oncology
May 1989
Volume 2 ©  A V Mark Hughson, 1989
FIGURE 2 - 1  —  D e s i g n  o f  t r i a l .  B a r s  r e p r e s e n t  t i m e s  o f  
a s s e s s m e n t s .  R = R a d i o t h e r a p y .  C = C h e m o t h e r a p y .  R+C = 
R a d i o t h e r a p y  p l u s  c h e m o t h e r a p y .
Months since mastectomy 
6 13 24
r ~ftEH"
R»C — J R -j- T Z F v p w
-HU II— H A - 4
FIGURE 2-2 —  Validation of soalas: orltarla for oasanass.
Depression
A nxiety
Under A ctiv ity
Depression
A nxie ty
Insomnia
Either score > 2 general health questio nn a ire  '(60 -item  and 28-item )
Score 2 — somatic symptoms
•severe depressionScore >. 2
Sum of scores 2 y -  anxiety  and insomnia
Routine upset
W ork/housework
Sum o f scores \ 2 > —social dysfunction
2
TABLE 3-1 —  Patient characteristics before surgery.
Cancer
(n=44)*
Benign
(n=47)*
Cholecystectomy
(n=30)*
Age at operation 
Mean (SD)
53.4 (11.0) 37.5 (11.2) 46.8 (12.6)t
Social class I+II 14 (31.8) 11 (23.4) 10 (33.3)t
Number {%) III 23 (52.3) 24 (51.1) 12 (40.0)
IV+V 7 (15.9) 12 (25.5) 8 (27.7)
Marital status Married 32 (72.7) 37 (78.7) 23 (76.7)t§
Number (%) Divorced 2 ( 4.5) 3 ( 6.4) 1 ( 3.3)
Widowed 7 (15.9) 2 ( 4.3) 2 ( 2.7)
Unmarried 3 ( 6.8) 5 (10.6) 4 (13.3)
Previous None 30 (68.2) 34 (72.3) 20 (66.7)til
psychiatric G. P. 10 (22.7) 10 (21.3) 10 (33.3)
treatment 
Number (%)
Psychiatrist 4 ( 9.1) 3 ( 6.4) 0 ( 0.0)
E.P.I. score Extraversion 10.9 (3.7) 10.7 (3.6) 12.1 (3.7)
Mean (SD) Neuroticism 9.6 (5.4) 11.5 (5.3) 10.3 (5-6)
♦For E.P.I. scores, numbers were 43, 42 & 26 respectively. tp<0.0001. 
$Not significant (X2 tests). §Married v. unmarried. I Some v. none.
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TABLE 3-2 —  Observer scales: numbers (percentages) scoring above 0.
Cancer
n=lili
Benign
n=47
Cholecystectomy
n=30
Rating 1 2 3 %>0 1 2 3 %>0 1 2 3 %>0
Depression 13 7 0 15 11 0 (55) 3 3 0 (20)*
Anxiety 23 7 1 (70) 24 15 0 (83) 16 3 0 (63)
Irritability 12 1 0 (30) 20 5 0 (53) 7 1 0 (27) t
Libido loss* 4 4 1 (29) 5 8 0 (35) 6 0 0 (26)
Lethargy 17 1 0 (HD 12 9 1 (47) 14 3 0 (57)
Social dysfunction 6 2 0 (18) 9 2 0 (29) 10 0 0 (33)
Inability to work 6 1 0 (16) 7 5 0 (26) 7 2 0 (30)
*p<0.01; tp<0.03 (for some V . no morbidity: X2 tests with 2 d.f. )
♦Married patients: sample sizes 31, 37 and 23 respectively.
TABLE 3-3 —  Scores on self rating scales.
Cancer
n=44
Benign
n=47
Cholecystectomy
n=30
Scale Median (inter­
quartile range)
Median (inter­
quartile range)
Median (inter­
quartile range)
General health 
questionnaire
6.5 (2-18) 14.0 (5-24) 11.5 (4-20)
Subscales
Somatic symptoms 4.0 (2-8) 5.0 (3-7) 7.0 (4-10)*
Anxiety & insomnia 6.5 (2-11) 10.0 (6-12) 7.0 (3-10)*
Social dysfunction 7.0 (6-8) 7.0 (7-10) 7.5 (7-10)t
Severe depression 0.0 (0-3) 1.0 (0-3) 0.0 (0-2)
Leeds depression 3.0 (1-6) 4.0 (2-8) Zl.O (3-6)
Leeds anxiety 6.0 (2-10) 8.0 (5-10) 6.0 (4-8)
*p<0.03; tp=0.05; *p=0.1 (Kruskal-Wallis analysis of variance)
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TABLE 3-4 —  Observe]? scales in breast biopsy patients: numbers
(percentages) scoring above 0, according to age.
Cancer Benign
Age a s
n=12
»46
n=32
a s
n=36
^46
n=ll
Rating >0 No (%) No (%) No (%) No (%)
Depression 7 (58) 13 (41) 17 (47) 9 (81)§
Anxiety 12 (100) 19 (59)* 30 (83) 9 (82)
Irritability 5 (42) 8 (25) 18 (50) 7 (64)
Libido loss 6 (60) 3 (14)t 11 (39) 2 (22)
Lethargy 5 (42) 13 (41) 17 (47) 5 (46)
Social dysfunction 2 (17) 6 (19) 4 (11) 7 (63)*
Inability to work 2 (17) 5 (16) 7 (19) 5 (45)
*P=0.013; tp-0.03; 
Yates’s correction),
*p=0.002 (Fisher tests) . §p<0.1 (X2 test with
TABLE 3~5 —  Scores on self rating scales, 
and interquartile ranges.
according to age: medians
Cancer Benign
Age a 5
n-12
^46
n=32
a s
n=36
^46
n=ll
Scale Median(IQR) Median (IQR) Median(IQR) Median(IQR)
General health 
questionnaire
4.0 (3-H) 5.5 (0-17) 13.0 (4-18) 15.0 (9-43)
Subscales
Somatic symptom 4.5 (2-6) 4.0 (2-8) 4.5 (3-7) 6.0 (4-11)
Anxiety & insomnia 10.0 (7-14)* 5.5 (2-10) 9.0 (5-12) 11.0 (9-16)
Social dysfunction 7.0 (6-8) 7.0 (7-8) 7.0 (7-9) t 10.0 (7-16)
Severe depression 0.5 (0-3) 0.0 (0-3) 0.5 (0-2) 3.0 (0-8)
Leeds depression 4.5 (3-6) t 2.0 (0-6) 3.0 (1-7) 6.0 (4-9)
Leeds anxiety 9.5 (7-12)§ 4.5 (1-7) 7.0 (4-9) 9.0 (5-12)
*p<0.03; tP<0.05; tpCO.07; §p<0.01 (Kruskal-Wallis ANOVA)
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TABLE 3-6 —  Spearman correlation coefficients between physical 
symptom scores and observer and self ratings in cholecystectomy 
patients.
Observer ratings Self ratings
Depression .27 General Health Questionnaire . 45t
Anxiety .26 Somatic symptoms .32
Irritability .35 Anxiety and insomnia .28
Libido loss .1191 Social dysfunction .21
Lethargy .52* Severe depression .01
Social dysfunction .58* Leeds depression .34
Inability to work .58* Leeds anxiety . 411
*p<0.01; tP<0.05
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TABLE 3 -7  —  Lower tr ia n g le  c o rre la tio n  m atrix in  breast cancer p atien ts  (n=44) (decimal points  
om itted)
1. 2. 3 . 4 . 5. 6. 7. 8. 9 . 10. 11. 12. 13. 14. 15.
1. Age
2. Social class 17
3 . M a rita l status 12 03
4 . R e lig . observance -2 7 * -08 -06
5 . Delay to  c l in ic 21 -02 -17 11
6. W aiting l i s t  time -02 -2 0 -23 -13 -0 3
7. Past med. h is to ry 3 5 | 23 12 03 -10 -12
8 . Past psych, h is to ry 14 13 19 -13 -13 -10 19
9. Breast oa. fam ily 24 16 -22 -11 13 -13 -17 -07
10. Breast ca. friends -18 16 -11 -02 -14 -16 02 -07 -0 3
11. School leaving age -05 -3 6 * 12 -05 -11 10 -2 4 23 -2 7 *  -1 6
12. Work -3 4 * -04 09 -20 -11 -1 3 -07 03 15 06 05
13. L iv ing  alone 37t 27* -5 9 | -04 -09 -07 -0 2 06 29* 27* -21 -1 5
14. GHQ-60 score -17 -05 01 07 -04 34* -10 05 04 -1 0 04 07 -13
15. Leeds depression -20 -07 21 15 11 23 -0 9 23
to1O1 28 * -01 -2 9 * 70t
16. Leeds anxiety -411 -06 11 07 -12 20 -09 22 -1 5  -1 0 30* 12 -2 6 * 72t 681-
#p<0.05; tp<0.01
TABLE 3-8 —  Results of multiple regression analysis after entry of 
two significant independent predictors
Variables entered: age; past psychiatric history*
Multiple R=0.50 R2=0.25
Adjusted R2=0.22
Analysis of variance
DF Sum of squares Mean square F P
Regression 1 131.10 131.10 8.689 .0052
Residual 4 2 633.69 15.09
B SE B Beta T P
Age -.175 .052 -.455 -3.335 .0018
Past psych. history 2.574 1.221 .288 2.108 .0412
Constant 14.592 2.830 5.157 .0000
Next variable nearest to entry into equation = time on waiting list, 
with p for entry of 0.10
*Absent coded 0; present coded 1
7
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FIGURE 4-1 --  Design of trial. Bars represent times of
a s s e s s m e n t s .  R = R a d i o t h e r a p y .  C = C h e m o t h e r a p y .  R+C = 
R a d i o t h e r a p y  p l u s  c h e m o t h e r a p y .
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FIGURE 4 - 2  —  P e r c e n t a g e s  o f  p a t i e n t s  w i t h  d e p r e s s i o n ,  
a n x i e t y  and b e h a v i o u r  u p s e t  on o b s e r v e r  s o a l e s .
Observer rated depression: scoring £1
Radiotherapy
(R)
Chemotherapy
<C>
Radio+chem
(RC)
Ho >1
Months 1 3  6
♦P<0.1 (Xz test with 2 df)
Observer rated anxiety: 'A scoring £1
60 i
Ho > i 
Months
tp<0.05 (X* test with 2 df)
Observer rated behaviour upset: ’A scoring £1
Ho *1  
Months
Jp=0.07 (Fisher exact test with groups C and RC combined)
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Figure 4-3 —  Percentages
general health questionnaire  
depression subscales.
GHQ 60-item: ‘A scoring £12
o f patients w ith morbidity on the  
and the anxiety/insomnia and severe
□  Radiotherapy (R)
Chemotherapy
■  Radio+chemo (RC)
X £12
Ho £12 
Honths
Anxiety/insomnia subscale: 'A scoring £7
50--
40--
X £7
30-
20-
10-
Ho £7 0--
Honths 1 3 6 13 18
Severe depression subscale: 'A scoring £3
X £3
40-
30--
20--
10- 
Ho £3 0._
Honths
rifj ji|h f^H
18 241 3 6 13
*P<0.03 (Fisher exact test with groups C and RC combined)
Figure 4-4 —  Percentages o f patients w ith morbidity on the Leeds 
depression and anxiety scales.
Leeds depression: X scoring £7
7. £7
40--
30--
20 - -
10- -
Ho £7 liJI liil liji o ttu OKI
18 24Honths 1 3 6 13
*P<0.03 (Fisher exact test with groups C and RC combined)
Leeds anxiety: X scoring £7
X £7
Ho £7 
Honths
50--
40--
30-
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10- -
0- -
r^fcrJI I
■  1.IWE
18 24
9
■ 
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FIGURE 4 -5  —  P e r c e n t a g e s  o f  p a t i e n t s  w i t h  u n d e r  a c t i v i t y ,  
r o u t i n e  u p s e t  and w o r k / h o u s e w o r k  p r o b l e m s  on o b s e r v e r  
s c a l e s .
Radiotherapy
(R)
Chemotherapy
(C)
Radio+chemo
(RC)
Observer rated under activity: V. scoring £1
y.n
Ho >1 
Honths
Observer rated routine upset: */. scoring £1
Ho £1 
Honths
*P<0.05 OP test with 2 df)
Observer rated (house)work problems: */. scoring 21
Ho 21 
Honths
10
■ 
I
D
FIGURE 4 -6  —  P e r c e n t a g e s  o f  p a t i e n t s  w i t h  m o r b i d i t y  on 
t h e  s o m a t i c  symptoms and s o c i a l  d y s f u n c t i o n  s u b s c a l e s  o f  
t h e  g e n e r a l  h e a l t h  q u e s t i o n n a i r e .
Radiotherapy
(R)
Chemotherapy
<C>
Radio+chemo
(RC)
FIGURE 4-7
Somatic symptom subscale: X scoring £7
Ho >7 
Honths
Social dysfunction subscale: 7. scoring £8
Ho £8 
Honths
Percentages of patients with loss of libido.
Observer rated loss of libido: X scoring ?1
70 
60 
50 
40
30
X £1 
'  20
10
Ho *1 0 .
Honths i 3 6 13 18 24
Sample M19J7 H19J7 MJ8J7 12 J8 J6 11 J5 H 9 J5 J4
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FIGURE 4 -8  —  P e r c e n t a g e s  o f  l a r g e r  c o h o r t  o f  p a t i e n t s  
w i t h  d e p r e s s i o n ,  a n x i e t y ,  b e h a v i o u r  u p s e t  o r  l o s s  o f  
l i b i d o  on o b s e r v e r  s c a l e s .
Depression: X £1 Anxiety: X £1
□  Radiotherapy (R)
^  Chemotherapy
■  Radio+chemo (RC)
X U
Ho >1 
Honths
60-
50-
40-
1
30- * m
20- i
10-
0- 9
*p=0.1; Tp<0.05 (X* tests with 2 df)
Behaviour upset: X £1 Loss of libido: X £1
Honths 13 18 24 13 18 24
FIGURE 4-9 —  Percentages of larger oohort of patients 
with morbidity on the general health questionnaire and the 
anxlety/lnsomnla and severe depression subsoales.
6HQ 60-item: X >12
X £12
50--
40--
30
2 0 - - . ,  
10-- Ell EllHo £12 fl 
Months 13 18 24
*p<0.05 (X* test with 2 df)
Anxiety/insomnia: */. £7 Severe depression: */. £3
Ho £ 
cut-off
Months
*P=0.01 <X* test with 2 df)
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FIGURE 4 - 1 0  —  P e r c e n t a g e s  o f  l a r g e r  c o h o r t  o f  p a t i e n t s  
w i t h  m o r b i d i t y  on t h e  Leeds  d e p r e s s i o n  and a n x i e t y  s c a l e s .
Leeds depression: 27 Leeds anxiety: X 27
□  Radiotherapy (R)
Chemotherapy
■  Radio+chemo (RC)
X 27
Ho >7
20 --
Honths 13 18 24
*P<0.04 (X2 test with 2 df)
FIGURE 4-11 —  Percentages of larger cohort of patients 
with under aotlvlty, routine upset and work/housework 
problems on observer soales.
Under activity: X 21 Routine upset: X 21
Ho 21 o
Honths 13 18 24
*P<0.02 (X2 test with 2 df)
(House)work problems: X 21
xn
Ho 21 
Honths
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FIGURE 4 - 1 2  —  P e r c e n t a g e s  o f  l a r g e r  c o h o r t  o f  p a t i e n t s  
w i t h  m o r b i d i t y  on t h e  s o m a t i c  symptoms and s o c i a l  
d y s f u n c t i o n  s u b s c a l e s  o f  t h e  g e n e r a l  h e a l t h  q u e s t i o n n a i r e .
Sosatic syraptofls: X. J7 Social dysfunction: X J8
j—| Radiotherapy
M  $f"ott’eraM
■  Radio+chemo (RC)
Ho J 
cut-off o 
Honths
*P=0.002 OP test with 2 df)
' ' v  • V-',. i  Vs,: .,sar,x:-.
, - ir'Z V.-\ -■
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TABLE 4 1 —  Patient characteristics (chemotherapy study).
Radiotherapy Chemotherapy Radio+chem
(n==24) (n==27) (n==23)
Age at operation 52.7 (12.3) 55.2 (11.2) 49.4 (10.
Mean (SD)
Social class I 1 (4) 0 2 (9)
Number (%) II 5 (21) 8 (30) 10 (43)
III 14 (58) 13 (48) 9 (39)
IV 3 (13) 4 (15) 1 (4)
V 1 (4) 2 (7) 1 (4)
Marital status Married 14 (58) 19 (70) 16 (69)
Number (%) Divorced 2 (8) 0 2 (9)
Widowed 5 (21) 6 (22) 2 (9)
Never married 3 (13) 2 (7) 3 (13)
Previous psychiatric None 16 (67) 21 (78) 14 (61)
treatment
G. P. 6 (25) 4 (15) 9 (39)
Number (%)
Psychiatrist 2 (8) 2 (7) 0
TABLE 4-2 —  Numbers of patients who refused further interviews or fur­
ther chemotherapy, relapsed, or died during study.
Treatment Radiotherapy Chemotherapy Combined treatment
Agreed to participate 24 27 23
Refused further interviews 1 5 0
Refused further chemotherapy 
(but not further interviews)
- 3 3
Recurrence Local 0 4 0
Systemic* 10 4 2
Died 9 3 3
*A few patients who developed 
be re-interviewed.
systemic relapse died before they could
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TABLE li-3 —  Numbers of patients receiving each type of treatment
during study.
Months since surgery Radiotherapy Chemotherapy Combined treatment
1 211 27 23
3 23 25 23
6 23 2 li* 23
13 211 2li* 22
18 I8t 21 20
2 li 1U 19 20
*Sample size one less for self 
depressed to complete thou. 
tSample size two less for self 
physically to complete thou.
rating scales as one patient felt too 
rating scales as patients felt too ill
TABLE ll-li —  Patient characteristics: 
13 months.
additional sample first seen at
Radiotherapy
(n-15)
Chemotherapy
(n-15)
Radio+chemo
(n-16)
Age at operation 
Mean (SD)
55.5 (9.9) 50.6 (11.8) 50.5 (9.0)
Social class I 0 0 0
Number (%) II li (27) 6 (A0) li (25)
III 8 (53) 7 (A7) 10 (63)
IV 0 1 (7) 1 (6)
V 3 (20) 1 (7) 1 (6)
Marital status Married 9 (60) 9 (60) 9 (56)
Number (%) Divorced 1 (7) 0 0
Widowed 2 (13) 1 (7) 3 (19)
Never married 3 (20) 5 (33) li (25)
Previous psychiatric None 
treatment
G.P.
Number (%)
Psychiatrist
11
3
1
(73)
(20)
(7)
12
3
0
(80)
(20)
11
3
2
(69)
(19)
(12)
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TABLE li-5 —  Numbers of patients receiving each type of treatment from 
13 months: combined cohort.
Months since surgery Radiotherapy Chemotherapy Combined treatment
13 36* 391 37
18 32* 35 36
2 li 27 31 35
Sample size two less for self rating scales as 
physically to complete them.
tSample size one less for self rating scales as 
depressed to complete them.
patients felt too ill 
one patient felt too
TABLE li-6 — Mean scores for physical symptoms
Months since surgery Radiotherapy Chemotherapy Combined treatment
1 0.2 0.2 0.3
3 3.2 3 .H 3.1
6 0.li * 3.8 3.6
13 0.7 * 3.7 3.8
18 1.3 t 0.3 0.3
2 li 1.0 0.1 0.3
*p<0.001; tp<0.1 (Kruskal-Wallis test on differences among groups)
TABLE li-7 —  Spearman correlation coefficients of ratings of mood with 
physical symptoms (total score and key individual symptoms).
Physical symptoms
Mood scales Total
score Nausea Vomiting
Mucous
Membranes Alopecia
Observer depression 0.22 0.21 0.35* 0.30 -0.10
Observer anxiety 0.12 0.22 0.37+ 0.32* -0.31*
GHQ Anxiety/insomnia 0.17 0.27 0.28 0.31* -0.29
GHQ Severe depression 0.25 0.20 0.31* 0.20 -0.09
Leeds depression 0.19 0.11 0.24 0.39+ -0.09
Leeds anxiety 0.11 0.07 0.11 0.39+ -0.17
*P<0.05; tp<0.02
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TABLE 4-8 —  Spearman correlation coefficients of ratings 
of mood with conditioned reflex symptoms.
Conditioned reflex
Mood scales Nausea Vomiting
Observer depression 0.33* 0.21
Observer anxiety 0.40* 0.35*
GHQ anxiety/insomnia 0.26 0.26
GHQ severe depression 0.31* 0.11
Leeds depression 0.36* 0.07
Leeds anxiety 0.37t 0.19
*P<0.05; tp<0.02
TABLE 4-9 —  Relationship of nausea, vomiting, and conditioned reflex 
(CR) nausea and vomiting.
Conditioned reflex (CR) symptoms
Drug-induced No CR symptoms CR nausea CR nausea+vomiting
symptom -------------  --------- -----------------
No No No
No nausea 7* It —
Nausea 3 3 —
Vomiting 6 9 17
♦Five of the seven stopped chemotherapy before 13 months 
tStopped chemotherapy at 9 months
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TABLE 4-10 —  Relationship between mood, nausea/vomiting, and condit­
ioned reflex nausea/vomiting.
Nausea or vomiting
Mean (SD) age 
Observer ratings
Depression
Anxiety
GHQ subscales
Anxiety/insomnia 
Severe depression 
Leeds depression 
Leeds anxiety
Score
0
n
0
n
Non-conditioned reflex 
(n-9)
53 (13)
No (%)
7 (78)
2 (22)
7 (78)
2 (22)
Median (inter­
quartile range)
H (2.5-5.5) 
0 (0-1.5)
2 (0.5-4)
2 (0-3.5)
Conditioned reflex 
(n-29)
50 (10)
No (%)
12 (41)
17 (59)
11 (38)
18 (62)
Median (inter­
quartile range)
6 (2-11.5)
1 (0-6)
4 (2-9.5)
4 (2.5-9)
*p<0.05; tP<0.02
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TABLE 5-1 —  Patient characteristics (radiotherapy study).
Age at operation 
Mean (SD)
Social class 
Number {%)
Marital status 
Number (%)
Previous 
psychiatric 
treatment 
Number (%)
E.P. I. score 
Mean (SD)
Verbal I.Q. 
Mean (SD)
I+II
III
IV+V
Married 
Divorced 
Widowed 
Never married
None
G.P.
Psychiatrist
Therapy 
None (n=39) Radio (n=47)
53.9(9.5)
15 (38.il) 
20 (51.3)
4 (10.3)
32 (82.0) 
1 ( 2.6)
5 (12.8) 
1 ( 2.6)
28 (71.8) 
10 (25.6) 
1 ( 2.6)
Extraversion 11.5 (3.8)
Neuroticism 9.9 (5.0)
30 (63.8) 
15 (31.9) 
2 ( ii.3)
51.1(11.5) n.s.
18 (38.3)
23 (48.9) n.s.
6 (12.8) 
30 (63.8)
4 ( 8.5)
7 (14.9) n.s.*
6 (12.8)
n. s. t
10.5 (3.3) n.s.
8.5 (5*4) n.s.
105-3 (11.5) 101.2 (11.2) n.s.
*X2 test on married versus unmarried. tXz test on seme versus none.
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TABLE 5~2 —  Comparisons between treatment groups on observer ratings
at one and three months: scores above 0.
Months since mastectomy
Score Score
Rating Therapy 1 2  3 %>0 n* pt 1 2  3 %>0 n* pt
Depression None 12 2 (37) 38 7 2 (24) 38
n.s. n.s.
Radio 14 3 1 (38) 47 12 2 (30) 46
Anxiety None 13 2 (39) 38 7 4 (29) 38
n.s. n.s,
Radio 8 5 3 (34) 47 7 4 (24) 46
Irritability None 34 4 (11) 38 32 5 1 (16) 38
n.s. n.s.
Radio 39 7 1 (17) 47 38 7 1 (17) 46
Libido None 4 5 5 (45) 31 5 3 3 (34) 32
n.s. n.s.
loss* Radio 3 4 9 (52) 31 2 6 7 (48) 31
Lethargy None 12 7 (50) 38 8 3 (29) 38
n.s. <0.001
(Under Radio 21 6 2 (62) 47 18 12 (65) 46
activity)
Routine None 12 2 (37) 38 6 2 (21) 38
n.s. <0.04
upset Radio 13 4 1 (38) 47 12 6 (39) 46
Inability None 14 9 (61) 38 10 1 (29) 38
n.s. n.s.
to work Radio 17 9 (55) 47 H  8 (37) 46
♦One Stage I patient could not attend the one month interview & another 
the three month; one Stage II patient refused the three month interview, 
fOne-tailed test comparing proportions with some and no morbidity. 
^Married/cohabiting patients only.
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TABLE 5_3 —  Comparisons between treatment groups at one and three
months: self rating scales
Months since mastectomy 1 3
Median (inter- Median (inter-
Scale Therapy quartile range) n* pt quartile range) n* pt
General health None 1.0 (1-12) 38 2.0 (0-8) 38
n. s. <0. 01
questionnaire Radio 5.0 (2-15) 17 IX. 0 (1-16) IX 6
Subscales
Somatic None 3.0 (1-5) 38 2.0 (1-5) 38
n. s. <0.05
symptoms Radio 3.0 (2-6) 1X7 IX. 0 (2-7) 16
Anxiety and None 3.0 (0-7) 38 IX. 5 (2-7) 38
n. s. n. s.
insomnia Radio 3.0 (1-7) 1X7 3.0 (1-7) 16
Social None 7.5 (7-9) 38 7.0 (7-8) 38
n.s. <0.07
dysfunction Radio 8.0 (7-10) 1X7 7.0 (7-10) 16
Severe None 0.0 (0-1) 38 0.0 (0-2) 38
n.s. n. s.
depression Radio 0.0 (0-1) 1X7 0.0 (0-1) 16
Leeds None 1.0 (0-3) 38 2.0 (0-IX) 38
n. s. n. s.
depression Radio 2.0 (1-5) 1X7 2.0 (0-5) 16
Leeds None 1.0 (1-7) 38 3.0 (1-7) 38
n. s. n. s.
anxiety Radio 3.0 (0-7) 1X7 2.0 (0-6) 16
*See Table 5-2
tOne-tailed probability using the Mann-Whitney U-test.
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TABLE 5-4 —  Comparisons between treatment groups on observer ratings
at six and 13 months: scores above 0.
Months since mastectomy 6 13
Score Score
Rating Therapy 1 2  3 %>0 n* pt 1 2  3 %>0 n* pt
Depression None 5 1 (16) 38 6 1 (19) 37
n.s. n.s.
Radio 1 1 1  (13) 23 2 1 (111) 21
Anxiety None 8 1 1 (26) 38 7 1 (22) 37
n.s. n.s.
Radio 2 2 1 (22) 23 1 2 (14) 21
Irritability None 3 (8) 38 2 (5) 37
n.s. n.s.
Radio 1 1  (9) 23 1 (5) 21
Libido None 6 2 (25) 32 6 1 1 (28) 29
n.s. n.s.
loss* Radio 1 4 (36) 14 1 3  (33) 12
Lethargy None 6 (16) 38 12 (32) 37
n.s. n.s.
(Under Radio 4 3 (30) 23 5 2 2 (43) 21
activity)
Routine None 5 (13) 38 4 1 (14) 37
n.s. n.s.
upset Radio 1 2 (13) 23 1 2  (14) 21
Inability None 3 (8) 38 2 2 (11) 37
n.s. n.s.
to work Radio 2 2 (17) 23 2 2 1 (24) 21
*Patients randomised to chemotherapy after three months excluded; one 
Stage I patient refused the 13 month interview; two Stage II patients 
died after six months.
tOne-tailed test comparing proportions with sane and no morbidity.
*Married/cohabiting patients only.
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TABLE 5-5 —  Comparisons between treatment groups at six and 13 months: 
self rating scales.
Months since mastectomy 6 13
Scale Therapy Median (inter- n* pt Median (inter- n* pt
quartile range) quartile range)
General health None 0.0 (0-4) 38 1.0 (0-12) 37
<0.04 n. s.
questionnaire Radio 2.0 (0-12) 23 0.0 (0-3) 19
Subscales
Somatic None 2.0 (1-4) 38 3.0 (2-6) 37
<0.04 n. s.
symptoms Radio 4.0 (1-8) 23 3.0 (1-5) 19
Anxiety and None 3.0 (1-6) 38 4.0 (2-8) 37
n. s. n. s.
insomnia Radio 3.0 (1-7) 23 3.0 (1-6) 19
Social None 7.0 (7-7) 38 7.0 (7-8) 37
n.s. n. s.
dysfunction Radio 7.0 (7-8) 23 7.0 (7-7) 19
Severe None 0.0 (0-1) 38 0.0 (0-1) 37
- n. s. n. s.
depression Radio 0.0 (0-0) 23 0.0 (0-0) 19
Leeds None 1.0 (0-3) 38 3.0 (1-5) 37
n. s. n. s.
depression Radio 2.0 (0-3) 23 2.0 (0-4) 19
Leeds None 2.5 (1-6) 38 3.0 (1-7) 37
n. s. n. s.
anxiety Radio 2.0 (0-6) 23 1.0 (0-3) 19
*See Table 5-4; also at 13 months two patients felt too ill to complete 
self rating scales.
tOne-tailed probability using the Mann-Whitney U-test.
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TABLE 5~6 —  Physical symptoms in treatment groups: median scores and
interquartile ranges
Months since
mastectomy 1 3 6 13
Therapy Median (IQR) n* Median(IQR) n* Median (IQR) n* Median (IQR) n*
None 0.0 (0-1) 38 0.0 (0-0) 38 0.0 (0-0) 38 0.0 (0-0) 37
t
Radio 0.0 (0-1) 47 3.0 (2-4) 46 0.0 (0-1) 23 0.0 (0-1) 21
*For explanation see Tables II to IV.
tpCO.0001 (one-tailed probability using the Mann-Whitney U-test).
TABLE 5-7 —  Spearman correlation coefficients between physical symptom 
scores and rating scales in radiotherapy patients at three months.
Observer ratings rho p* Self ratings rho p*
Depression .15 .33 General health questionnaire .19 .21
Anxiety .02 .87 Somatic symptoms .27 .07
Irritability .27 .07 Anxiety and insomnia .04 .77
Libido loss .17 .36 Social dysfunction .25 .09
Under activity .00 1.00 Severe depression .17 .27
Routine upset .58 .24 Leeds depression .14 .35
Inability to work .58 .11 Leeds anxiety .01 .96
^Two-tailed
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TABLE 6—1 —  Observer scales in benign group: scores above 0.
Months after 
surgery
Rating 
Depression 
Anxiety 
Irritability 
Libido loss* 
Under activity 
Routine upset 
Work problems
One
n=34
1 2 3 %>0
5 1 0 (18)
6 1 0 (21)
4 0 0 (12)
2 0 0 (8)
7 3 0 (29)
1 0 0 (3)
1 1 0 (6)
Three
n==34
1 2 3 %>0
6 0 0 (18)
6 1 0 (21)
2 0 0 (6)
1 1 0 (8)
6 1 0 (21)
3 0 0 (9)
2 0 0 (6)
n=30
1 2 3 %>0
2 1 0 (10)
4 0 0 (13)
2 0 0 (7)
1 0 0 (5)
4 1 0 (17)
1 0 0 (3)
2 0 0 (7)
*Married/cohabiting patients: sample sizes 26,26,22 respectively 
Changes in scores on all scales not significant (Cochran’s Q tests 
comparing sane versus no morbidity over the three time intervals).
TABLE 6-2 —  Self rating scales in benign group: median scores and
interquartile ranges
Months after One Three 13
surgery
n==34 n==34 n=30
Scale Median (IQR) Median (IQR) Median (IQR)
General health 
questionnaire
2.0 (0-7) 0.0 (0-6) 0.0 (0-1)
Somatic symptoms 4.0 (2-5) 2.0 (1-4) 0.0 (0-7)
Anxiety & insomnia 5-0 (2-6) 3.0 (1-7) 3.0 (1-7)
Social dysfunction 7.0 (7-7) 7.0 (7-7) 7.0 (7-7)
Severe depression 0.0 (0-2) 0.0 (0-1) 0.0 (0-1)
Leeds depression 1.5 (0-5) 1.5 (0-4) 1.0 (0-3)
Leeds anxiety 3.0 (1-7) 2.5 (0-5) 3.0 (0-7)
Changes in scores on all scales not significant (Friedman analysis of 
variance).
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TABLE 6-3 —  Benign breast group: correlations between age and scores 
on rating scales (n=3ii)
Rating Spearman rho Scale Spearman rho
Depression 0.07 General health 
questionnaire
-0.01
Anxiety -0.10 Somatic symptoms -0.21
Irritability 0.03 Anxiety & insomnia 0.01
Libido loss* 0.07 Social dysfunction -0.10
Under activity 0.20 Severe depression 0.08
Routine upset 0.31 Leeds depression 0.15
Work problems 0.34t Leeds anxiety 0.05
*Married/cohabiting patients only: 
tp=0.052
sample size=26.
TABLE 6-H —  Cholecystectomy patients at three months: 
between age and scores on rating scales (n=26*)
correlations
Rating Spearman rho Scale Spearman rho
Depression 0.08 General health 
questionnaire
0.05
Anxiety 0.15 Somatic symptoms O.OH
Irritability 0.12 Anxiety & insomnia 0.12
Libido losst 0.09 Social dysfunction 0.21
Under activity 0.17 Severe depression 0.06
Routine upset 0.15 Leeds depression 0.37
Work problems 0.26 Leeds anxiety 0.11
*Four of the original 30 patients refused to be seen after surgery, 
tMarried/cohabiting patients only: sample size=21.
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TABLE 6 -5  C lin ic a l depression and anxie ty  on observer scales in  cancer p atien ts : numbers, 
percentages and 95% confidence in te rv a ls  (C l) .
Months a fte r
mastectomy 1 (n=89) 3 (n=86) 6 (n=85) 13 (n=81) 18 (n=73) 24 (n=68)
Soore £2 No (%) Cl No (%) Cl No (%) Cl No (%) Cl No (%) Cl No (%) Cl
Depression 7  (8 )  2-14% 6 (7 )  1-13% 4 (5 ) 0-10% 6 (7 )  2-14% 1 (1 ) # 1 (2 )  *
Anxiety 13 (15) 8-22% 7 (8 )  2-14% 5  (6 )  1-11% 2 (2 )  *  4  (5 )  0-10% 1 (2 ) *
♦Percentages were too low fo r  v a lid  confidence in te rv a ls .
TABLE 6 -6  —  O bserver s c a le s  a t  one month: numbers o f  p a t ie n ts  w ith  m o rb id ity  and
p e rc e n ta g e s  w ith  c l i n i c a l  symptoms (s c o re  o f  2  o r  above)
M atched B enign Cancer
Age<50 Age £50
n=31 n=31 n=58
R a tin g 1 2 3 %£2 P* 1 2 3 %£2 P t 1 2 3 %£2
D epress io n 3 1 0 ( 3 ) 0 .0 0 3 15 2 1 (1 0 ) 0 .0 0 8 13 4 0 (7 )
A n x ie ty 4 0 0 (0 ) 0 .0 1 3 8 4 3 (2 3 ) 0 .0 7 11 5 1 (1 0 )
I r r i t a b i l i t y 3 0 0 (0 ) 0 .0 4 10 1 0 (3 6 ) 0 .0 1 6 0 0 (1 0 )
L ib id o  lo s s t 2 0 0 (0 ) 0 .0 0 1 7 7 6 (4 8 ) 0 .0 01 2 2 8 (2 4 )
Under a c t i v i t y 7 2 0 ( 7 ) 0 .1 4 12 3 1 (1 3 ) 0 .2 0 20 10 0 (1 7 )
R o u tin e  u pset 1 0 0 (0 ) 0 .0 0 1 12 2 1 (1 0 ) 0 .5 3 19 5 0 (9 )
I n a b i l i t y  to  work 1 0 0 ( 0 ) 0 .0 0 1 15 4 0 (1 3 ) 0 .5 7 18 20 1 (3 6 )
♦B en ign  compared w ith  cancer aged <50 y e a rs ; some versu s  no m o rb id ity .
tC a n c e r aged <50 y e a rs  compared w ith  cancer aged £50  y e a rs ; some versu s  no m o rb id ity .
tM a r r ie d /c o h a b it in g  p a t ie n ts  o n ly :  sample s iz e s  2 7 ,2 7 ,4 2  r e s p e c t iv e ly
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TABLE 6-7 —  Self rating scales at one month: median scores and
interquartile ranges
Matched benign Cancer
Age<50 Age£ 50
n=31 n=31 n=58
Scale Median (IQR) p* Median (IQR) pt Median (IQR)
General health 1.0 (0-4) 0.005 7.0 (2-23) 0.12 4.0 (1-11)
questionnaire
Somatic symptoms 4.0 (2-5) 0.62 4.0 (2-7) 0.29 3.0 (1-6)
Anxiety and 5.0 (2-6) 0.09 6.0 (2-11) 0.004 2.0 (1-6)
insomnia
Social dysfunction 7.0 (6-7) 0.005 8.0 (7-10) 0.82 8.0 (7-10)
Severe depression 0.0 (0-2) 0.52 0.0 (0-2) 0.23 0.0 (0-1)
Leeds depression 1.0 (0-4) 0.21 2.0 (0-5) 0.49 1.0 (0-4)
Leeds anxiety 2.0 (0-6) 0.08 5*0 (2-9) 0.03 2.5 (0-6)
♦Benign versus cancer aged <50 years, 
tCancer aged <50 years versus cancer aged £50 years.
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TABLE 6 -8  O bserver s c a le s  a t  th r e e  months: numbers o f p a t ie n ts  w ith  m o rb id ity  
and p erc e n ta g e s  w ith  c l i n i c a l  symptoms (s c o re  o f  2 o r above)
C holecystectom y Cancer
Age<50 Age £50
n:=26 n:=29 n=57
R a tin g 1 2 3 %£2 1 2 3 %£ 2 P* 1 2 3 %£2
D epress io n 5 3 0 (1 2 ) 8 4 0 (1 4 ) 0 .2 3 13 1 1 (4 )
A n x ie ty 6 2 0 ( 8 ) 9 3 1 (1 4 ) 0 .0 1 5 7 2 1 (5 )
I r r i t a b i l i t y 3 0 0 ( 0 ) 8 2 0 (7 ) 0 .0 0 3 4 0 0 (0 )
L ib id o  lo s s t 3 0 0 (0 ) 4 7 6 (4 8 ) 0 .0 0 7 4 3 6 (2 1 )
Under a c t i v i t y 10 5 0 (1 9 ) 6 8 0 (2 8 ) 0 .5 9 18 11 2 (2 3 )
R o u tin e  u pset 4 1 0 (4 ) 2 6 0 (2 1 ) 0 .3 5 16 6 1 (1 2 )
I n a b i l i t y  to  work 6 0 0 (0 ) 6 3 0 10) 0 .2 5 17 6 2 (1 4 )
KCancer aged <50 y e a rs  compared w ith  cancer aged £50 y e a rs ; some v .  no m o rb id ity  
fM a r r ie d /c o h a b it in g  p a t ie n ts  o n ly :  sam ple s iz e  2 1 ,2 7 ,4 3  r e s p e c t iv e ly
TABLE 6-9 —  Self rating scales at three months: median scores and
interquartile ranges
Cholecystectomy Cancer
Age<50 Age£50
n=26 n=29 n=57
Scale Median (IQR) Median (IQR) p* Median (IQR)
General health 
questionnaire
2.5 (0-10) 5.0 (0-23) 0.22 3.0 (0-11)
Somatic symptoms 2.0 (1-6) 11.0 (2-7) 0.73 a.o (2-7)
Anxiety/insomnia Zi.O (1-8) 6.0 (3-11) 0.003 3.0 (2-6)
Social dysfunction 7.0 (6-9) 7.0 (7-9) 0.Z18 7.0 (7-10)
Severe depression 0.0 (0-3) 1.0 (0-3) o.oa 0.0 (0-1)
Leeds depression 2.0 (1-ft) a.o (2-6) o.o a 2.0 d -a )
Leeds anxiety a .5 (0-5) ZI.O (2-9) 0.03 2.0 (0-6)
*Cancer aged <50 years versus cancer aged £50 years.
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TABLE 6 10 —  Observer* scales at six months: numbers of cancer
patients with morbidity and percentages with clinical symptoms 
(score of 2 or above)
Age A o Age £50
n=29 n=56
Rating 1 2 3 %>,z p* 1 2 3 %£2
Depression 6 3 0 (10) 0.01X6 5 1 0 (2)
Anxiety 9 2 0 (7) 0.085 7 2 1 (5)
Irritability 5 1 0 (7) 0.15 li 0 0 (0)
Libido losst 6 5 4 (33) 0.004 3 0 5 (12)
Under activity 10 2 0 (7) 0.31 12 5 0 (9)
Routine upset 7 2 0 (7) 0.37 10 1 0 (2)
Inability to work 4 1 0 (3) 1.00 8 2 1 (5)
*X2 test: some versus no morbidity.
TMarried/cohabiting patients only: sample sizes 27 and 42.
TABLE 6-11 —  Self rating scales in cancer patients at six 
months: median scores and interquartile ranges.
Age<50 Age£50
n==29 n==55
Scale Median (IQR) p* Median (IQR)
General health 
questionnaire
5.0 (0-14) 0.006 1.0 (0-5)
Somatic symptoms 4.0 (2-8) 0.02 3.0 (1-5)
Anxiety/insomnia 5.0 (1-10) 0.097 3.0 (1-6)
Social dysfunction 7.0 (7-9) 0.11 7.0 (6-8)
Severe depression 0.0 (0-2) 0.16 0.0 (0-1)
Leeds depression 2.0 (1-6) 0.27 2.0 (1-3)
Leeds anxiety 5.0 (2-9) 0.009 2.0 (0-4)
*Mann-Whitney test
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TABLE 6-12 —  Observer scales at 13 months: numbers of cancer
patients with morbidity and percentages with clinical symptoms
(score of 2 or above)
Age <50 Age >50
n=29 n-52
Rating 1 2 3 %>,Z P* 1 2 3 %>2
Depression 9 3 0 (10) 0.06 7 1 2 (6)
Anxiety 15 0 0 (0) 0.001 7 2 0 (4)
Irritability 5 2 0 (7) 0.01 4 0 0 (0)
Libido losst 5 4 6 (35) 0.12 4 2 3 (14)
Under activity 11 5 0 (17) 0.20 19 2 0 (4)
Routine upset 7 1 0 (3) 1.00 10 3 0 (6)
Inability to work 3 3 0 (10) 1.00 8 2 1 (6)
*Some versus no morbidity.
tMarried/cohabiting patients only: sample sizes 26 and 37.
TABLE 6-13 —  Self rating scales in cancer patients at 13 
months: median scores and interquartile ranges.
Age<50 Age>50
n==29 n=51
Scale Median (IQR) P* Median (IQR)
General health 
questionnaire
12.0 (0-20) 0.02 1.0 (0-5)
Somatic symptoms 5.0 (2-9) 0.06 3.0 (2-5)
Anxiety/insomnia 6.0 (3-11) 0.02 3.0 (1-6)
Social dysfunction 7.0 (7-10) 0.14 7.0 (7-8)
Severe depression 0.0 (0-3) 0.16 0.0 (0-1)
Leeds depression 4.0 (1-6) 0.19 2.0 (1-4)
Leeds anxiety 5.0 (2-8) 0.0 7 2.0 (1-5)
*Mann-Whitney test
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TABLE 6 14 —  Observer scales at 18 months: numbers of cancer
patients with morbidity and percentages with clinical symptoms
(score of 2 or above)
Age <50 Age £50
n*28 n=45
Rating 1 2 3 %£2 p* 1 2 3 %£2
Depression 8 0 0 (0) 0.06 3 1 1 (2)
Anxiety 8 3 0 (11) 0.04 6 1 0 (2)
Irritability 11 0 0 (0) 0.14t 1 0 0 (0)
Libido loss* 6 4 2 (23) 0.01 1 0 3 (10)
Under activity 7 3 0 (11) 0.22 8 1 0 (2)
Routine upset 3 2 0 (7) 0.85 6 0 0 (0)
Inability to work 3 1 0 (4) 0.74 3 1 0 (2)
*X2 (Fisher exactt) tests: some versus no morbidity. 
^Married/cohabiting patients only: sample sizes 26 and 31.
TABLE 6-15 —  Self rating scales in cancer patients at 18 
months: median scores and interquartile ranges.
Scale
Age<50 
n=28 
Median (IQR) P*
Age£50 
n=45 
Median (IQR)
General health 4.0 (0-12) 0.02 0.0 (0-4)
questionnaire 
Somatic symptoms 4.5 (2-8) 0.02 2.0 (1-5)
Anxiety/insomnia 5.5 (2-8) 0.03 3.0 (1-5)
Social dysfunction 7.0 (6-8) 0.88 7.0 (6-7)
Severe depression 0.5 (0-1) 0.09 0.0 (0-1)
Leeds depression 2.0 (0-4) 0.93 2.0 (1-3)
Leeds anxiety 4.5 (1-7) 0.07 2.0 (0-7)
*Mann-Whitney test
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TABLE 6 16 Observer scales at 2/i months: numbers of cancer
patients with morbidity and percentages with clinical symptoms
(score of 2 or above)
Age <50 Age »50
Rating 1
n=
2
25
3 %>,2. P* 1
n=
2
Zi3
3 %}2
Depression 5 0 0 (0) 0.56 Zi 1 0 (2)
Anxiety 8 1 0 (3) 0.0006 1 0 0 (0)
Irritability 1 0 0 (0) 1.00 1 0 0 (0)
Libido losst Zi Zi 1 (21) 0.15 2 0 3 (10)
Under activity 6 0 0 (0) 1.00 8 1 1 (5)
Routine upset Zi 0 0 (0) 1.00 Zi 2 0 (5)
Inability to work 2 0 0 (0) 1.00 2 2 0 (9)
*X2 tests: some versus no morbidity.
tMarried/cohabiting patients only: sample sizes 2/i and 30.
TABLE 6-17 —  Self rating scales in cancer patients at 2/1 
months: median scores and interquartile ranges.
Age<50 Age£50
n==25 n-Zi3
Scale Median (IQR) P* Median (IQR)
General health 
questionnaire
2.0 (0-7) 0.075 0.0 (0-Zi)
Somatic symptoms Zi.O (2-6) 0.51 3.0 (1-5)
Anxiety/insomnia 5.0 (2-8) 0.16 2.0 (1-6)
Social dysfunction 7.0 (7-8) 0.83 7.0 (7-7)
Severe depression 0.0 (0-2) 0.30 0.0 (0-1)
Leeds depression 2.0 (1-5) 0.72 2.0 (1-3)
Leeds anxiety 5.0 (1-8) 0.05 2.0 (0-6)
*Mann-Whitney test
3/i
TABLE 6-18 —  Numbers (percentages) resuming work.
Months after 
mastectomy 1 3 6 13 18 24
Score No (%) No (%) No (*) No (%) No (%) No (%)
Full-hours* 6 (17) 15 (44) 23 l\> 11 (79) 21 (78) 22 (88)
Reduced hours 1 (3) 2 (6) 4 (13) 3 (10) 0 (0) 0 (0)
Not back at work 29 (80) 17 (50) 5 (16) 6 (20) 6 (22) 3 (12)
Total 36 34 32 30 27 25
*See text.
•*'- *K7 -P*- : ^  ■ r/:>;
•7 -n n ■•■.k
; v ,  ■!& ■ ’■*:■:■
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TABLE 6 -19  Lower tr ia n g le  c o rre la tio n  m atrix in  79 cancer p atien ts  (deciaal points om itted)
1. 2 . 3. 4. 5 . 6. 7. 8 . 9 . 10. 11. 12. 13. 14.
1. Age
2 . Social class 16
3 . M a rita l status -3 6 t -12
4 . Religious observance -11 -19 -15
5 . Past medical h is to ry 23* 10 07 16
6 . Past p sych ia tric  h is to ry 15 12 00 -19 23*
7 . Breast cancer in  fam ily 27* 17 -12 -10 -08 -03
8 . Breast cancer in  friends -08 14 -09 -08 -01 00 09
9 . School leaving age -03 -4 0 t 04 05 03 27* -17 -0 8
10. Further education -16 -4 2 t 11 11 -13 -05 -12 23* 41t
11. Work -3 2 t 00 20 -15 02 00 -02 23* 01 13
12. Chemotherapy treatment -14 03 09 10 01 01 05 -02 07 08 04
13. 1 /12  GHG-60 score -2 8 * -2 6 * -04 04 -09 -0 8 -11 -0 2 10 17 02 09
14. 1/12 anxiety/insom nia -4 8 t -17 02 14 -16 -04
Ir -0 5 13 08 -0 3 11 81t
15. 1/12 severe depression -19 -12 -06 -04 -02 -01 -15 06 04 18 00 13 49t 451"
16. 1/12 somatic symptoms -17 -10 05 -08 -09 00 01 -0 8 00 06 -0 2 14 70t 581"
17. 1/12 socia l dysfunction -04 -2 5 * -14 -08 -06 -06 -02 -08 15 18 14 04 80t 5 1 |
18. 1 /12  Leeds depression -20 -12 09 04 -03 -11 -2 2 * -09 04 03 -17 11 67t 731"
19. 1 /12 Leeds anxiety -3 0 t -10 11 02 -08 03 -18 -1 0 15 05 -07 01 73f 791"
20. 13/12 GHQ-60 score -311 -15 19 11 10 03 00 -04 02 00 12 25* 26* 29t
21. 13/12 anxiety/insom nia -40T -10 19 10 -06 -03 -04 -02 09 -04 01 18 30t 481"
22. 13/12 severe depression -3 2 t -05 19 00 00 -02 -08 -16 -02 -09 11 19 12 25*
23. 13/12 somatic symptoms -24 * 00 14 15 06 04 00 00 08 -01 11 28* 19 20
24. 13/12 socia l dysfunction -12 -2 5 * 13 -04 12 01 01 02 07 06 13 19 24* 16
25. 13/12 Leeds depression -26 * -02 08 04 08 04 02 -14 -09 -2 1 * -02 21 26* 381"
26. 13/12 Leeds anxiety -3 3 f -11 09 00 -07 10 -08 -1 6 06 -05 02 08 25* 44t
27. Eysenck neuroticism -13 02 04 -16 -01 14 -06 -0 6 11 -17 -0 2 -06 421" 42t
28. Eysenck extraversion -12 01 29t -06 -12 -07 00 10 -21 01 09 01 -12 -14
29. Verbal IQ 21 -3 6 t -02 00 08 -0 5 10 10 34f 40t -0 5 -18 15 00
15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28.
15. 1 /12 severe depression
16. 1 /12 somatic symptoms 25*
17. 1 /12 socia l dysfunction 28* 60t
18. 1 /12  Leeds depression 58T 49t 37t
19. 1 /12  Leeds anxiety 40t 58 t 48 t 721"
20. 13/12 GHQ-60 score 25* 25* 10 39t 37t
21. 13/12 anxiety/insom nia 24* 39t 11 45f 47t 80 t
22. 13/12 severe depression 35t 12 04 3 6 | 23* 65 t 67T
23. 13/12 somatic symptoms 12 29t 14 17 28t 78 t 66T 38 t
24. 13/12 socia l dysfunction 22* 20 21 3 3 | 27t 80 t 58t 42 t 61t
25. 13/12 Leeds depression 36t 34t 13 54t 43t 72t 76 f 77t 48 t 51T
26. 13/12 Leeds anxiety 19 29t 15 34t 49t 63f 73 f 61t 49 t 42t 71 t
27. Eysenck neuroticism 32f 441- 30t 41 t 63T 341" 4 7 | 32 t 32t 23* 44t 571"
28. Eysenck extraversion -18 OS -1 7 -19 -12 00 03 01 -01 09 -12 -06 -08
29. Verbal IQ 07 -07 26* 00 -03 05 00 -05 02 05 -04 -02 02 -36
*p<0.05; tp<0.01 ( tw o -ta ile d )
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TABLE 6-20 —  Independent predictors of morbidity at 13 months after
mastectomy in 79 patients (GHQ-60 = 60-item General Health
Questionnaire).
Dependent variable Predictors Adjusted R2
GHQ-60 Leeds depression at one month; 
age
0. IB
Somatic symptoms Eysenck neuroticism; 
chemotherapy treatment
0.20
Anxiety/insomnia Anxiety/insomnia at one month 
Eysenck neuroticism; age
0.3/i
Social dysfunction Social class; Leeds 
depression at one month
0.13
Severe depression GHQ-60 score at one month; 
Leeds depression at one month; 
Eysenck neuroticism; age
0.29
Leeds depression GHQ-60 score at one month; 
Leeds depression at one month; 
Eysenck neuroticism; 
chemotherapy treatment
0.39
Leeds anxiety Eysenck neuroticism; 
age
0.37
TABLE 6-21 —  Independent predictors of morbidity at 13 months after 
mastectomy in 79 patients, after transformation of dependent variables. 
(GHQ-60 = 60-item General Health Questionnaire).
Dependent variable Predictors Adjusted R2
Loge (GHQ-60+1) Leeds depression at one month; 
Eysenck neuroticism; verbal 
intelligence quotient; age; 
chemotherapy treatment
0.3^
Loge (Somatic symptoms+1) Eysenck neuroticism; 
chemotherapy treatment
0.23
Loge (Social dysfunction+1) Social class; Leeds 
depression at one month; 
chemotherapy treatment
0.15
4/(Severe depression) GHQ-60 score at one month; 
Leeds depression at one month; 
Eysenck neuroticism; age
0.28
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TABLE 6-22 —  Regression equations to predict morbidity at 13 months.
Dependent v a r ia b le  untran sfo rm ed
A n x ie ty /in s o m n ia  = 6 .9 7  + .1 8 ( 1 /1 2  a n x ie ty /in s o m n ia )  + .2 6 (E y s e n c k  n e u ro t ic is m ) - .1 0 ( a g e )
Leeds d e p re s s io n  = 0 .3 7  + .6 1 ( 1 /1 2  Leeds d e p re s s io n ) + .1 8 (E y s e n c k  n e u ro t ic is m )
- . 0 7 ( 1 / 1 2  GHQ60 score  + 1 .1 1 (chem otherapy tre a tm e n t# )
Leeds a n x ie ty  = 5 .1 3  + .3 3 (E y s e n c k  n e u ro t ic is m ) - .0 8 ( a g e )
Dependent v a r ia b le  tra n s fo rm e d
Loge (GHQ-60 + 1 ) ~  - . 3 2  + .1 2 ( 1 /1 2  Leeds d e p re s s io n ) + .0 6 (E y s e n c k  n e u ro t ic is m ) - .0 4 ( a g e )
+ .74 (ch em o th erap y  tre a tm e n t# )  + .0 2 (v e r b a l  in t e l l ig e n c e  q u o t ie n t )
Loge (s o m a tic  symptoms +1) = .8 2  + .0 6 (E y s e n c k  n e u ro t ic is m ) + .45 (ch em o th erap y  tre a tm e n t# )
Loge ( s o c ia l  d y s fu n c tio n  + 1 ) = 2 .2 7  + .0 2 (1 /1 2  Leeds d e p re s s io n ) - . 0 9 ( s o c ia l  c la s s )
+ . 12(chem otherapy tre a tm e n t# )
4 /  (s e v e re  d e p re s s io n ) = 1 .0 2  + .1 1 (1 /1 2  Leeds d e p re s s io n ) + .05 (E ysen ck  n e u ro t ic is m )
- . 0 7 ( 1 / 1 2  Leeds a n x ie ty )  - ,0 2 ( a g e )
#The term  "chem otherapy tre a tm e n t"  can be re p la c e d  by i t s  code o f  1 .
3.,,' 2
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■ £ 1 ;  ■
- . . ^  "X  ■
•*J? '•
-V-: ; r : ' • —
t > , ■ •
. • • - '
I*
f f  . ■ -
X  - -r,l ■ :: - X  .
. .i- , -  •' ' 
: x " :
38
Figure 6-1 —  Histogram of standardized residuals for 60-item GHQ
Observed Expected SD
n n (* = i Case) (:. = Normal Curve)
1 .06 >3.00 *
1 .12 3.00 *
0 .31 2.67
0 .70 2.33 .
0 1.44 2.00
1 2.6 li 1.67 * .
7 4. 33 1.33 ***;***
6 6.37 1.00 *****;
3 8.39 .67 ***
4 9.90 .33 ****
12 10.46 .00 *********; Me*
17 9.90 -.33 ********** *******
16 8.39 -.67 ******** 4a|a|o|4a|B|E9K
8 6.37 -1.00 *****; **
2 4.33 -1.33 ** .
1 2.64 -1.67 * .
0 1.44 -2.00 .
0 .70 -2.33 •
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
Figure 6-2 —  Histogram of standardized residuals for somatic 
symptoms subscale.
Observed Expected SD
n n (* = 1 Case) (:. = Normal Curve)
1 .06 >3.00 *
0 .12 3.00
0 .31 2.67
1 .71 2.33 :
2 1.46 2.00 :*
3 2.67 1.67 **:
3 4.39 1.33 ***.
4 6.45 1.00 **** .
7 8.50 .67
7 10.02 .33 *******
13 10.59 .00 **********:**
10 10.02 -.33 *********:
14 8.50 -.67 *******:******
10 6.45 -1.00 *****.****
4 4.39 -1.33 ***:
1 2.67 -1.67 * .
0 1.46 -2.00 .
0 .71 -2.33 .
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
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Figure 6 3 Histogram of standardized residuals for severe
depression subscale.
Observed Expected SD
n n (* = 1 Case) (:. = Normal Curve)
2 .06 >3.00 **
0 .12 3.00
0 • 31 2.67
0 .70 2.33 #
4 l.lili 2.00 • ***
1 2.64 1.67 * .
1 k. 33 1.33 * .
0 6.37 1.00 .
5 8.39 .67 ***** .
17 9.90 .33 *********:*******
8 10. k6 .00 ******** .
18 9.90 -.33 ******************
11 8.39 -.67 *******:***
5 6.37 -1.00 *****.
6 4.33 -1.33 ***:**
1 2.64 -1.67 * .
0 1.44 -2.00 #
0 .70 -2.33 •
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
Figure 6-4 —  Histogram of 
dysfunction subscale.
standardized residuals for social
Observed Expected SD
n n (* = 1 Case) (:. = Normal Curve)
1 .06 >3.00 *
2 .12 3.00 **
0 .31 2.67
0 .70 2.33 .
0 1.44 2.00 .
2 2.64 1.67 **.
5 4.33 1.33 ***:*
0 6.37 1.00 .
4 8.39 .67 ****
10 9.90 .33 *********:
17 10.46 .00 *********;*******
16 9.90 -.33 *********:******
14 8.39 -.67 *******:******
3 6.37 -1.00 *** .
2 4.33 -1.33 ** .
1 2.64 -1.67 * .
2 1.44 -2.00 :*
0 .70 -2.33 .
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
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Figure 6-5 —  Histogram of standardized residuals for 60-item GHQ
after transformation by Naperian logarithms.
Observed Expected SD
n n (* = 1 Case)
0 .06 >3.00
0 .12 3.00
0 • 31 2.67
0 .70 2.33 .
3 1 .Ml 2.00 :**
5 2.64 1.67 **:**
6 k. 33 1.33 ***;**
2 6.37 1.00 **
8 8.39 .67 *******:
7 9.90 .33 ft******
10 10.46 .00 *********:
12 9.90 -.33 4Q|3|C^MQ|0|i9|!; $$
11 8.39 -.67 *******;***
4 6.37 -1.00 **** .
7 4.33 -1.33 ***;***
2 2.64 -1.67 Halt.
2 1.44 -2.00 : He
0 .70 -2.33 .
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
(:. = Normal Curve)
Figure 6-6 —  Histogram of standardized residuals for somatic 
symptoms subscale after transformation by Naperian logarithms.
(:. = Normal Curve)
Observed Expected SD
n n (* = 1 Case) <
0 .06 >3.00
0 .12 3.00
0 .31 2.67
0 .71 2.33 .
2 1.46 2.00 :*
2 2.67 1.67
7 4.39 1.33 ***:***
5 6.45 1.00 *****.
10 8.50 .67 *******:**
13 10.02 .33 H e * * * * * * * * :  * * *
6 10.59 .00 ******
9 10.02 -.33 *********.
10 8.50 -.67 H e * * * * * * ;  * *
6 6.45 -1.00 *****;
5 4.39 -1.33 ***: *
2 2.67 -1.67 **.
3 1.46 -2.00 :**
0 .71 -2.33 .
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
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Figure 6 7 Histogram of standardized residuals for severe
depression subscale after fourth root transformation.
Observed Expected SD
n n (* = 1 Case) (:. = Normal Curve)
0 .06 >3.00
0 .12 3.00
0 .31 2.67
1 • 70 2.33 :
3 1 .44 2.00 :
0 2,6k 1.67
7 k. 33 1.33 jfaMC; JMc$
6 6.37 1.00
7 8.39 .67
7 9.90 .33 *******
13 10.46 .00 *********; hs**
6 9.90 -.33 j*j|s****
11 8.39 -.67 *******:***
10 6.37 -1.00 Hu****; ****
5 4.33 -1.33 ***:*
3 2.64 -1.67 HSJjSj
0 1.44 -2.00 .
0 .70 -2.33 .
0 .31 -2.67
0 .12 -3.00
0 .06 <-3.00
Figure 6-8 —  Histogram of standardized residuals for social 
dysfunction subscale after transformation by Naperian logarithms.
Observed Expected SD
n n (Hs = l Case) (:. = Normal Curve)
0 .06 >3.00
0 .12 3.00
2 .31 2.67 **
1 .70 2.33 :
0 1.44 2.00 .
3 2.64 1.67 **:
2 4.33 1.33 ** .
3 6.37 1.00 *jfc* .
7 8.39 .67 *******.
13 9.90 .33 ***
17 10.46 .00 *********: ***jic***
12 9.90 -.33 *********: **
10 8.39 -.67 *******: **
4 6.37 -1.00 **** .
1 4.33 -1.33 * .
1 2.64 -1.67 * .
0 1.44 -2.00 .
1 .70 -2.33 :
1 .31 -2.67 *
0 .12 -3.00
1 .06 <-3.00 *
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Figure 7-1 -- ROC curves: GHQ-60 (e--») and GHQ-28 (
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Figure 7-2 —  ROC curves: somatic symptoms (•--• ) and
anxiety/insomnia (o o)
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7-3   ROC curves: social dysfunction (•--e) and
d e p r e s s i o n  ( o  o )
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TABLE 7 1 Correlation coefficients between observer ratings and 
general health questionnaire.
Self rating Observer rating (range) Spearman rho*
GHQ-60 Caseness (0-1) 0.72
GHQ-28 Caseness (0-1) 0.73
Somatic symptoms Under activity (0-3) 0.55
Anxiety/insomnia Anxiety/insomnia (0-6) 0.68
Social dysfunction Social dysfunction (0-6) 0.68
Severe depression Depression (0-3) 0.54
*p<0.001 for all coefficients
TABLE 7-2 —  Validity coefficients of 
threshold scores.
60--item GHQ at different
Threshold 10+ 11+ 12+ 13+ 14+ 15+ 16+ 17+ 18+ 19+ 20+
Sensitivity 100 100 100 100 100 100 100 100 93 93 87
Specificity 70 72 76 76 78 81 83 83 85 88 90
Threshold 21+ 22+ 23+ 24+ 25+ 26+ 27+ 28+ 29+ 30+ 31+
Sensitivity 87 87 87 87 87 87 87 80 73 73 73
Specificity 92 95 97 97 97 97 97 97 98 98 98
TABLE 7-3 —  Validity coefficients of 28-item at different threshold 
scores.
Threshold 4+ 5+ 6+ 7+ 8+ 9+ 10+ 11+ 12+ 13+ 14+ 15+
Sensitivity 100 100 100 100 100 100 93 87 80 80 80 73
Specificity 67 68 75 78 80 87 92 93 93 97 97 97
TABLE 7-4 —  Validity coefficients of subscales of the GHQ at
different threshold scores.
Threshold 1+ 2+ 3+ 4+ 5+ 6+ 7+ 8+ 9+ o + 11+ 12+
Somatic symptoms
Sensitivity 100 95 95 91 86 86 82 73 59 50 36 27
Specificity 4 17 24 36 51 70 74 83 87 89 94 96
Anxiety/insomnia
Sensitivity 100 100 100 96 91 91 83 78 70 70 61 43
Specificity 13 33 40 48 56 77 88 90 92 92 94 96
Social dysfunction
Sensitivity 100 100 100 100 100 100 96 89 70 56 52 48
Specificity 2 2 4 4 6 8 17 73 81 90 92 92
Severe depression
Sensitivity 86 86 86 71 71 64 50 43 36 21 7 7
Specificity 59 75 85 87 87 89 92 95 97 97 97 97
TABLE 7 -5  —  V a l i d i t y c o e f f i c i e n ts o f Leeds s c a le s a t d i f f e r e n t  th re s h o ld s c o re s .
T h res h o ld 0+ 1 + 2+ 3+ 4+ 5+ 6+ 7* 8+ 9+ 10+ 11+ 12+ 13+ 14+ 15+ 16+ 17+
Leeds depression
S e n s i t i v i t y 100 100 100 100 100 100 93 86 79 71 50 36 36 29 29 14 14 0
S p e c i f i c i t y 0 18 33 46 59 72 79 85 90 90 92 97 100 100 100 100 100 100
% F a ls e  p o s i t iv e 100 92 67 54 41 28 21 15 10 10 8 3 0 0 0 0 0 0
Leeds anxiety
S e n s i t i v i t y 100 100 100 100 86 86 86 86 57 57 57 57 43 43 29 14 14 14
S p e c i f i c i t y 0 18 28 44 57 65 76 79 84 84 84 88 93 97 97 100 100 100
% F a ls e  p o s i t iv e 100 82 72 56 43 35 24 21 16 16 16 12 7 3 3 0 0 0
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TABLE 7 6 Leeds depression and anxiety scales: correlations of 
total scores and item scores with observer ratings of mood.
Observer depression (0-3)
Self ratings Pearson jr Spearman rho
Leeds depression total score 0.75 0.77
Depression items
1. I wake early and then sleep 
badly for the rest of the night
0.47 0.46
3* I feel miserable and sad 0.71 0.69
5. I have lost interest in things 0.68 0.73
7. I still enjoy the things I 
used to
0.45 0.56
9. I feel life is not worth living 0.59 0.61
10. I have a good appetite 0.36 0.33
Observer anxiety (0-3)
Leeds anxiety total score 0.62 0.62
Anxiety items
2. I get very frightened or panic 
feelings for apparently no 
reason at all
0.48 0.43
4. I feel anxious when I go out 
of the house on my own
0.36 0.28
6. I get palpitations or a
sensation of ’butterflies* in 
my stomach
0.30 0.31
8. I feel scared or frightened 0.58 0.57
11. I am restless and can’t keep 
still
0.49 0.45
12. I am more irritable than usual 0.49 0.50
47
APPENDIX 1_:
OBSERVER SCALES
Copies of these scales were kindly provided by Dr Peter Maguire. 
Names of scales as supplied: Depressed mood, Anxiety/fears/worry, 
Under activity, Appetite, Sex, Sleep, Change in behaviour. Change 
in routine. Housework/work.
DEPRESSED MOOD
A. Crying
Feeling miserable
Looking miserable, unable to smile or laugh 
Feelings of hopelessness about the future 
Suicidal thoughts 
Suicidal attempt
Increased morbid interest —  not associated with worry
1 —  Minor
B. i) occasional crying
ii) occasional periods of feeling miserable, which is a clear 
departure from how the person normally looks, or 
occasionally complains of feeling miserable (should last 
more than 2 or 3 minutes and occur several times per day)
C.
2 —  Moderate
b. i) frequent crying (e.g. would burst into tears for no
apparent reason while watching T.V. These episodes occurred 
nearly every night, but interspersed with periods of 
appearing perfectly all right)
ii) frequently looks miserable —  rarely smiles or laughs and 
often complains of feeling miserable/unhappy for a week or 
more (e.g. for a whole week felt life had become **a real 
struggle’* and unable to smile or laugh)
iii) holds ideas of hopelessness about the future (but less 
strongly and persistently than ”3" —  see below)
iv) occasional serious suicidal ideas without plan (with other 
signs of depressive mood change) —  or minor self inflicted 
injury (not dangerous to life) e.g. scratching arms
3 —  Marked
B. i) continual or almost continual crying
ii) so depressed seems to have no feelings at all, shows no 
emotion in response to anything
iii) strongly holds ideas of hopelessness about the future,
or* aH  of the time; e.g. would prefer* to be dead, doesn’t 
want to get better —  believes there is no future and that 
nothing can help him
iv) depressive stupor
v) frequent suicidal ideas without plan (with other signs of 
depressive mood change); or occasional with plan (e.g. 
decided to attempt suicide —  planned to use potassium 
cyanide which was readily available in her laboratory —  
and took a flat by herself specifically for the attempt).
vi) suicidal attempt or serious self-inflicted injury (e.g. 
setting fire to clothes) with other signs of depressive 
mood change
C. Felt miserable and hopeless. Depression very marked in the 
morning, but present throughout the day. He cried at least 
twice a week in private. Unable to smile or laugh. Suicidal 
thoughts.
Complained future was bleak —  that there was no future. 
This feeling lasted longer than a week. Complained strongly 
of depression and she cried for part of every day. Felt the 
end was coming. Finally broke down in doctor’s surgery, 
saying she couldn’t go on living.
ANXIETY/FEARS/WORRY
A. Psychosomatic accompaniments 
Tenseness/anxiety 
Specific worry
Panic attacks 
Phobias
1 —  Minor
B. i) some increased anxiety, tenseness, specific worry anxious
worry (i.e. diffuse/free-floating), or one of its somatic 
accompaniments e.g. palpitations, cold sweats, recent 
unusual bowel irregularity, indigestion, headaches lasting 
for 2 or 3 days
ii) phobias which cause some anxiety unless avoids situation
C.
2 —  Moderate
B. i) very frequent (several times a week) worry, tenseness,
anxiety or one of above psychosomatic symptoms (e.g. had 
diarrhoea which remained constant for 12 weeks)
ii) infrequent acute attacks of worry tenseness or anxiety —  
but short of panic
iii) very infrequent panic attacks
k  9
iv) phobia(s) producing much anxiety unless avoids situation
C. Worried a lot about his Job and the possibility of failing. 
Had occasional diarrhoea, palpitations or sweating. Felt 
very tense and anxious —  paced up and down. Got rather 
anxious when having to meet people. Anxiety present most 
days of the week.
3 —  Marked
B. i) continual and severe tenseness, anxiety etc. (e.g. rigid
and nervous all week before admission)
ii) frequent and severe anxiety attacks (e.g. (1) on several 
occasions woke in the night and thought heart had stopped 
—  couldn't breathe (2) had several "bad turns” when 
thought going to have a stroke, felt faint, frightening 
thoughts went round in head. Felt something awful going to 
happen —  became ”all worked up”) N.B. Not panic attacks 
because not acted on
iii) panic attacks (unless very infrequent)
iv) phobias of such severity cause panic attack unless avoids 
situation
C. Complained of occasional diarrhoea, palpitations and 
sweating. Some worry and tenseness about his work. Became 
increasingly anxious about meeting people. On frequent 
occasions had to get up and leave room because he felt 
panicky.
UNDER ACTIVITY/RETARDATION
A. Slowness of thinking/speech 
Slowness of action i.e. retardation
Feeling tired/complains no energy/getting up late/falling
asleep in chair
Stupor
1 —  Minor
B. i) has occasional and unusual periods of tiredness
ii) some unusual difficulty in carrying on work or leisure
activity because of tiredness
iii) some unusual difficulty in getting up in the morning
iv) some trouble with muddled/inconclusive thinking but not due
to thought disorder
2 —  Moderate
B. i) frequently feels tired, several things are too much of an 
effort
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ii) stops carrying out several activities e.g. hobbies. Tends 
to sit around doing nothing or watching T.V. rather than be 
involved with usual interests
iii) or keeps on with usual work or leisure activities but finds
great difficulty in doing them as well a s   or at same
pace as used to
iv) great difficulty in getting up in the morning, often stays 
in bed later or goes to bed during day
C. After birth of baby felt very tired. Things became too much 
of an effort. Felt had no energy —  did things very slowly. 
Lost interest in knitting and crochet. Sat around doing 
nothing much of the time. But managed to keep on looking 
after baby (a high 2 —  nearly a 3)
3 —  Marked
B. i) almost everything becomes too much of an effort —  
continually feels tired
ii) stops practically all activities —  hobbies, work,
housework (practically all r81e functioning interrupted). 
Spends all time, or almost all time, sitting around doing 
nothing
iii) frequently stays in bed all day
DRIVE (APPETITE)
A. Appetite up 
Appetite down
N.B. Scale points differ from other scales in clinical section 
Nil = point 3 on scale
1 —  Minor (Point 2 or ii on scale)
B. i) some loss of appetite (e.g. felt a little "off” food: no
meal refusal, but ate slightly less)
ii) some increased hunger
2 —  Moderate (Point 1 or 5 on scale)
B. i) considerable loss of appetite
ii) considerable increase in appetite. Eats much more at, and 
in between meals
3 —  Marked (Point 0 or 6 on scale)
B. i) complete or almost complete refusal of food and/or drink
ii) eats all or almost all before him
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DRIVE (SEX)
A. Sex up 
Sex down
N.B. Scale points differ
Nil = 3 on 0 to 6 scale
1 —  Minor (Point 2 or k on scale)
B. i) some loss of interest in sex
ii) some increase of interest in sex
2 —  Moderate (Point 1 or 5 on scale)
B. i) considerable loss of interest in sex 
ii) considerable increase of interest in sex
3 —  Marked (Point 0 or 6 on scale)
B. i) complete or almost complete refusal of sex
SLEEP
A. Difficulty in getting off 
Waking early
Waking during night —  getting off again
1 —  Minor (where total sleep is not more than one hour less than
usual)
B. i) difficulty in getting off to sleep, waking up early, or
waking during night and getting off again
ii) some disturbance because of occasional nightmares
2 —  Moderate
B. i) total sleep usually 2 hours less than before (e.g. unable 
to get to sleep before 3 a.m. for over a week —  but as on 
holiday able to sleep much later in the mornings
ii) frequent nightmares
3 —  Marked
B. i) total sleep usually 3 hours less than before (e.g. (1)
complained that he lay awake for "hours" —  variable number 
—  before getting off to sleep. Also waking in early 
morning at about lx a.m. —  but eventually able to get back 
to sleep again. (2) awoke at about 5 a.m. each morning for 
12 weeks —  even though taking sedation —  and was unable 
to return to sleep)
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SOCIALLY UNACCEPTABLE BEHAVIOUR
A. Irritability 
Verbal attacks
Violence/destructive behaviour 
Odd/bizarre behaviour
1 —  Minor
B. i) increased irritability
ii) for women, crying occasionally in "public" i.e. before 
friend or close relatives
iii) minor infringements of social manners, causing some 
annoyance
iv) some screaming and shouting at home; verbal attacks on 
others if provoked
v) occasionally knocking things about in the house
vi) minor infringement of the law (shop-lifting, driving) on 
one occasion
2 —  Moderate
B. i) for men, crying occasionally in "public"; for women, crying 
often in "public"
ii) causing embarrassment by being rude or offensive, picking 
quarrels etc.
iii) frequent screaming and shouting at home. Frequent 
unprovoked verbal attacks
iv) occasional unprovoked physical attacks
v) "odd" behaviour (e.g. on 3 different occasions ran out of 
house and spent night in Waterloo Station)
vi) minor infringements of the law on several occasions, 
without apparent motive
3 —  Marked
B. i) for men, crying often in public
ii) falling out persistently with friends, relatives, 
neighbours
iii) frequent unprovoked outbursts of shouting and screaming in 
one day
iv) making physical attacks on others, with apparent intention 
of doing them serious harm
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v) very strange behaviour, e.g. partial undressing, urinating, 
walking naked etc. in public
vi) major offence without apparent motive
vii) done in public, serious self-inflicted injury (other
than suicidal attempt) such as burning of skin, pushing a 
hand through a window, etc.)
EFFECT ON DAY-TO-DAY ROUTINE
A. Being less talkative/not answering back
Avoids seeing friends and relatives/draws the curtains
loses interest in things (work, hobbies, family)/sitting
around doing nothing
Appearance
Decisions
1 —  Minor
B. i) slightly less talkative
ii) some decrease in desire to see/speak to friends, relatives 
etc.
iii) some decrease in pursuit of hobbies, leisure activities and 
accomplishments of usual Jobs around the house; or leaves 
them unfinished or not done properly
iv) some loss of interest in appearance
v) some difficulty in making decisions: affects usual activity 
to some degree —  e.g. avoids going shopping when can
2 —  Moderate
B. i) much less talkative than usual, frequently doesn’t answer 
when spoken to
ii) considerable decrease in desire to see/speak to friends, 
relatives etc. (e.g. (1) only occasionally consents to 
visit friends, then shows discomfort (2) often refuses to 
answer ’phone or doorbell)
iii) considerable decrease in pursuit of hobbies, leisure
activities and (for men) enthusiasm for doing Jobs around 
the house
iv) spends part of each day in bed (gets up very late, etc.)
v) considerable loss of interest in appearance (e.g. hair, 
shaving, washing, make-up)
5/1
3 —  Severe
B. i) extremely withdrawn and retarded, virtually at a standstill 
ii) neglect of self care
iii) loss of interest in all activities; shuns contact with 
people
IMPACT ON EMPLOYMENT (for men/women) & HOUSEWORK & CHILD CARE (for 
women)
A. Employment and/or housework/child care 
Impaired performance
Stopping work
1 —  Minor
B. Some fall-off in performance
2 —  Moderate
B. For employment or housework;
Definite fall-off in quality of performance or some time 
off/or amount done
3 —  Marked
B. Largely stopped activities
APPENDIX 2: 
RELIABILITY STUDY.
TABLE A2-1 — Inter-rater reliability for depression and anxiety
Rater Hughson
Cooper Depression Anxiety
Rating 0 1 2 3 Total 0 1 2 3 Total
0 10 1 0 0 11 9 0 0 0 9
1 1 2 0 0 3 0 3 1 0 IX
2 0 0 2 0 2 0 2 1 0 3
3 0 0 0 0 0 0 0 0 0 0
Totals 11 3 2 0 16 9 5 2 0 16
Kappa 0.74 0.68
TABLE A2-2 — Inter-rater reliability for irritability and loss
of libido
Rater Hughson
Cooper Irritability Loss of libido*
Rating 0 1 2 3 Total 0 1 2 3 Total
0 8 2 0 0 10 8 0 0 0 8
1 1 3 0 0 IX 0 1 0 0 1
2 0 0 2 0 2 0 0 0 0 0
3 0 0 0 0 0 0 0 0 3 3
Totals 9 5 2 0 16 8 1 0 3 12
Kappa 0.67 1.00
#Married/cohabiting patients only
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TABLE A2 3 I n't 02? rater reliability for1 under1 activity and
routine upset
Rater
Cooper
Hughson
Under activity Routine
Rating 0 1 2 3 Total 0 1 2 3 Total
0 3 0 0 0 3 12 0 0 0 12
1 0 6 1 0 7 0 2 0 0 2
2 0 1 5 0 6 0 1 1 0 2
3 0 0 0 0 0 0 0 0 0 0
Totals 3 7 6 0 16 12 3 1 0 16
Kappa 0.81 0.85
TABLE A2- 
insomnia
-li — Inter-rater reliability for (house)work and
Rater Hughson
Cooper (House) work Insomnia
Rating 0 1 2 3 Total 0 1 2 3 Total
0 9 0 0 0 9 9 0 0 0 9
1 0 2 0 0 2 1 1 0 0 2
2 0 1 2 0 3 0 1 2 0 3
3 0 0 0 2 2 0 0 0 2 2
Totals 9 3 2 2 16 10 2 2 2 16
Kappa 0.90 0.79
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A P P E N D I X  3 s
SELF RATING SCALES
GENERAL HEALTH QUESTIONNAIRE 
P le a s e  re a d  t h is  c a r e f u l ly
We sho u ld  l i k e  to  know i f  you have had any s e d ic a l c o s p la in ts ,  and how 
your h e a lth  has been in  g e n e ra l,  o ve r th e  p as t few weeks. P le a s e  answer 
ALL th e  q u e s tio n s  on th e  fo l lo w in g  pages s in p ly  by u n d e r lin in g  th e  answer 
w hich you th in k  most n e a r ly  a p p lie s  to  you. Resesber th a t  we want to  know 
about re c e n t  c o s p la in ts ,  no t tho se  you had in  th e  p a s t.
I t  i s  im p o rta n t th a t  you t r y  to answer ALL THE QUESTIONS.
Thank you v e ry  such f o r  your co--o p e ra tio n .
HAVE YOU RECENTLY
1. Been f e e l in g  p e r f e c t ly  w e ll B e t te r than Saae Uorse than Much
and in  good h e a lth ? usual as usual usual than
2 . Been f e e l in g  in  need o f a Not a t No sore R a th e r more Much
good to n ic ? a l l than  usual than  usual than
3 . Been f e e l in g  ru n  down and Not a t No more R ath er more Much
o ut o f  s o r ts ? a l l than  usual than  usual than
4 . F e l t  you a re  i l l ? Not a t  
a l l
No more 
than  usual
R a th e r more 
than  usual
Much
than
5 .  Been g e t t in g  any p a in s Not a t No more R a th e r more Much
in  you r head? a l l than  usual than  usual than
6 . Been g e t t in g  a f e e l in g  o f Not a t No more R a th e r more Much
t ig h tn e s s  o r p re s s u re  in a l l than  usual than  usual than
you r head?
7 . Been a b le  to  c o n c e n tra te B e t te r than Same as Less than Much
on w h atever y o u 'r e  doing? usual usual usual than
8 . Been a f r a id  you were Not a t No more R a th e r more Much
g o in g  to  c o lla p s e  in  a a l l than  usual than  usual than
p u b lic  p la c e ?
9 . Been h av in g  h o t o r c o ld Not a t No more R ath er more Much
s p e lls ? a l l than  usual than  usual than
10 . Been p e r s p ir in g  (s w e a tin g ) Not a t No more R ath er more Much
a lo t? a l l than  usual than  usual than
11 . Found y o u r s e lf  waking e a r ly Not a t No more R ather more Much
and u n a b le  to  g e t back a l l than  usual than  usual than
to  s le ep ?
12 . Been g e t t in g  up fe e l in g Not a t No more R ath er more Much
your s le e p  h a s n 't a l l than  usual than  usual than
re fre s h e d  you?
worse
usual
sore
usual
more
usual
more
usual
more
usual
more
usual
le s s
usual
more
usual
more
usual
more
usual
more
usual
more
usual
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13 . Been f e e l in g  to o  t i r e d  Not a t  No more R a th e r more Much more
and exhau sted  even to  e a t?  a l l  than  usual than  usual than  usual
14. L ost much s le e p  o ver Not a t No more R ath er more Much more
worry? a l l than  usual than  usual th a n  usual
15 . Been f e e l in g  m e n ta lly  a l e r t B e t te r  than Same as Less a l e r t Much le s s
and w ide  awake? usual usual than  usual a l e r t
16 . Been f e e l in g  f u l l  o f B e t te r  than Same as Less energy Much le s s
energy? usual usual than  usual e n e r g e t ic
17. Had d i f f i c u l t y  in  g e t t in g Not a t No more R ath er more Much more
o f f  to  s le ep ? a l l than  usual than  usual than  usual
18 . Had d i f f i c u l t y  in  s ta y in g Not a t No more R a th e r more Much more
a s le e p  once you a re  o f f? a l l than  usual than  usual than  usual
19 . Been h av in g  f r ig h te n in g Not a t No more R ath er more Much more
o r u n p le a s a n t dreams? a l l than  usual than  usual than  usual
oCM Been h av in g  r e s t le s s , Not a t No more R ath er more Much more
d is tu r b e d  n ig h ts ? a l l than  usual than  usual than  usual
2 1 . Been managing to  keep More so Same as R a th e r le s s Much le s s
y o u rs e lf  busy and occupied? than  usual usual than  usual than  usual
2 2 . Been ta k in g  lo n g e r o ver Q u icker Same as Longer than Much lon ge i
th e  th in g s  you do? than  usual usual usual than  usual
2 3 . Tended to  lo s e  in t e r e s t  in Not a t No more R a th e r more Much more
you r o rd in a ry  a c t iv i t i e s ? a l l than  usual than  usual than  usual
dCM Been lo s in g  in t e r e s t  in Not a t No more R a th e r more Much more
your p ers o n a l appearance? a l l than  usual than  usual than  usual
2 5 . Been ta k in g  le s s  t ro u b le More tro u b le About th e Less t ro u b le Much le s s
w ith  your c lo th e s ? than  usual same than  usual t ro u b le
2 6 . Been g e t t in g  o u t o f th e More than Same as Less than Much le s s
house as much as usual? usual usual usual than  usual
r-'CM Been managing as w e ll as B e t te r  than About th e R ath er le s s Much le s s
most p eo p le  would in most same w e ll w e ll
your shoes?
2 8 . F e l t  on th e  w hole you were B e t te r  than About th e Less w e ll Much le s s
d o in g  th in g s  w e ll? usual same than  usual w e ll
2 9 . Been l a t e  g e t t in g  to  work 
o r  g e t t in g  s ta r te d  on 
housework?
Not a t  
a l l
No l a t e r  
than  usual
R a th e r l a t e r  
than  usual
Much l a t e r  
than  usual
3 0 . Been s a t i s f i e d  w ith  th e  
way y o u 'v e  c a r r ie d  out
More
s a t is f ie d
About same 
as usual
Less
s a t is f ie d  
than  usual
Much le s s  
s a t is f ie d
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3 1 . Been a b le  to  f e e l  warmth B e t te r  than  About same Less w e ll Much le s s
and a f f e c t io n  fo r  those usu a l as usual than  usual w e ll
n e a r to  you?
3 2 . Been f in d in g  i t  easy to  
g e t on w ith  people?
B e t te r  
than  usual
About same 
as usual
Less w e ll 
than  usual
Much
w e ll
le s s
3 3 . Spent much tim e  c h a t t in g More tim e About same Less than Much le s s
to  peo p le? than  usual as usual usual than usual
3 4 . Kept f e e l in g  a f r a id  to  say Not a t No more R a th e r more Much more
a n y th in g  to  p eo p le  in  case a l l than  usual than  usual than usual
you made a fo o l o f  y o u rs e lf?
3 5 . F e l t  you a re  p la y in g  a More so Same
u s e fu l p a r t  in  th in g s ?  than  usual as usual
Less u s e fu l Much le s s  
than  usual u s e fu l
3 6 . F e l t  c a p a b le  o f  making More so Same as Less so Much le s s
d e c is io n s  about th in g s ?  than  usual usual than  usual cap ab le
3 7 . F e l t  y o u 'r e  ju s t  n o t a b le  Not a t  
to  make a s t a r t  on a l l
a n y th in g ?
No more R a th e r more Much more
than  usual than  usual than  usual
3 8 . F e l t  y o u r s e lf  d re a d in g  Not a t  No more
e v e ry th in g  you have to  do? a l l  than  usual
R a th e r more Much more 
th an  usual than  usual
3 9 . F e l t  c o n s ta n t ly  under Not a t  No more
s t r a in ?  a l l  than  usual
R a th e r more Much more 
than  usual than  usual
4 0 . F e l t  you c o u ld n 't  overcome Not a t  No more
your d i f f i c u l t i e s ?  a l l  than  usual
R a th er more Much more 
than  usual than  usual
4 1 . Been f in d in g  l i f e  a  Not a t  No more
s tr u g g le  a l l  th e  tim e?  a l l  than  usual
R a th e r more Much more 
than  usual than  usual
4 2 . Been a b le  to  e n jo y  your More so Same as Less so Much le s s
norm al day- to - day than  usual usual than  usual than  usual
a c t i v i t i e s ?
4 3 . Been ta k in g  th in g s  hard? Not a t  No more R a th er more Much more
a l l  than  usual than  usual than  usual
4 4 . Been g e t t in g  edgy and 
bad-tem pered?
4 5 . Been g e t t in g  scared  and 
p an ic k y  f o r  no good reason?
4 6 . Been a b le  to  fa c e  up to  
your problem s?
4 7 . Found e v e ry th in g  g e t t in g  
on to p  o f  you?
4 8 . Had th e  f e e l in g  th a t  peo p le  
w ere lo o k in g  a t  you?
4 9 . Been f e e l in g  unhappy and 
depressed?
Not a t  
a l l
Not a t  
a l l
More so 
than  usual
Not a t  
a l l
Not a t  
a l l
Not a t  
a l l
No more 
than  usual
No more 
than  usual
Same as 
usual
No more 
than  usual
No more 
than  usual
No more 
than usual
R a th er more Much more 
than  usual than  usual
R a th er more Much more 
than  usual than  usual
Less a b le  
than  usual
Much le s s  
a b le
R ath er more Much more 
than  usual than  usual
R a th e r more Much more 
than  usual than  usual
R a th er more Much more 
than  usual than usual
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5 0 . Been lo s in g  c o n fid e n c e  Not a t  No more
in  y o u rs e lf?  a l l  than  usual
R a th er more Much more 
than  usual than  usual
5 1 . Been th in k in g  o f y o u rs e lf  Not a t  No more
as a w o rth le s s  person? a l l  than  usual
R a th e r more Much more 
than  usual than  usual
5 2 . F e l t  th a t  l i f e  is  e n t i r e l y  Not a t  No more
h opeless?  a l l  than  usual
R a th e r more Much more 
than  usual than  usual
5 3 . Been f e e l in g  h o p e fu l about More so About same
y o u r own fu tu re ?  than  usual as usual
Less so Much le s s
than  usual than  usual
5 4 . Been f e e l in g  re a s o n a b ly  More so About same
happy, a l l  th in g s  than  usual as usual
c o n s id ered ?
Less so Much le s s
than  usual than  usual
5 5 . Been f e e l in g  nervous and Not a t  No more
s tru n g -u p  a l l  th e  tim e?  a l l  than  usual
R a th e r more Much more 
than  usual than  usual
5 6 . F e l t  th a t  l i f e  i s n ' t  w orth  Not a t  No more
l iv in g ?  a l l  than  usual
R a th er more Much more 
than  usual than  usual
5 7 . Thought o f  th e  p o s s ib i l i t y  D e f in i t e ly  I d o n 't
t h a t  you m ight make away n o t th in k  so
w ith  y o u rs e lf?
Had crossed  D e f in i t e ly  
my mind has
5 8 . Found a t  t im e s  th a t  you Not a t  No more
c o u ld n 't  do a n y th in g  because a l l  than  usual
your n erv e s  were to o  bad?
R ath er more Much more 
than  usual than  usual
5 9 . Found y o u r s e lf  w is h in g  you Not a t  No more
w ere dead and away from  a l l  than  usual
i t  a l l ?
R a th e r more Much more 
than  usu a l th a n  usu a l
6 0 . Found t h a t  th e  id e a  o f  D e f in i t e ly  I d o n 't
ta k in g  you r l i f e  k e p t n o t th in k  so
coming in t o  your mind?
Had crossed  D e f in i t e ly  
my mind has
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LEEDS SELF ASSESSMENT SCALES
P le a s e  in d ic a te  how you have been fe e l in g  in  th e  la s t  few weeks, by 
UNDERLINING th e  c o r re c t  response to  each o f th e  fo l lo w in g  i t e a s .
1. I wake e a r ly  and then  s le e p  Yes Yes No not
b a d ly  f o r  th e  r e s t  o f  th e  n ig h t  d e f i n i t e l y  s o a e tia e s  auch
2 . I g e t v e ry  f r ig h te n e d  o r p a n ic  Yes Yes No not
fe e l in g s  f o r  a p p a re n tly  no d e f i n i t e l y  s o a e tia e s  auch
reaso n  a t  a l l
3 .  I  f e e l  a is e r a b le  and sad
4 . I f e e l  an x io u s  when I go out 
o f th e  house on ay own
5 .  I  have lo s t  in t e r e s t  in  th in g s
6 . I  g e t  p a lp i t a t io n s  o r a 
s e n s a t io n  o f  'b u t t e r f l i e s '  in  
ay s to aach
7 . I  s t i l l  e n jo y  th e  th in g s  I 
used to
8 . I  f e e l  s c a re d  o r  f r ig h te n e d
9 . I  f e e l  l i f e  is  n o t w orth  l i v in g
1 0 . I  have a  good a p p e t i t e
11 . I  aa  r e s t le s s  and c a n ' t  keep  
s t i l l
1 2 . I as s o re  i r r i t a b l e  than  usual
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
Yes Yes No not
d e f i n i t e l y  s o a e tia e s  auch
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
No not 
a t  a l l
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A P P E N D I X  4 i 
PROFORMA
DATE SEEN:
NAME:
ADDRESS:
TELEPHONE:
GENERAL PRACTITIONER:
SURGEON:
PROJECT NUMBER: 
HOSPITAL NUMBER: 
DATE OF BIRTH: 
DATE OF OPERATION: 
AGE AT OPERATION:
DATE SEEN BY SURGEON:
RELIGION
Protestant=l
Catholic=2
Jewish=3
Other=Zj.
None=5
CHURCH ATTENDANCE
Frequent (more than once a month) =1 
Infrequent (less than once a month)=0
TIME FROM DISCOVERY OF BREAST TROUBLE 
TO BEING SEEN BY SURGEON (weeks):
TIME FROM OUTPATIENT CLINIC TO OPERATION (weeks):
PREVIOUS ILLNESS:
None/minor illness=0 
Significant illness=l
Examples of minor illnesses: influenza, uncomplicated 
appendicectomy, diagnostic dilatation and curettage of uterus.
Examples of significant illness: diabetes, symptomatic 
tuberculosis, major surgery
PREVIOUS PSYCHIATRIC HISTORY
None=0
Treatment from general practitioner only=l 
(E.g.:minor tranquillizers for "nerves”) 
Treatment from psychiatrist=2
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HISTORY OF BREAST DISEASE
Breast cancer in family: absent=0; presents 
Breast cancer in friends: absent=0; present=l
PERSONAL HISTORY 
School leaving age 
Minimum=l 
Minimum+1=2 
Minimum+2»3 
Minimum+3=/J. etc.
Further education 
None=0 
College=l 
University=2
CURRENT EMPLOYMENT (exact description)
None=0
Part-time=l
Full-time=2
PREVIOUS EMPLOYMENT
IF MARRIED, HUSBAND’S EMPLOYMENT (exact description)
SOCIAL CLASS:161 (1=1) (11=2) (111=3) (IV=Z!) (V=5): 
MARRIAGE
Presently married=l 
Divorced/separated=2 
Widowed=3 
Never married®/!.
Pregnancies (and number of surviving children):
Domestic situation 
Living alone=l 
Not living alone=0
Domestic roles, social activites, interests:
RECENT MEDICATION
Drugs before discovery of breast trouble:
Drugs since discovery of breast trouble:
Psychotropic drugs taken since discovery of breast trouble=l 
No psychotropic drugs taken since discovery of breast trouble—0
6U
MENSTRUAL STATUS
Periods in past two years: premenopausal=l 
No periods in past two years: postmenopausal=2
KNOWLEDGE EXPRESSED ABOUT POSSIBLE CANCER 
No clear statement=0
Indirect but clear reference to possibility of cancer=l 
(E.g.: "A friend had it - it went to her liver and she died”) 
Direct statement=2
(E.g.: used the word "cancer” or "malignant”)
SPONTANEOUS COMMENTS
APPENDIX 5:
REFUSALS, EXCLUSIONS AND LOSSES TO FOLLOW-UP
Refusals to take part in study
Stage II patients
Marital Social Further 
Age status class# treatment! Reasons given for refusal
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H7
US
Widowed
Married
Married
III
II
III
C
RC
RC
U0 Married IV RC
UU Married III RC
"I'm too nervous"
"I don’t like questionnaires"
No reason given. Subsequently this 
lady became depressed while on 
chemotherapy. Her general 
practitioner contacted her surgeon 
because of this, but she refused 
to see a psychiatrist.
"I’ve too much on my hands with 
the children and everything." This 
patient, who seemed very tense 
and defensive, subsequently 
defaulted from follow-up treatment.
"Enjoyed talking to you but I don’t 
want to take part." This patient 
seemed well adjusted and later to 
tolerate the treatment very well.
Stage II patients in additional cohort first seen at 13 months.
H9 II RC "I certainly don’t want to take
part." This patient was adamant 
she would have as little as 
possible to do with those treating 
her.
55 III RC Not known
♦Social class for refusals was usually obtained from information in 
the surgical case notes. It may therefore be slightly inaccurate.
tC=Chemotherapy; RC=Radiotherapy+chemotherapy.
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S t a g e  I  p a t i e n t s
Marital Social Further 
Age status class* treatmentt Reasons given for refusal
67 Married
64 Married
45 Married 
59 Married
II
III
II
III
"Don’t like questionnaires." Past 
history of nervous trouble treated 
by her GP.
No reason given, but friendly with 
immediately preceding patient.
"I don’t like surveys."
No reason given.
Patients with benign disease 
39 Married II
42 Married IV
"It’s very wrong that you’re seeing 
me and being a psychiatrist."
"I’m too nervous". This patient, 
thought to have a large cancer, felt 
too upset to talk about anything. (In 
fact she had a giant fibroadenoma.)
Cholecystectomy group: no refusals.
Exclusions
Two patients, both in the benign group, had to be excluded. One could 
not speak English, and the other had mental handicap.
LOSSES TO FOLLOW UP
Stage II patients
Deaths: radiotherapy patients
Age
Marital
status
Social
class
Time last 
interviewed Comment
38 Married III 6 months
51 Widowed II 13 months
62 Married III 13 months Died of biliary carcinoma
41 Single III 18 months
63 Married IV 6 months
31 Married III 18 months
62 Divorced III 13 months At 13 months too ill for self
67
Marital Social Time last 
Age status class interviewed
43 Widowed IV 18 months
38 Married V 18 months
Deaths: chemotherapy patients 
66 Widowed IV 18 months
35 Married III 13 months
68 Widowed
Deaths:
66 Single
51 Married
39 Married
Deaths: Stage I patients
64 Married III Before
surgery
56 Married III 13 months
Comment
At 18 months too ill for self 
ratings
At 18 months too ill for self 
ratings
Died suddenly of myocardial infarct
patients
Died following surgery for primary 
cancer of transverse colon
Died following investigation 
of renal failure.
II 1 month
radiotherapy + chemotherapy 
II 13 months
II 6 months
III 13 months
Refusals to continue in study
Radiotherapy patients
Marital Social Time last 
Age status class interviewed
33 Divorced III 1 month
Chemotherapy patients 
43 Married III 18 months
63 Married III 13 months
Comment
Said she was "too nervous" to 
continue. Part of her nervousness 
stemmed from a very real delay 
in being notified of her 
radiotherapy appointment.
Seen briefly at one
year; said she was a lot better
Angry and in pain after developing 
spinal secondaries
Too depressed to continue. At 
six and 13 months was too depressed 
to complete self rating scales
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Marital Social Time last 
Age status class interviewed Comment
66 Married II 18 months Appeared to want to deny illness
58 Married III 3 months Said she was annoyed because her
husband's GP had stopped his 
clofibrate. Thought this was very 
wrong —  not pleased with doctors
59 Widowed V 1 month Limited intellect. Had great
difficulty with self rating scales. 
Didn't want any more of it.
Padiotherapy + chemotherapy patients 
None
Stage I patients
59 Married III 6 months
67 Married III 6 months
Patients with benign disease
Probably refused because didn't 
want to think about her illness. 
Relapsed at a year and died before 
18 months
Husband developed cancer of colon; 
patient felt it was too much all 
at once
30 Married III
115 Married V
39 Divorced III
32 Married III
19 Single IV
26 Married III
45 Married III
Before
surgery
Before
surgery
Before
surgery
Before
surgery
B e f o r e
s u r g e r y
3  m o n th s  
3  m o n th s
Husband didn't approve
Afraid that husband wouldn't 
approve
Living with parents; agreed to be 
seen in principle, but said that 
parents didn't like confidential 
surveys. It did not prove possible 
to arrange an interview.
On staff of hospital; 
understandably didn’t want to 
divulge confidential information 
to someone she might meet at work
"Nfc/ f a t h e r  d o e s n ' t  l i k e  s u r v e y s "
A p p e a re d  t o  b e  s t a y i n g  e ls e w h e r e ;  
n e v e r  a t  hem e
O s t e n s ib ly  im p o s s ib le  t o  f i x  
s u i t a b l e  t im e ;  o b v io u s l y  n o t  k e e n
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Marital Social Time last
Age status class interviewed
27 Married II 3 months
6k Widowed II 3 months
Cholecystectomy patients
H7 Married II Before
surgery
/ll Married V Before
surgery
53 Single III Before
surgery
61 Married II Before
surgery
Comment 
Moved house
Not well physically; family felt 
it would be too much for her
Would only agree to follow-up by 
post but didn’t return forms
No reason given
No reason given
Not keen to be seen at heme; 
husband ?has alcohol problem
Comment on refusals and losses to follow-up.
Had the missing data from refusals and losses to follow-up been 
available, would the results have been affected? The main positive 
finding in the thesis was an excess of psychological morbidity in 
patients treated with chemotherapy (alone or after radiotherapy). 
No stage II patient who received radiotherapy alone refused to 
take part. In the two chemotherapy groups, psychological factors 
appeared relevant in three of the five patients who would not 
participate. One felt too nervous to take part, another became 
depressed, and another probably had many psychosocial problems. 
Therefore, had scores for the five been available, it seems most 
unlikely that psychosocial morbidity would have fallen in the 
chemotherapy groups; indeed, it might well have risen.
On the other hand, a further five patients who received 
chemotherapy dropped out later. However, for three of them
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observer scores were available up to 13 months. One of the three, 
with a long history of endogenous depression, was unable to 
complete the self rating scales at 13 months; had she done so, she 
would undoubtedly have had very high scores. In the two cases lost 
before 13 months, the effect on scores is harder to Judge, but 
proportionately would have to be small. The 59 year-old lady of 
limited intellect seemed to cope surprisingly well with 
chemotherapy, according to the clinic staff.
The effect of the excess of deaths in the radiotherapy group on 
the conclusions is discussed in chapter 8.
In the stage I group, one of four the refusals had a known past 
history of treatment for nervous complaints. Again a significant 
reduction in morbidity in the stage I group seems unlikely, had 
scores for the four been available.
There were two refusals in the benign group before surgery. One of 
the two was spoken to only briefly, but showed very obvious 
distress. The other was seen at greater length, and was certainly 
somewhat anxious. Pre-operative morbidity in the benign group 
would not have fallen, had scores for the two been included.
Several patients in the benign group dropped out later: nine of 
the 39 intended to be followed up over a year. In particular, the 
level of morbidity in the benign group at 13 months might be 
questionable. After considering the previous ratings of the 
individual patients who dropped out, the author thought that 
morbidity in the benign group might have been marginally higher at 
13 months, but essentially the same at one month.
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In the cholecystectomy group the only problem was missing data for 
four of 30 patients at three months after operation. The pre­
operative 60-item general health questionnaire scores of the four 
were 0, 8, 9 and 26. The last of the four had an observer rating 
of one for anxiety (the high GHQ score partly reflected physical 
symptoms); the others showed no psychological morbidity. There was 
nothing to suggest that their post-operative scores would have 
been unusual.
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APPENDIX 6:
REACTIONS TO TREATMENT
At the six month interview, patients* opinions of adjuvant 
treatment were sought. The same question, **How do you feel about 
your treatment?** was asked of each patient. The following were the 
immediate verbatim replies, classified according to treatment 
received.
Radiotherapy-alone patients
**After I got the radiotherapy I felt very secure —  They’re going 
to give me checks. Then insecurity —  I don’t think anybody is 
bothering here. I’m just a number. I’ve seen so many different 
doctors.”
”1 found it very good.”
”1 think everybody did all they could. The team in radiotherapy 
were very nice and very kind.”
”1 think I’ve had wonderful treatment, son. I’ve been treated like 
a queen.”
’’Very good. Everything is very good. They were all very kind. It 
never really got me down.”
’’The only thing I always say... They were very kind and helpful.”
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"The operation's nothing, but radium's terrible —  mentally as 
well as physically. It’s a very severs treatment.”
”1 found it was all right. I didn’t find it bad. It was the 
travelling. It was awful in the bad weather.”
”1 felt bored by having to stay in hospital for three weeks —  it 
was awful to bear. I could have travelled with my son in the 
morning. The treatment itself was no problem.”
’’Very severe. It made me very nervous. The travelling to and fro 
and the big things on top of me. I said to somebody I’d go through 
the operation again but not the treatment.”
”It gets me down going back every time. The radiotherapy is the 
lesser of the evils. It’s very unpleasant but it’s better than 
chemotherapy...” [This patient had not undergone chemotherapy, but 
had observed the effects of chemotherapy on other patients.]
’’Horrible. I didn’t like the radium treatment at all. They don’t 
give you confidence. The machines go burst. I have a fear of 
radiation. I feel in this country they feel a little extra doesn’t 
matter.”
”It was a bit tiresome when I went but I felt quite good after it. 
I’d recommend anybody to go.”
’’It’s very rough on you.”
”1 could never go through that again. It terrified me. I had to 
get Valium. My nerves went for me. I got very scared. That Friday 
[her first day of treatment] that machine was iust like a monster 
to me. I was cold, shaky and crying. On Monday I couldn’t take it. 
As soon as I got up, my nerves started because I knew I had to go 
under that machine. The following Friday, I went under it but I 
was a total wreck. I had pins and needles all over me. I couldn’t 
relax at all.*’
”1 felt quite squeamish but otherwise it wasn’t too bad.”
’’Quite honestly, at the time, it’s quite traumatic to go through: 
the fear of the unknown. Once you have experienced it, it’s not 
too bad. It’s behind you in the past and life goes on.”
’’I’m glad it’s over. That’s all one can say about it. I hope it’s 
successful.”
”Well, I felt it was necessary and the treatment itself was 
nothing at all. My biggest problem was the vomiting.” [This 
patient’s radiotherapy had exacerbated a pre-existing oesophageal 
stricture.]
”Well, there’s really nothing in the treatment, but it’s the 
after-effects. It burned under my arm.”
’’That therapy... well, I was all right getting it.”
”1 was quite happy with the radiotherapy.
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Chemotherapy-alone patients
"It’s all right. Sometimes you’re sick with it, but you have no 
pain. I’ve lost weight. Last September I said to my husband, ’I’ll 
never go through with it.’ It’s better now. I’m looking forward to 
stopping the treatment. I’m counting the months.”
’’I’m not bad not so bad as some of them. I’ve often said I’m 
not going back. I think it would be foolish, now I’ve had all this 
done.”
”1 haven’t been back. I said I’m not taking any more. One 
injection and all my hair fell out. I thought they might have told 
me that. Two hours after each injection, I was flat on my back. My 
doctor had to give me injections for sickness. I stopped eating 
for two weeks: liquids only. I felt they could kill me. I said I’m 
taking a chance and I’m not having them. Having no hair was worse 
than getting over the operation. I couldn’t go outside the door 
for a month.”
”1 Just hate it. It would take very little to stop you going. You 
really have to push yourself to come.”
"Well, I don’t like it at all.”
”1 feel horrible about the treatment. I wish I didn’t have to take 
it. At the same time I’ll go through with it. The day after it, I 
say, ’That’s the last time. Til no take any mair’. I hate it."
"Ach well, it has the sort of side effects. I also appreciate it’s
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for my own good; so I’m perfectly willing to take the treatment. 
When you're feeling rough, you think to yourself, 'I wonder how 
much more I can take.’ ”
"You’ve dust got to take it: there’s nothing else for it. I hope 
everything is all right once I've finished the inductions. The 
cure is worse than the disease."
"I think the treatment has done me quite well. At first I felt I 
wouldnae go for it. It becomes part of your life. I say I dust 
have to go. I think it’s been quite good."
"I could put it lucidly. It makes me terribly ill. It makes me 
sick. The two weeks running of indections: that nearly kills me."
"You see, of course I don’t like the treatment because of the side 
effects, but I must suffer the side effects if the treatment is 
going to prevent any further trouble."
"It’s horrible."
"I don’t like the treatment: that’s one thing I don’t like."
"Well, I don’t really care for it. I feel if it’s necessary then 
that’s it. I used to think, *What will happen at the end of the 
indections?’ They’ll do their best, whatever it is."
"The indections make me feel very frightened."
"If I didn’t have a good husband or a good daushter. I couldn’t
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carry on with these injections. I’ve everything to live for. If I 
didn’t get these injections, it might be worse for myself. I know 
these injections are for your own good. See, so far as cooking 
meals... tomorrow they won’t have a cooked meal because I can’t 
stand the smell of it. See the night before... I get tensed up. I 
feel the taste of the injection going right up —  horrible 
sensation.”
”1 dread these days [injection days]. There is no other word. I 
suppose it’s because the whole thing is sort of humiliating as 
much as anything. The last three weeks I was sick with the thought 
of them. I thought I was a strong-willed person but there’s 
nothing I can do about it. It’s horrible. The sickness is horrible 
—  in front of a doctor and other women. On Thursday [the day 
after her injection] I have a day off. I crawl from the bed to the 
bathroom. But I am coping with them. Does that make sense? I’ll go 
on with them to the end of the course.”
”1 find this is a big thing, this waiting around. That to me is
the biggest bore of the whole lot. It’s like two weeks in the 
month. It involves really the day you go to hospital and the day 
after. I’m always sick. I’ve been told my scan is clear. I’m very 
thankful.”
’’Horrible. I wish I could stop it. When I was coming here, I 
thought it was a lot of tablets, and that was me finished. I do
hate it. I dread every Tuesday [day before injection].”
”As soon as I walk into the waiting room, you feel this terrible 
squeamishness coming on. At home, you think of it and you beco
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squeamish. Itfs tiresome and I’d sooner not have it. But every 
time my husband says it’s essential you have it. I could be a lot 
worse.”
"Well, I’m not fond of it actually, but, touch wood, compared with 
the other women. I’m not too bad, really. I get that squeamish 
feeling but I’ve not been sick.”
”1 know it’s got to be done but I don’t like it. Sometimes I’m 
awful depressed. It’s not me. I could Just sit and let the whole 
place fall about me."
"You want me to tell you? Absolutely horrible. I could put it 
stronger. I think the treatment is ghastly. Hellish."
"I’ve Just got to put up with it because I know it’s better safe 
than sorry. It’s reassuring. It’s always different people giving 
the treatment. Some are more expert than others at doing 
injections. They are always very kind and understanding."
Radiotherapy plus chemotherapy patients.
"It doesn’t make me feel any better, I can tell you. After the 
operation I felt a lot better. After three weeks, I was beginning 
to feel normal again, and thereafter I was back to square one."
"I suppose the injections were more successful than the 
radiotherapy. At the beginning of the injections I lacked energy. 
It’s not so bad now."
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”1 know it’s to do me good. I’m not shying away from it.”
’’It’s very debilitating and I'm very weak and unable to do 
anything. I’m sick and very exhausted. I start to recover on the 
Saturday.”
”1 can understand getting that radium treatment but the 
injections... I can’t see how they can make you better when they 
pull you down. I wouldn’t mind at all if it was definitely doing 
good. He [her surgeon] said it was in case there were any 
cancerous cells. I certainly don’t relish the idea of a whole year 
like this.”
”1 feel all right. The only thing I’m thinking about is it’s bound 
to do me good. I don’t like going for treatment. I’d rather go to 
the radiotherapy than to the injections. Definitely, yes.”
’’You ask yourself, ’Is it all worth it?* You don’t have a clue if
it’s doing you any good. When they turn round and say you should
have the injections, but they don’t really know, you begin to 
wonder about the treatment. When I’m feeling fine and I’m going to 
be made ill, I think I must be going daft in the head or 
something. But then you think, ’The doctors know best.’ ”
"What can you say about something which makes you feel pretty
miserable. It’s the length of time. Before you start it seems a
very long time. It doesn’t seem so long now."
"If this is got to be, I’ll just have to take it and suffer it. 
When you’re sick, you feel as if you are going to die. Th
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radiotherapy was a walkover compared with this.”
"AU right, really. I don't think I’ve got really anything to 
complain about. It’s Just going for the injections. Once I’m there 
I’m fine. The injections upset me more than the radiotherapy.”
”1 feel that it’s marvellous that I’m getting it. I really do. I 
know it’s helping me. It’s for my benefit, not for theirs. That’s 
the way I feel about it.”
"The treatment is so atrocious that it’s taken up all my thoughts. 
All my aggression has been taken up with the treatment. I think 
it’s the most atrocious thing that has been ever thought up. The 
effect is very distressing. Radiotherapy was over in three weeks. 
It’s much worse than the effects of radiotherapy."
"I hate it. Oh, I hate it. I dread it, doctor. I keep thinking 
they’ll say I don’t need 12 months. I Just hate it. I think it’s 
because of the sickness and weakness in my legs. Whenever you walk 
into the hospital... See the smell of the hospital: this treatment 
affects your sense of smell. Certain perfumes I now scunner at. 
Every fortnight after the treatment, I say to myself, ’How will I 
ever get through it?’ You feel you’re getting better and then 
you’re back to square one. The operation and the radiotherapy was 
a walkover to me, but this chemotherapy... It’s an awful 
afternoon. It’s a nerve-racking afternoon because you’re uptight 
before you go and you’re sick and vomiting going home.
”1 don’t like the injections. I’m frightened of the needle. I hate 
it. I didn’t like the radiotherapy but it wasn’t so bad."
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•Well at the present time it’s not too bad. This is my three week 
break in treatment. In my treatment week I’ve been dreadful: no 
energy at all and dizzy not dizzy —  my balance. I spent one 
and a half days in bed. I could Just sleep all the time. I haven’t 
been out this week because I couldn’t trust myself to keep my 
balance.”
TfI feel I’m getting better —  making a bit of progress. Sometimes 
after the injections I have a feeling of sickness."
"I didn’t feel frightened with the radiotherapy. I didn’t feel 
sick until the end. This treatment now is different. I’m 
terrified. Not about the actual side effects —  the sickness and
the vomiting -- but they have the most awful Job getting the blood
out of me and the drugs into me. That’s what really scares me."
"I’m fine with chemotherapy. The biggest problem is a sort of 
nausea. The other thing is dry skin. It’s quite unpleasant. I'd 
say it’s easier than the radiotherapy." [This patient was one of 
only two receiving combined therapy who, at the six month 
assessmment, thought that chemotherapy was less unpleasant than 
radiotherapy. By the end of her chemotherapy, however, she had 
become clinically depressed, and thought chemotherapy was worse 
than radiotherapy.]
"I’ve no complaints —  nothing but the best attention from 
everyone. I had no problems with radiotherapy." [This patient 
should have received chemotherapy subsequently, but wasn t so 
informed until the day she was due to start treatment. She refused
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chemotherapy, partly because she hadn’t been warned about it, but 
mainly because she had heard of another patient who had 
experienced severe vomiting.]
f,It takes over your whole life. I don’t understand how it does. It 
does on occasion make you feel extremely depressed... I have never 
had this in my whole life. This seems a different thing entirely 
—  like a big black thing —  you couldn’t get out of it.’’
’’See when I go for these injections —  they ask me how I feel. I 
say fine. I could be dying. I could be dying but I say fine. I 
Just freeze. I Just want to get out... They smile and ask, ’How 
are you?* You think to yourself, ’You know bloody well how I feel, 
you bastard.’ I’d make them take the injections themselves and see 
how they like that. I wouldn’t feel sorry for them. They’re so
cheerful and you feel like saying, ’Go to hell. Get the f out
of here.* You’re feeling so bad... it’s a horrible feeling.”
”1 don’t try to think too much about it. I don’t like it. The
thing I feel about it is... I'm not ill; the treatment makes me
feel ill. If it wasn't for the treatment I’d be back at work.
Sometimes I feel it’s a lost year.”
’’Fine. I mean if it’s going to help me, I ought to take my
treatment —  if it’s going to prolong my life.”
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A P P E N D I X  7: 
ILLUSTRATIVE CASE HISTORIES
These histories, chosen mainly on the basis of positive features, 
illustrate ratings of morbidity.
Case not 003
Date first seen: 6 October 1977 (day before mastectomy).
Age at operation: 38.
Stage II breast cancer. Randomized to radiotherapy.
Married with three children aged 8, 13 and 16. Former severe 
alcoholic, totally abstinent over previous six years. Husband also 
recovered alcoholic. She now works as social work assistant. 
Member of Alcoholics Anonymous. Out at all hours to help 
alcoholics. Previous physical and mental health otherwise good. 
ffPretty happy-go-lucky” by nature. Good family life.
Pre-operative ratings: depression 0, anxiety 1, sex 3. behaviour 
1. Other ratings zero. GHQ-60 score: 21. Leeds depression score: 
6. Leeds anxiety score 10. Worry about possible loss of breast has 
caused total loss of interest in sex. Not worried about death per 
se; concerned about leaving children without mother.
One month interview. Very severe post-operative reaction. Ratings: 
depression 3, anxiety 3, under activity 3. sex 3, behaviour 2, 
routine upset 3» housework 2. GHQ—60 score: 5^-* Leeds depression 
score: 16. Leeds anxiety score: 11. Continual crying, spends all
& U
morning in bed, hardly sleeps at night. "When I came out of
hospital, all the props were removed. I was like a rag doll. I 
cried all the time for a solid week. I felt that my clothes were 
those of a dead person. I felt someone had died. The emotional 
thing was terrible... a fantastic feeling of fear... complete 
loneliness."
Three month interview, after radiotherapy. All ratings zero, 
except sex rating of 2 (definite loss of interest but beginning to 
pick up thanks to husband’s support). GHQ-60 score: 0. Leeds
depression score: 1 Leeds anxiety score: 0. "I’ve no fear of
whether anything may happen or not. Anything can happen to
anybody. It doesn’t worry me. I have faith in God —  a standby for
me." Being treated with radiotherapy had also given her a sense of 
security.
Six month interview. Again very emotional (depression 1, anxiety 
2, behaviour 2; GHQ-60 score U 9; Leeds depression 12, Leeds 
anxiety 9). Suspects (correctly) that has cancer in other breast. 
Missing support from radiotherapy unit. At surgical outpatient 
clinic feels she is "Just a number."
Hou) do you feel about your illness? "When I got the one breast 
removed, I felt very optimistic. Recently when I feared about the 
other one going, I felt I was doomed. The relatives I’ve had have 
died from cancer."
Hou) do you feel about the mastectomy? "It in no way bothers me as 
far as my appearance is concerned. I can go to parties and dances. 
I feel pretty repulsive as far as my sexuality is concerned."
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13 months. Has died in hospital, after second mastectomy and 
course of chemotherapy.
Comment. Despite past history of alcoholism, had been well 
adjusted emotionally before developing breast cancer. Some anxiety 
before surgery, but very severe emotional reaction immediately 
afterwards. Much calmer after radiotherapy, but then increasingly 
worried —  with good reason —  about recurrent disease. Her 
history shows that receiving treatment may reassure and reduce 
psychological morbidity.
Case nos 032
Date first seen: 26 February 1979 (one month after mastectomy).
Age at operation: 51.
Stage II breast cancer. Randomized to chemotherapy alone.
Married with two children aged 10 and 12. Works as part-time 
clerkess. Husband nurse and part-time chiropodist. Past history of 
thoracoplasty for tuberculosis. No other serious illness. Never 
had treatment for nervous complaints, but thinks she is a worrier. 
No family problems.
One month. Observer ratings: all zero. GHQ-60 score: 0. Leeds
depression score: 0. Leeds anxiety score: 0.
Three month interview (after two months of chemotherapy). Observer 
ratings: depression 1, anxiety 1, sex 1. Other observer ratings 
zero. GHQ-60 score: 7. Leeds depression score: 1. Leeds anxiety 
score: 5. Depressed last weekend and generally a bit worried.
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Gives another lady a lift to chemotherapy injections. "Taking her 
in the car depresses me; the minute I see her she feels sick. She 
talks all the time about illness. I told her she was lucky not to 
have had illness up till now... Sometimes you think about the 
injection and the nausea comes over you again. Butterscotch 
relieves the sickness." Not yet back at work, but wants back.
Six month interview. Back at work. ("The best thing I ever did.") 
Observer ratings; all zero except sex 1 ("not so important as 
before"). GHQ-60 score; 0. Leeds depression score; 1. Leeds 
anxiety score: 3. Vomiting before her chemotherapy injections as 
well as after them. "I get a rotten taste in my mouth... and the 
smell —  Just when you come in that door. Maybe next week Ifll try 
eau de Cologne..."
Hou? do you feel about your illness? "Well, I feel it was... the 
worst time was before going into hospital. If there was anything 
there it would be the major operation. Since then, after it’s all 
over, you realise it was nothing. It could be a lot worse... if 
they said there was nothing more they could do for you."
Hou? do you feel about the mastectomy? I don’t think about it too 
much. You’re given an appliance. You don’t really want to look at 
yourself... My husband said it was fortunate it was a neat wound. 
I don’t think it’s neat at all."
13 month interview (Just before last two chemotherapy injections). 
Observer ratings: depression 2, anxiety 1, sex 1, under activity 
1, behaviour 1, routine 1, housework 1. GHQ-60 score: 51. Leeds 
depression score: 9. Leeds anxiety score: 10. Still vomiting
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before and after injections. Takes perfume with her to counteract 
the smell of leather in the car, which makes her feel sick. Has a 
wig for hair loss. "After I saw Mr Mack for an X-ray recently I 
thought I had TB as well. I wished I would Just sleep away.” 
Occasional suicidal ideation. Pretty miserable much of the time. 
Very tired and run down. Rather tense and irritable. Sleeping 
badly: losing a couple of hours a night. Thinks she is eating too 
much: describes it as "comfort eating". On Triptafen Minor.
18 month interview (5 months off chemotherapy). All observer 
ratings zero. GHQ-60 score: 0. Leeds depression and anxiety
scores: both 1. Felt sick going back to chemotherapy clinic
recently. "Even the doctor’s white coat made me feel sick. I felt 
it coming in waves... but I feel better than I’ve felt for a long 
time... these injections... they really made me feel dreadful... I 
think it was going back to work which saved my life."
2k month interview. All observer ratings zero. GHQ-60 and Leeds 
anxiety scores both zero. Leeds depression score: 1. Still feels 
sick going up to the clinic. But generally well: "To come out of 
the Victoria and get a good report —  it’s like getting a pot of 
gold."
Comm&nt. Although she described herself as a worrier, her 
personality did not seem in any way unusual. Coped very well with 
mastectomy and early part of chemotherapy course. Severe 
conditioned reflex nausea and vomiting in second half of 
chemotherapy course, with conditioned nausea persisting during 
second year. Clinically depressed by the end of the chemotherapy 
course, recovering after chemotherapy was stopped.
88
Case no: 064
Date first seen: 26 June 1980 (one month after mastectomy).
Age at operation: H2.
Stage II breast cancer. Randomized to radiotherapy followed by 
chemotherapy.
Divorced, with son aged 21 and daughter aged 19. Left school at 
16. Later passed Higher English and took secretarial course. Now 
runs a large pub. Comes across as a competent and intelligent 
person. However, says she has always been bothered with depression 
and nerves, especially if under pressure, and has sometimes had 
treatment for nerves from her GP. No psychiatric referrals. 
Normally a sociable person who mixes easily. Good physical health 
in the past. Five years ago she had cosmetic surgery to enlarge 
both breasts (bilateral implants).
One month interview. Observer ratings. Depression 1, anxiety 0, 
activity 1, behaviour 0, routine 1, work 1. GHQ-60 score: 22.
Leeds depression score: 9. Leeds anxiety score: 1. Felt low and 
”down,? for a week during month after surgery. A bit tired after 
working and shopping. Went back to work one week after operation. 
Enthusiasm for work and leisure activities slightly impaired.
Three month interview. Observer ratings all zero. GHQ-60 score: 1. 
Leeds depression score: 2. Leeds anxiety score: 1. Moderate side 
effects of radiotherapy, mainly sickness, sore throat and skin 
reaction. However, coped well and continued working, albeit with
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some time off, despite treatment. Back full time now and doing 
everything as usual.
Six month interview. Observer ratings all zero. GHQ-60 score: 2. 
Leeds depression score: 2. Leeds anxiety score: k. Says she’s
fine with chemotherapy, though has slight nausea before as well as 
after injections. Thinks chemotherapy is less severe than 
radiotherapy (the only patient to think so at six months).
Hou) do you feel about your 'illness? ’’I’ll tell you the God’s 
truth, doctor. I don’t think about it. I just cut off. It’s my way 
of handling it. I just don’t think about it.”
Hou) do you feel about the mastectomy? ’’Again, doctor —  maybe 
mentally I just don’t think about it. It’s a terrible 
psychological thing —  an attack on femininity. I quite 
deliberately shut off. I’d be really upset. I’m hoping to have a 
reconstruction done.”
13 month interview. Observer ratings: depression 2, anxiety 1, 
activity 2, behaviour 1, routine 1, work 1. GHQ-60 score: ZJ3.
Leeds depression score 1U. Leeds anxiety score 111. Feeling very 
low. Quite definitely depressed. Sometimes pretty bad. Fleeting 
suicidal thoughts. Very little energy. GP has put her on ’’librium” 
at night because of poor sleep. Looks a different person compared 
with six months. Has lost her usual liveliness and enthusiasm. 
Seems withdrawn. Physically lacks lustre. Skin and hair look dry. 
Recognises a very definite change in herself, which she attributes 
to chemotherapy. Now thinks that chemotherapy is a lot worse than 
radiotherapy. Conditioned reflex nausea persists.
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18 month interview. Observer ratings all zero. GHQ-60 score: 1. 
Leeds depression score: 1. Leeds anxiety score: 0. ffIfm feeling
better than ever.” No further conditioned reflex nausea.
2ll month interview. Zero scores on all observer ratings, GHQ-60 
and both Leeds scales.
Comm&nt. This patient, though generally competent, recognised she 
had some underlying liability to depression and anxiety under 
stress. She showed a mild psychological reaction during the month 
after mastectomy, but at three and six months seemed to have 
recovered emotionally, perhaps by use of the mental mechanism of 
denial. But at the end of chemotherapy, she was clinically 
depressed. She made a complete recovery after chemotherapy was 
stopped.
Case no: 141
Date first seen: 25 July 1978 (day before mastectomy).
Age at operation: til.
Stage I breast cancer. No further treatment after mastectomy.
Married with three sons aged 9, 11 and 12. Eldest son has 
epilepsy, well controlled. Works as teacher —  happy enough but 
would prefer part-time work, which is not available. Also husband 
gave up dob as bank accountant after 25 years to Join a small 
shipping firm which then folded up. He is now out of work; this 
causes some worry. Otherwise no particular problems. She has had 
no serious illnesses and no psychiatric history. However, probably
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somewhat anxious by nature.
Pre-operative ratings: depression 0, anxiety 1, sex 2. Other
ratings zero. GHQ-60 score: 6. Leeds depression score: k. Leeds 
anxiety score 10. There has been a lot of uncertainty about the 
nature of the breast lump. Originally told it was "breast mouse", 
but now surgeon’s doubt has caused some increased anxiety, but no 
acute worry or panic.
One month interview. Ratings: depression 0, anxiety 2, under
activity 1, sex 2, behaviour 0, routine upset 1, housework 1. 
GHQ-60 score: 6. Leeds depression score: U. Leeds anxiety score: 
10. "The second day home was a panic day. In hospital it was a 
different atmosphere. I weathered it pretty well. A lady I know 
had a mastectomy two years ago. She couldn’t look at herself. I 
said, ’I’m not going to go home and find myself like that’.... On 
Thursday I really panicked. I couldn’t put my finger on anything. 
Fortunately the children were away and my husband was at home. 
He’s a very calm and reassuring person. It was a very unpleasant 
day. I felt I was losing my grip. It was a totally new experience. 
I practically took off. It was irrational." Worried about a mole 
on the side of her face. Might be something dreadfully wrong. 
Cried one day (not enough to rate a ”1" for depression).
Three month interview, Ratings: depression 0, anxiety 2, under
activity 1, sex 3« Other ratings zero. GHQ-60 score: 6. Leeds
depression score: 5* Leeds anxiety score: 13.
Now emerges that while in hospital she became friendly with 
another lady who also underwent mastectomy. Like herself, this
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lady had no further treatment, but died of lung involvement only a 
few weeks after discharge from hospital. Began to wonder why she 
herself had no further treatment. Thought it might mean that 
nothing further could be done for her. Became very anxious, 
acutely so at times, with sensations of breathlesses. Began to 
believe that breathlessness meant lung involvement. Entered 
viscious spiral of increased anxiety and breathlessness and had 
panic attack which forced her to go out of the room.
Six month interview. Feeling better. Back at work. Reassured about 
health by GP. Ratings: all zero except sex=l. GHQ-60 score 5;
Leeds depression score 5, Leeds anxiety score 9.
Hou? do you /eel about your illness? "I didn’t consider I was ill 
prior to it."
Hou? do you feel about the mastectomy? "The bulk of the time I 
don’t think about it."
13 month interview. Again somewhat anxious and also feeling low. 
"I started getting pains at the other side. The doctor says it’s 
tension." Observer ratings: depression 1, anxiety 1, activity 1, 
sex 1; remainder zero. GHQ-60 score: 2k. Leeds depression score 7. 
Leeds anxiety score 8.
18 month interview. Discomfort in other breast persists and had 
quite a lot of pain down other side and upper arm. "It’s worrying 
me." Had a panic attack which forced her to open the window and 
lean out because felt she couldn’t breathe properly. Less 
enjoyment of activities. Observer ratings: depression 0, anxiety
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2, sex 1, routine 1, remainder zero. GHQ-60 score: U. Leeds
depression score: H. Leeds anxiety score: 10.
2H month interview, "...up and down. When I started getting this 
pain off and on I really was a coward." Still a bit anxious and 
feels tired all the time, but doing everything. Observer ratings: 
depression 0, anxiety 1, activity 1, sex 1, remainder zero. GHQ-60 
score: 5* Leeds depression score: 7. Leeds anxiety score: 11.
Comment. Her history shows that not receiving further treatment 
may be misconstrued and cause anxiety leading to panic. She was 
seen as an outpatient only every six months, allowing fears about 
cancer to build up in between times. Might have been helped by 
counselling. GHQ scores often surprisingly low in view of observer 
ratings and Leeds anxiety scores. This is probably because she has 
an anxious personality and GHQ measures symptoms present more than 
usual rather than absolute levels.
APPENDIX 3 5
ITEM ANALYSIS OF GENERAL HEALTH QUESTIONNAIRE
ITEM GROUP 0
GHQ
1 2 3
Score
Gradient
1. Been feeling perfectly well Normal 14 69 la 3 17
and in good health? Mild 17 57 26 - 26
Case 6 19 50 25 75
2. Been feeling in need of a Normal 53 36 11 — 11
good tonic? Mild 30 17 48 n 52
Case 6 - 50 nn 94
3. Been feeling run down and Normal 53 no 8 — 8
out of sorts? Mild 9 35 57 - 57
Case 6 6 50 38 88
4. Felt you are ill? Normal 69 25 6 _ 6
Mild UH 30 26 - 26
Case 19 6 nn 31 74
5. Been getting any pains Normal 78 19 3 — 3
in your head? Mild 65 30 n - 4
Case 69 19 12 - 12
6. Been getting a feeling of Normal 86 in — — " 0
tightness or pressure in Mild 61 30 9 - 9
your head? Case 69 19 12 12
7. Been able to concentrate Normal 8 81 11 — 11
on whatever you’re doing? Mild 9 52 35 n 39
Case - 25 56 19 75
8. Been afraid you were Normal 89 8 3 — 3
going to collapse in a Mild 83 9 9 - 9
public place? Case 38 12 nn 6 50
9. Been having hot or cold Normal 39 n? 8 6 14
spells? Mild 35 30 26 9 35
Case 13 13 31 nn 75
10. Been perspiring (sweating) Normal 39 47 8 6 14
a lot? Mild 30 39 22 8 30
Case 6 38 19 38 56
11. Found yourself waking early Normal 53 39 8 - 8
and unable to get back Mild 17 52 26 n 30
to sleep? Case 13 31 31 25 56
12. Been getting up feeling Normal H7 ni 3 3 6
your sleep hasn’t Mild 17 n8 30 n 35
refreshed you? Case 19 56 25 81
13. Been feeling too tired Normal 83 17 - - 0
and exhausted even to eat? Mild 61 26 13 — 13
Case 50 13 25 13 38
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ITEM GROUP 0
GHQ
1 2 3
Score
Gradient
14. Lost much sleep over Normal 75 22 3 — 3
worry? Mild 57 26 17 - 17
Case 13 38 31 19 50
15* Been feeling mentally alert Normal 3 86 8 3 11
and wide awake? Mild 13 52 30 4 35
Case — 13 63 25 88
16. Been feeling full of Normal 11 64 22 3 25
energy? Mild - 26 61 13 74
Case - 13 50 38 88
17. Had difficulty in getting Normal 50 42 8 _ 8
off to sleep? Mild 22 48 30 - 30
Case 19 31 25 25 50
18. Had difficulty in staying Normal 64 31 6 — 6
asleep once you are off? Mild 26 52 22 - 22
Case 25 19 38 19 56
19. Been having frightening Normal 81 17 — 3 3
or unpleasant dreams? Mild 61 30 9 - 9
Case 63 19 13 6 19
20. Been having restless, Normal 72 22 6 — 6
disturbed nights? Mild 26 44 26 4 30
Case 13 13 50 25 75
21. Been managing to keep Normal 11 83 3 3 5
yourself busy and occupied? Mild 13 78 9 - 9
Case 6 44 44 6 50
22. Been taking longer over Normal 6 72 22 — 22
the things you do? Mild 4 48 44 4 48
Case - 13 75 13 88
23. Tended to lose interest in Normal 61 33 6 — 6
your ordinary activities? Mild 39 35 17 9 26
Case 13 19 31 38 69
24. Been losing interest in Normal 83 14 — 3 3
your personal appearance? Mild 44 26 26 4 30
Case 31 13 38 19 56
25. Been taking less trouble Normal 3 94 - 3 3
with your clothes? Mild 13 61 22 4 26
Case 6 50 25 19 44
26. Been getting out of the Normal - 92 8 - 8
house as much as usual? Mild 9 44 44 4 48
Case — 25 44 31 75
27. Been managing as well as Normal 17 83 - - 0
most people would in Mild 26 70 4 - 4
your shoes? Case 13 38 31 19 50
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ITEM GROUP 0
GHQ
1 2 3
Score
Gradient
28. Felt on the whole you were Normal 6 94 _ _ 0
doing things well? Mild 9 61 30 - 30
Case - 25 75 - 75
29. Been late getting to work Normal 39 53 8 _ 8
or getting started on Mild 17 48 30 4 35
housework? Case 13 19 63 6 69
30. Been satisfied with the Normal 8 89 3 — 3
way you've carried out Mild 4 70 22 4 26
your tasks? Case — 31 50 19 69
31. Been able to feel warmth Normal 19 81 — — 0
and affection for those Mild 26 70 4 - 4
near to you? Case 19 56 19 6 25
32. Been finding it easy to Normal 8 92 _ _ 0
get on with people? Mild 13 83 4 - 4
Case - 56 44 - 44
33* Spent much time chatting Normal 17 83 — — 0
to people? Mild 26 61 13 - 13
Case 6 38 44 13 56
34. Kept feeling afraid to say Normal 64 36 — _ 0
anything to people in case Mild 57 39 - 4 4
you made a fool of yourself? Case 44 31 19 6 25
35. Felt you are playing a Normal 3 89 8 - 8
useful part in things? Mild 4 74 22 - 22
Case — 31 44 25 69
36. Felt capable of making Normal 6 92 3 - 3
decisions about things? Mild 9 83 9 - 9
Case - 31 44 25 69
37. Felt you're Just not able Normal 44 53 3 - 3
to make a start on Mild 30 52 17 - 17
anything? Case 13 31 44 13 56
38. Felt yourself dreading Normal 72 25 3 - 3
everything you have to do? Mild 48 52 - - 0
Case 31 13 38 19 56
39. Felt constantly under Normal 64 28 8 - 8
strain? Mild 30 44 26 - 26
Case 6 6 75 13 88
40. Felt you couldn't overcome Normal 61 36 3 - 3
your difficulties? Mild 35 57 9 - 9
Case 6 38 38 19 56
41. Been finding life a Normal 58 39 3 - 3
struggle all the time? Mild 26 52 22 - 22
Case - 25 63 13 75
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ITEM GROUP 0
GHQ
1 2 3
Score
Gradient
H2. Been able to enjoy your Normal 3 9H 3 — 3
normal day-to-day Mild 4 70 22 H 26
activities? Case - 25 50 25 75
43. Been taking things hard? Normal 56 H2 3 _ 3
Mild 30 52 17 - 17
Case 6 19 63 13 75
Ml. Been getting edgy and Normal Ml 50 3 3 6
bad-tempered? Mild 17 H8 30 4 35
Case 19 - 69 13 81
45. Been getting scared and Normal 69 28 3 _ 3
panicky for no good reason? Mild Ml 30 17 9 26
Case 19 19 50 13 63
46. Been able to face up to Normal 3 97 _ _ 0
your problems? Mild 9 87 ll - 4
Case 13 31 Ml 13 56
H7. Found everything getting Normal 58 39 3 — 3
on top of you? Mild 22 61 17 - 17
Case 6 19 56 19 75
48. Had the feeling that people Normal 89 11 — — 0
were looking at you? Mild 83 9 9 - 9
Case 56 19 13 13 25
k9. Been feeling unhappy and Normal 75 22 3 - 3
depressed? Mild 26 39 35 - 35
Case — 6 81 13 9U
50. Been losing confidence Normal 78 19 3 - 3
in yourself? Mild 57 13 30 - 30
Case 25 6 Ml 25 69
51. Been thinking of yourself Normal 86 11 - 3 3
as a worthless person? Mild 70 17 13 - 13
Case Ml 31 6 19 25
52. Felt that life is entirely Normal 9H 3 3 - 3
hopeless? Mild 83 9 9 - 9
Case 38 31 25 6 31
53. Been feeling hopeful about Normal 17 81 - 3 3
your own future? Mild 13 83 4 - 4
Case 6 50 31 13 Ml
54. Been feeling reasonably Normal 11 86 3 - 3
happy, all things Mild 13 83 4 - 4
considered? Case — 31 56 13 69
55. Been feeling nervous and Normal 53 H7 - - 0
strung-up all the time? Mild 30 52 17 - 17
Case - 19 63 19 81
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GHQ Score
ITEM GROUP 0 1 2 3 Gradient
56. Felt that life isn’t worth Normal 9H 3 — 3 3
living? Mild 70 17 9 H 13
Case Ml 19 31 6 38
57. Thought of the possibility Normal 9U 3 3 _ 3
that you might make away Mild 91 H ll - H
with yourself? Case 56 19 19 6 25
58. Found at times that you Normal 86 11 3 — 3
couldn’t do anything because Mild 61 30 9 - 9
your nerves were too bad? Case Ml 19 38 - 38
59. Found yourself wishing you Normal 97 - - 3 3
were dead and away from Mild 83 9 U ll 9
it all? Case Ml 13 31 13 Ml
60. Found that the idea of Normal 9k — 6 — 6
taking your life kept Mild 87 9 ll - H
coming into your mind? Case Ml 19 31 6 38
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